2e - Volume 1
Tabular List, 2023
U.S. Department of Health and Human Services
Centers for Disease Control and Prevention
National Center for Health Statistics
INTRODUCTION
A classification of diseases may be defined as a system of categories to which morbid entities are assigned according to established criteria. There are many possible axes of classification and the one selected will depend upon the use to be made of the statistics to be compiled. A statistical classification of diseases must encompass the entire range of morbid conditions within a manageable number of categories.
The Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems is the latest in a series that was formalized in 1893 as the Bertillon Classification or International List of Causes of Death. A complete review of the historical background to the classification is given in Part 2a Instruction Manual (NCHS). While the title has been amended to make clearer the content and purpose and to reflect the progressive extension of the scope of the classification beyond diseases and injuries, the familiar abbreviation "ICD" has been retained. In the updated classification, conditions have been grouped in a way that was felt to be most suitable for general epidemiological purposes and the evaluation of health care.
Work on the Tenth Revision of the ICD started in September 1983 when a Preparatory Meeting on ICD-10 was convened in Geneva. The programme of work was guided by regular meetings of Heads of WHO Collaborating Centres for Classification of Diseases. Policy guidance was provided by a number of special meetings including those of the Expert Committee on the International Classification of Disease -Tenth Revision, held in 1984 and 1987.
In addition to the technical contributions provided by many specialist groups and individual experts, a large number of comments and suggestions were received from WHO Member States and Regional Offices as a result of the global circulation of draft proposals for revision in 1984 and 1986. From the comments received, it was clear that many users wished the ICD to encompass types of data other than the "diagnostic information" (in the broadest sense of the term) that it has always covered. In order to accommodate the perceived needs of these users, the concept arose of a "family" of classifications centred on the traditional ICD with its familiar form and structure. The ICD itself would thus meet the requirement for diagnostic information for general purposes, while a variety of other classifications would be used in conjunction with it and would deal either with different approaches to the same information or with different information (notably medical and surgical procedures and disablement).
Following suggestions at the time of development of the Ninth Revision of the classification that a different basic structure might better serve the needs of the many and varied users, several alternative models were evaluated. It became clear, however, that the traditional single-variable-axis design of the classification, and other aspects of its structure that gave emphasis to conditions that were frequent, costly or otherwise of public health importance, had withstood the test of time and that many users would be unhappy with any of the models that had been proposed as a possible replacement.
Consequently, as study of the Tenth Revision will show, the traditional ICD structure has been retained but an alphanumeric coding scheme replaces the previous numeric one. This provides a larger coding frame and leaves room for future revision without disruption of the numbering system, as has occurred at previous revisions.
In order to make optimum use of the available space, certain disorders of the immune mechanism are included with diseases of the blood and blood-forming organs (Chapter III). New chapters have been created for diseases of the eye and adnexa and diseases of the ear and mastoid process. The former supplementary classifications of external causes and of factors influencing health status and contact with health services now form part of the main classification.
The dagger and asterisk system of dual classification for certain diagnostic statements, introduced in the Ninth Revision, has been retained and extended, with the asterisk axis being contained in homogeneous categories at the three-character level.
Content of the three volumes of ICD-10
The presentation of the classification has been changed and there are now three volumes:
Volume 1. Tabular List. This contains the report of the International Conference for the Tenth Revision, the classification itself at the three-and four-character levels, the classification of the morphology of neoplasms, special tabulation lists for mortality and morbidity, definitions, and the nomenclature regulations.
Part 2a. Instruction Manual. This brings together the notes on certification and classification formerly included in Volume 1 with a good deal of new background and instructional matter and guidance on the use of Volume 1, on tabulations, and on planning for the use of ICD, which was seen as lacking in earlier revisions. It also includes the historical material formerly presented in the introduction to Volume 1.
Volume 3. Alphabetical Index. This presents the index itself with an introduction and expanded instructions on its use.
* * *
The classification was approved by the International Conference for the Tenth Revision of the International Classification of Diseases in 1989 and adopted by the Forty-third World Health Assembly in the following resolution:
The Forty-third World Health Assembly,
Having considered the report of the International Conference for the Tenth Revision of the International Classification of Diseases;
1. ADOPTS the following, recommended by the Conference:
(1) the detailed list of three-character categories and optional four-character subcategories with the Short Tabulation Lists for Mortality and Morbidity, constituting the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems, due to come into effect on 1 January 1993;
(2) the definitions, standards and reporting requirements related to maternal, fetal, perinatal, neonatal and infant mortality;
(3) the rules and instructions for underlying cause coding for mortality and main condition coding for morbidity;
2. REQUESTS the Director-General to issue the Manual of the International Statistical Classification of Diseases and Related Health Problems;
3. ENDORSES the recommendations of the Conference concerning:
(1) the concept and implementation of the family of disease and health-related classifications, with the International Statistical Classification of Diseases and Related Health Problems as the core classification surrounded by a number of related and supplementary classifications and the International Nomenclature of Diseases;
(2) the establishment of an updating process within the ten-year revision cycle.
Acknowledgements
The periodic revision of the ICD has, since the Sixth Revision in 1948, been coordinated by the World Health Organization. As the use of the classification has increased, so, understandably, has the desire among its users to contribute to the revision process. The Tenth Revision is the product of a vast amount of international activity, cooperation and compromise. WHO acknowledges with gratitude the contributions of the international and national specialist groups and individuals in numerous many countries.
WHO Collaborating Centres for Classification of Diseases
Nine WHO Collaborating Centres for Classification of Diseases have been established to assist countries with problems encountered in the development and use of health-related classifications and, in particular, in the use of the ICD.
It is important that countries bring to the attention of the respective Centre any significant problems they might encounter in the use of the ICD and especially when a new disease for which the ICD does not provide a suitable classification is encountered frequently. Until now the ICD has not been updated between revisions but it has been proposed that, through the Centres, a mechanism will be introduced to provide suitable codes for new diseases where necessary.
In addition to the official WHO Collaborating Centres, there are a number of national reference centres and individual users should first consult these, or their appropriate national office, when they encounter problems.
There are three Centres for English-language users. Communications should be addressed to the Head, WHO Collaborating Centre for Classification of Diseases at:
Australian Institute of Health
GPO Box 570
Canberra ACT 2601,
Australia
Office of Population and Censuses and Surveys
St. Catherine's House
Kingsway 10
London WC2B 6JP
England
National Center for Health Statistics
3311 Toledo Road
Hyattsville, MD 27703
United States of America
The other six centres, each based on an individual language or group of languages, are located in the following institutions:
Peking Union Medical College Hospital
Chinese Academy of Medical Sciences
Beijing 100730
China (for Chinese)
INSERM
44 Chemin de Ronde
F-78110 Le Vesinet
France (for French)
Department of Social Medicine
University Hospital
S-751 85 Uppsala
Sweden (for the Nordic countries)
Faculdade de Saude Publica/Universidade de Sao Paulo
Avenida Dr Arnaldo 715,
01246-904 Sao Paulo, SP
Brazil (for Portuguese)
The N.A. Semasko Institute,
U1. Obuha 12
Moscow B-20
Russian Federation Republic (for Russian)
Centro Venezolano de Clasificacion de Enfermedades
Edificio Sur, 9o Piso
M.S.A.S.,
Centro Simon Bolivar,
P.O. Box 6653
Caracas
Venezuela (for Spanish)
Report of the International Conference for the Tenth Revision of the International Classification of Diseases
The International Conference for the Tenth Revision of the International Classification of Diseases was convened by the World Health Organization at WHO headquarters in Geneva from 26 September to 2 October 1989. The Conference was attended by delegates from 43 Member States:
Angola Luxembourg
Australia Madagascar
Bahamas Mali
Belgium Malta
Brazil Mozambique
Bulgaria Netherlands
Burundi Niger
Canada Portugal
China Republic of Korea
Cuba Senegal
Cyprus Singapore
Denmark Spain
Finland Sweden
France Switzerland
German Democratic Republic Thailand
Germany, Federal Republic of Uganda
Hungary Union of Soviet Socialist Republics
India United Arab Emirates
Indonesia United Kingdom of Great Britain
Israel and Northern Ireland
Japan United States of America
Kuwait Venezuela
The United Nations, the International Labour Organisation and the WHO Regional Offices sent representatives to participate in the Conference, as did the Council for International Organizations of Medical Sciences, and twelve other nongovernmental organizations concerned with cancer registration, the deaf, epidemiology, family medicine, gynaecology and obstetrics, hypertension, health records, preventive and social medicine, neurology, psychiatry, rehabilitation and sexually transmitted diseases.
The Conference was opened by Dr J.-P. Jardel, Assistant Director-General, on behalf of the Director-General. Dr Jardel spoke of the extensive consultations and preparatory work that had gone into the revision proposals and had necessitated a longer than usual interval between
revisions. He noted that the Tenth Revision would have a new title, International Statistical Classification of Diseases and Related Health Problems, to emphasize its statistical purpose and reflect the widening of its scope. The convenient abbreviation ICD would, however, be retained. He also mentioned the new alphanumeric coding scheme, which had made it possible to provide a better balance between the content of the chapters and to leave room for future additions and changes, as well as the intention to produce an ICD manual of three-character categories with an alphabetical index for use where the more complex detailed four-character version would be inappropriate.
The Conference elected the following officers:
Dr R.H.C. Wells, Australia (Chairman)
Dr H. Bay-Nielsen, Denmark (Vice-Chairman)
Dr R. Braun, German Democratic Republic (Vice-Chairman)
Mr R.A. Israel, United States of America (Vice-Chairman)
Dr R. Laurenti, Brazil (Vice-Chairman)
Dr P. Maguin, France (Rapporteur)
Ms E. Taylor, Canada (Rapporteur)
The secretariat of the Conference was as follows:
Dr J.-P. Jardel, Assistant Director-General, WHO, Geneva, Switzerland
Dr H.R. Hapsara, Director, Division of Epidemiological Surveillance and Health Situation and Trend Assessment, WHO, Geneva, Switzerland
Dr J.-C. Alary, Chief Medical Officer, Development of Epidemiological and Health Statistical Services, WHO, Geneva, Switzerland
Dr G.R. Bramer, Medical Officer, Development of Epidemiological and Health Statistical Services, WHO, Geneva, Switzerland (Secretary)
Mr A. L'Hours, Technical Officer, Development of Epidemiological and Health Statistical Services, WHO, Geneva, Switzerland
Professor W. Janisch, German Democratic Republic (Temporary Adviser)
Mr T. Kruse, Denmark (Temporary Adviser)
Dr K. Kupka, France (Temporary Adviser)
Dr J. Leowski, Poland (Temporary Adviser)
Ms R.M. Loy, United Kingdom of Great Britain and Northern Ireland (Temporary Adviser)
Mr R.H. Seeman, United States of America (Temporary Adviser)
The secretariat of the Conference was assisted by representatives of other relevant technical units of WHO headquarters.
The Conference adopted an agenda dealing with the proposed content of the chapters of the Tenth Revision, and material to be incorporated in the published manual; the process for its introduction; and the family of classifications and related matters.
1. History and development of uses of the International Classification of Diseases (ICD)
The Conference was reminded of the impressive history of a statistical classification which dated back to the eighteenth century. While early revisions of the classification had been concerned only with causes of death, its scope had been extended at the Sixth Revision in 1948 to include non-fatal diseases. This extension had continued through the Ninth Revision, with certain innovations being made to meet the statistical needs of widely differing organizations. In addition, at the International Conference for the Ninth Revision (Geneva, 1975) (1), recommendations had been made and approved for the publication for trial purposes of supplementary classifications of procedures in medicine and of impairments, disabilities, and handicaps.
2. Review of activities in the preparation of proposals for the Tenth Revision of the ICD
The proposals before the Conference were the product of a vast amount of activity at WHO headquarters and around the world. The programme of work had been guided by regular meetings of the heads of WHO Collaborating Centres for Classification of Diseases. Policy guidance had been provided by a number of special meetings and by the Expert Committee on the International Classification of Diseases - Tenth Revision, which met in 1984 (2) and 1987 (3) to make decisions on the direction the work should take and the form of the final proposals.
Extensive preparatory activity had been devoted to a radical review of the suitability of the structure of the ICD, essentially a statistical classification of diseases and other health problems, to serve a wide variety of needs for mortality and health-care data. Ways of stabilizing the coding system to minimize disruption at successive revisions had been investigated, as had the possibility of providing a better balance between the content of the different chapters of the ICD.
Even with a new structure, it was plain that one classification could not cope with the extremes of the requirements. The concept had therefore been developed of a "family" of classifications, with the main ICD as the core, covering the centre ground of needs for traditional mortality and morbidity statistics, while needs for more detailed, less detailed or different classifications and associated matters would be dealt with by other members of the family.
Several alternative models for the structure of the ICD had been investigated by the Collaborating Centres, but it had been found that each had unsatisfactory features and none had sufficient advantages over the existing structure to justify replacing it. Special meetings held to evaluate the Ninth Revision had confirmed that, although some potential users found the existing structure of the ICD unsuitable, there was a large body of satisfied users who considered it had many inherent strengths, whatever its apparent inconsistencies, and wished it to continue in its existing form.
Various schemes involving alphanumeric notation had been examined with a view to producing a coding frame that would give a better balance to the chapters and allow sufficient space for future additions and changes without disrupting the codes.
Decisions made on these matters had paved the way for the preparation of successive drafts of chapter proposals for the Tenth Revision. These had twice been circulated to Member States for comment as well as being reviewed by other interested bodies, meetings of Centre Heads, and the Expert Committee. A large number of international professional specialist associations, individual specialists and experts, other WHO headquarters units and regional offices had given advice and guidance to the WHO unit responsible for the ICD and to the Collaborating Centres on the preparation of the proposals and the associated material placed before the Conference. WHO gratefully acknowledged this assistance.
3. General characteristics and content of the proposed Tenth Revision of the ICD
The main innovation in the proposals for the Tenth Revision was the use of an alphanumeric coding scheme of one letter followed by three numbers at the four-character level. This had the effect of more than doubling the size of the coding frame in comparison with the Ninth Revision and enabled the vast majority of chapters to be assigned a unique letter or group of letters, each capable of providing 100 three-character categories. Of the 26 available letters, 25 had been used, the letter U being left vacant for future additions and changes and for possible interim classifications to solve difficulties arising at the national and international level between revisions.
As a matter of policy, some three-character categories had been left vacant for future expansion and revision, the number varying according to the chapters: those with a primarily anatomical axis of classification had fewer vacant categories as it was considered that future changes in their content would be more limited in nature.
The Ninth Revision contained 17 chapters plus two supplementary classifications: the Supplementary Classification of External Causes of Injury and Poisoning (the E code) and the Supplementary Classification of Factors Influencing Health Status and Contact with Health Services (the V code). As recommended by the Preparatory Meeting on the Tenth Revision (Geneva, 1983) (4) and endorsed by subsequent meetings, these two chapters were no longer considered to be supplementary but were included as a part of the core classification.
The order of entry of chapters in the proposals for the Tenth Revision had originally been the same as in the Ninth Revision; however, to make effective use of the available space, disorders of the immune mechanism were later included with diseases of the blood and blood-forming organs, whereas in the Ninth Revision they had been included with endocrine, nutritional and metabolic diseases. The new chapter on "Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism" now followed the "Neoplasms" chapter, with which it shared the letter D.
During the elaboration of early drafts of the chapter on "Diseases of the nervous system and sense organs", it had soon become clear that it would not be possible to accommodate all the required detail under one letter in 100 three-character categories. It had been decided, therefore, to create three separate chapters - "Diseases of the nervous system" having the letter G, and the two chapters on "Diseases of the eye and adnexa" and on "Diseases of the ear and mastoid process" sharing the letter H.
Also, the chapters on "Diseases of the genitourinary system", on "Pregnancy, childbirth and the puerperium", on "Certain conditions originating in the perinatal period, and on "Congenital malformations, deformations and chromosomal abnormalities" had been brought together as contiguous chapters XIV to XVII.
With the inclusion of the former supplementary classifications as part of the core classification and the creation of two new chapters, the total number of chapters in the proposal for the Tenth Revision had become 21. The titles of some chapters had been amended to give a better indication of their content.
Where radical changes to the ICD had been proposed, field-testing had been appropriate. This had been the case for the following chapters:
V. Mental and behavioural disorders
XIX. Injury, poisoning and certain other consequences of external causes
XX. External causes of morbidity and mortality
Chapter II, "Neoplasms", had also been subject to some field-testing, although the changes in its content had been of a minor nature.
Some new features of the proposals for the Tenth Revision were as follows:
• The exclusion notes at the beginning of each chapter had been expanded to explain the relative hierarchy of chapters, and to make it clear that the "special group" chapters had priority of assignment over the organ or system chapters and that, among the special group chapters, those on "Pregnancy, childbirth and the puerperium" and on "Certain conditions originating in the perinatal period" had priority over the others.
• Also, at the beginning of each chapter an overview was given of the blocks of three-character categories and, where relevant, the asterisk categories; this had been done to clarify the structure of the chapters and to facilitate the use of the asterisk categories.
• The notes in the tabular list applied to all uses of the classification; if a note was appropriate only to morbidity or only to mortality, it was included in the special notes accompanying either the morbidity coding rules or the mortality coding rules.
• The Ninth Revision had identified a certain number of conditions as being drug-induced; this approach had been continued in drawing up the proposals for the Tenth Revision and many such conditions were now separately identified.
An important innovation was the creation towards the end of certain chapters of categories for postprocedural disorders. These identified important conditions that constituted a medical care problem in their own right and included such examples as endocrine and metabolic diseases following ablation of an organ and other specific conditions such as postgastrectomy dumping syndrome. Postprocedural conditions that were not specific to a particular body system, including immediate complications such as air embolism and postoperative shock, continued to be classified in the chapter on "Injury, poisoning and certain other consequences of external causes".
Another change was that in the Ninth Revision, the four-digit titles had often had to be read in conjunction with the three-digit titles to ascertain the full meaning and intent of the subcategory, whereas in the draft presented to the Conference the titles were almost invariably complete and could stand alone.
The dual classification scheme for etiology and manifestation, known as the dagger and asterisk system, introduced in the Ninth Revision, had been the subject of a certain amount of criticism. This related mainly to the fact that the classification frequently contained a mixture of manifestation and other information at the three- and four-digit levels, with the same diagnostic labels sometimes appearing under both axes. Also, many considered the system to be
insufficiently comprehensive. To overcome these problems, in the draft for the Tenth Revision, the asterisk information was contained in 82 homogeneous three-character categories for optional use. This approach enabled those diagnostic statements containing information about both a generalized underlying disease process and a manifestation or complication in a particular organ or site to receive two codes, allowing retrieval or tabulation according to either axis.
These characteristics of the proposed Tenth Revision were accepted by the Conference.
Each of the chapters was introduced to the Conference with a presentation on changes introduced since the Ninth Revision and some background information about certain innovations. Some issues related to changes in chapter structure and content were discussed by the Conference and agreement reached on follow-up and modification by the secretariat.
4. Standards and definitions related to maternal and child health
The Conference considered with interest the recommended definitions, standards and reporting requirements for the Tenth Revision with regard to maternal mortality and to fetal, perinatal, neonatal and infant mortality. These recommendations were the outcome of a series of special meetings and consultations and were directed towards improving the comparability of data.
The Conference agreed that it was desirable to retain the definitions of live birth and fetal death as they appeared in the Ninth Revision.
After some discussion, the Conference set up a working party on the subject of maternal mortality and, on the basis of its recommendations, also agreed to retain the definition of maternal death as it appeared in the Ninth Revision.
In order to improve the quality of maternal mortality data and provide alternative methods of collecting data on deaths during pregnancy or related to it, as well as to encourage the recording of deaths from obstetric causes occurring more than 42 days following termination of pregnancy, two additional definitions, for "pregnancy-related deaths" and "late maternal deaths", were formulated by the working party.
The Conference
RECOMMENDED that countries consider the inclusion on death certificates of questions regarding current pregnancy and pregnancy within one year preceding death.
The Conference agreed that, since the number of live births was more universally available than the number of total births (live births plus fetal deaths), it should be used as the denominator in the ratios related to maternal mortality [as contained in Part 2a Instruction Manual (NCHS)].
With respect to perinatal, neonatal and infant mortality, it was strongly advised that published rates based on birth cohorts should be so identified and differentiated.
The Conference confirmed the practice of expressing age in completed units of time and thus designating the first day of life as day zero.
The Conference
RECOMMENDED the inclusion, in the manual of the Tenth Revision of the ICD, of definitions, standards and reporting requirements related to maternal mortality and to fetal, perinatal, neonatal and infant mortality.
5. Coding and selection rules and tabulation lists
5.1 Coding and selection rules for mortality
The Conference was informed about a process for review of the selection and modification rules for underlying cause of death and the associated notes, as they appeared in the Ninth Revision, which had resulted in several recommended changes in the rules and extensive changes to the notes.
The Conference
RECOMMENDED that the rules for selection of cause of death for primary mortality tabulation, as they appear in the Ninth Revision, be replaced in the Tenth Revision [by those contained in Part 2a Instruction Manual (NCHS)].
The Conference was further informed that additional notes for use in underlying cause coding and the interpretation of entries of causes of death had been drafted and were being reviewed. As these notes were intended to improve consistency in coding, the Conference agreed that they would also be incorporated in the Tenth Revision.
The Conference noted the continued use of multiple-condition coding and analysis in relation to causes of death. It expressed encouragement for such activities, but did not recommend that the Tenth Revision should contain any particular rules or methods of analysis to be followed.
In considering the international form of medical certificate of cause of death, the Expert Committee had recognized that the situation of an aging population with a greater proportion of deaths involving multiple disease processes, and the effects of associated therapeutic interventions, tended to increase the number of possible statements between the underlying cause and the direct cause of death: this meant that an increasing number of conditions were being entered on death certificates in many countries. This led the Committee to recommend the inclusion of an additional line (d) in Part I of the certificate.
The Conference therefore
RECOMMENDED that, where a need has been identified, countries consider the possibility of including an additional line (d) in Part I of the medical certificate of cause of death.
5.2 Coding and selection rules for morbidity
For the first time, the Ninth Revision contained guidance on recording and coding for morbidity and specifically for the selection of a single condition for presentation of morbidity statistics. Experience gained in the use of the definitions and rules in the Ninth Revision had proved their usefulness and generated requests for their clarification, for further elaboration regarding the recording of diagnostic information by health care practitioners, and for more guidance on dealing with specific problem situations.
The Conference endorsed the recommendations of the 1975 Revision Conference about the condition to be selected for single-condition analysis of episodes of health care, and its view that, where practicable, multiple-condition coding and analysis should be undertaken to supplement routine statistics. It stressed that the Tenth Revision should make it clear that much of the guidance was applicable only when the tabulation of a "main condition" for an episode was appropriate and when the concept of an "episode" per se was relevant to the way in which data collection was organized.
The Conference accordingly
RECOMMENDED that additional guidance on the recording and coding of morbidity should be included in the Tenth Revision, and that the definitions of "main condition" and "other conditions" should be incorporated, together with the modified rules for dealing with obviously incorrectly reported "main condition". [These are included in Part 2a Instruction Manual (NCHS).]
The Conference also
RECOMMENDED that where the "main condition" is subject to the dual classification system provided in the ICD, both the dagger and asterisk codes should be recorded, to permit alternative tabulation by either.
The Conference agreed that extensive notes and examples should be added to provide further assistance.
5.3 Lists for tabulation of mortality and morbidity
The Conference was informed about difficulties that had arisen in the use of the Basic Tabulation List based on the Ninth Revision and about the activities that had been undertaken, particularly by WHO, to develop new lists for the tabulation and publication of mortality data. In this process it had become apparent that, in many countries, mortality up to the age of five was a more robust indicator than infant mortality, and that it would therefore be preferable to have a list that included infant deaths and deaths of children up to the age of five years, rather than a list for infants only.
Two versions of the general mortality list and of the infant and child mortality list had been prepared for consideration by the Conference, with the second version including chapter titles and residual items for chapters as necessary.
As some concerns were expressed regarding the mortality lists as presented, a small working party was convened to consider the possible inclusion of some additional items. The report of the working party was accepted by the Conference.
On the topic of lists for the tabulation of morbidity, the Conference reviewed both a proposed tabulation list and a model publication list based on chapter titles, with selected items included as examples under each title. Considerable concern was expressed about the applicability of such lists to all morbidity in the broadest sense. There was general agreement that the lists as presented were probably more suited to inpatient morbidity, and it was felt that further efforts should be made to develop lists suitable for other morbidity applications and also that both mortality and morbidity tabulation lists should be accompanied in the Tenth Revision by appropriate explanations and instructions on their use.
In the light of the concerns raised in the Conference and the conclusions of the working party, the Conference agreed that the tabulation and publication lists should appear in the Tenth Revision, while an effort should be made to establish clearer, more descriptive titles for these lists. It was also agreed that, to facilitate the alternative tabulation of asterisk categories, a second version of the morbidity tabulation list should be developed, which included the asterisk categories.
6. Family of classifications
6.1 Concept of the family of classifications
During the preparation of the Ninth Revision it had already been realized that the ICD alone could not cover all the information required and that only a "family" of disease and health-related classifications would meet the different requirements in public health. Since the late 1970s, therefore, various possible solutions had been envisaged, one of which called for a core classification (ICD) with a series of modules, some hierarchically related and others of a supplementary nature.
After studies and discussions in cooperation with the various Collaborating Centres, a concept of a family of classifications had been elaborated and subsequently revised by the Expert Committee in 1987, which had recommended the scheme shown opposite.
The Conference
RECOMMENDED that the concept of the family of disease and health-related classifications should be followed up by WHO.
In order to maintain the integrity of the ICD itself and this family concept, the Conference
RECOMMENDED that, in the interests of international comparability, no changes should be made to the content (as indicated by the titles) of the three-character categories and four-character sub-categories of the Tenth Revision in the preparation of translations or adaptations, except as authorized by WHO. The Secretariat of WHO is responsible for the ICD and acts as central clearing-house for any publication (except national statistical publications) or translation to be derived from it. WHO should be promptly notified about the intention to produce translations and adaptations or other ICD-related classifications.
Family of disease and health-related classifications
The Conference viewed with interest a presentation of the use and linkage of different members of the ICD family in the medicosocial and multidimensional assessment of the elderly in relation not only to health but also to activities of daily living as well as the social and physical environment. It was demonstrated that effective information could be obtained through use of the ICD and the International Classification of Impairments, Disabilities, and Handicaps (ICIDH), and especially through use of the codes from the proposed Chapter XXI of the Tenth Revision.
6.2 Specialty-based adaptations
The Conference was informed about plans for the development of adaptations of the Tenth Revision in the mental health programme area. Clinical guidelines would accompany a version intended for use by clinicians working in the field of psychiatry; research criteria would be proposed for use in investigations of mental health problems; and multi-axial presentations for use in dealing with childhood disorders and for the classification of adult problems would be developed as well as a version for use by general practitioners. Compilations of ICD codes relevant to psychiatry and to neurology would also be produced along the lines of previous publications on this subject.
The Conference also heard about the methods used to ensure that the basic structure and function of the ICD were preserved in the initial development of the application for medical specialists in dentistry and stomatology (ICD-DA) and was informed that a new revision of the ICD-DA linked to the Tenth Revision was in the final stages of preparation.
A presentation was given on the International Classification of Diseases for Oncology (ICD-O), Second Edition, a multi-axial classification including both the topography and morphology of neoplasms. The morphology codes of the ICD-O, which had evolved over a long period of time, had been revised and extensively field-tested. The topography codes of the second edition would be based on categories C00-C80 in the Tenth Revision and publication would, therefore, await World Health Assembly approval of the Tenth Revision.
There was agreement on the value of an adaptation in the area of general medical practice and the Conference was informed about the willingness of groups working in this area to collaborate with WHO. In respect of other specialty-based adaptations, which were likely to become more numerous, the recommended role of WHO as a clearing-house was considered to be extremely important.
6.3 Information support to primary health care
In accordance with the recommendations of the 1975 Revision Conference, a working group had been convened by the WHO Regional Office for South-East Asia in Delhi in 1976. It had drawn up a detailed list of symptom associations, and from this, two short lists were derived, one for causes of death and one for reasons for contact with health services. Field trials of this system had been carried out in countries of the Region and the results used to revise the list of symptom associations and the reporting forms. This revised version had been published by WHO in 1978 in the booklet Lay reporting of health information (5).
The Global Strategy for Health for All by the Year 2000, launched in 1978, had raised a number of challenges for the development of information systems in Member States. At the International Conference on Health Statistics for the Year 2000 (Bellagio, Italy, 1982) (6), the integration of "lay reporting" information with other information generated and used for health management purposes had been identified as a major problem inhibiting the wider implementation of lay reporting schemes. The Consultation on Primary Care Classifications (Geneva, 1985) (7) had stressed the need for an approach that could unify information support, health service management and community services through information based on lay reporting in the expanded sense of community-based information.
The Conference was informed about the experience of countries in developing and applying community-based health information that covered health problems and needs, related risk factors and resources. It supported the concept of developing non-conventional methods at the community level as a method of filling information gaps in individual countries and strengthening their information systems. It was stressed that, for both developed and developing countries, such methods or systems should be developed locally and that, because of factors such as morbidity patterns as well as language and cultural variations, transfer to other areas or countries should not be attempted.
6.4 Impairments, disabilities and handicaps
The International Classification of Impairments, Disabilities, and Handicaps (ICIDH) (8) had been published by WHO in English in 1980 for trial purposes, in accordance with the recommendations of the 1975 Revision Conference and resolution WHA29.35 (9) of the 1976 World Health Assembly. Since that time, research and development on the classification had followed a number of paths.
The major definitions of the three elements - impairment, disability and handicap - had undoubtedly been instrumental in changing attitudes to disablement. The definition of impairment, an area where there was considerable overlap with the terms included in the ICD, had been widely accepted. The definition of disability broadly matched the field of action of rehabilitation professionals and groups, although there was felt to be a need for more attention in the associated code to the gradation of severity, which was often a predictor of handicap. There had also been increasing requests to revise the definition of handicap so as to put more emphasis on the effect of interaction with the environment.
The rapid evolution of ideas and practices in the management of disablement had ruled out the production of a revised ICIDH in time to be submitted to the Conference. It was stated that the publication of a new version was unlikely before implementation of the Tenth Revision.
6.5 Procedures in medicine
The International Classification of Procedures in Medicine (ICPM) (10) had been published by WHO in 1978 for trial purposes, in accordance with the recommendations of the 1975 Revision Conference and resolution WHA29.35 (9) of the 1976 World Health Assembly. The classification had been adopted by a few countries and was used as a basis for national classifications of surgical operations by a number of other countries.
The Heads of WHO Collaborating Centres for Classification of Diseases had recognized that the process of drafting proposals, obtaining comments, redrafting and soliciting further comments, which WHO necessarily had to go through before finalization and publication, was inappropriate in such a rapidly advancing field as that of procedures. The Centre Heads had therefore recommended that there should be no revision of the ICPM in conjunction with the Tenth Revision of ICD.
In 1987 the Expert Committee had asked that WHO consider updating for the Tenth Revision at least the outline of Chapter 5, “Surgical procedures", of the trial ICPM. In response to this request and the needs expressed by a number of countries, an attempt had been made by the Secretariat to prepare a tabulation list for procedures.
This list had been presented to the Centre Heads at their 1989 meeting and it had been agreed that it could serve as a guide for national presentation or publication of statistics on surgical procedures and could also facilitate intercountry comparisons. The aim of the list was to identify procedures and groups of procedures and define them as a basis for the development of national classifications, thereby improving the comparability of such classifications.
The Conference agreed that such a list was of value and that work should continue on its development, even though any publication would follow the implementation of the Tenth Revision.
6.6 International Nomenclature of Diseases
Since 1970 the Council for International Organizations of Medical Sciences (CIOMS) had been involved in the preparation of an International Nomenclature of Diseases (IND) which would serve as a complement to the ICD.
The main purpose of the IND was to provide a single recommended name for every disease entity. The main criteria for selection of that name were that it should be specific, unambiguous, as self-descriptive and simple as possible, and based on cause wherever feasible. Each disease or syndrome for which a name was recommended was defined as unambiguously, and yet briefly, as possible. A list of synonyms was appended to each definition.
At the time of the Conference, volumes had been published on diseases of the lower respiratory tract, infectious diseases (viral, bacterial and parasitic diseases and mycoses) and cardiac and vascular diseases, and work was under way on volumes for the digestive system, female genital system, urinary and male genital system, metabolic and endocrine diseases, blood and blood-forming organs, immunological system, musculoskeletal system and nervous system. Subjects proposed for future volumes included psychiatric diseases, as well as diseases of the skin, ear, nose and throat, and eye and adnexa.
The Conference recognized that an authoritative, up-to-date and international nomenclature of diseases was important in developing the ICD and improving the comparability of health information. The Conference therefore
RECOMMENDED that WHO and CIOMS be encouraged to explore cost-efficient ways to achieve the timely completion and maintenance of such a nomenclature.
7. Implementation of the Tenth Revision of the ICD
The Conference was informed of WHO's intention to publish the detailed four-character version of the Tenth Revision in three volumes: one containing the Tabular List, a second containing all related definitions, standards, rules and instructions, and a third containing the Alphabetical Index.
The Conference was further informed that a three-character version of the Tenth Revision would be published as a single volume which would contain, in the Tabular List, all inclusion and exclusion notes. It would also contain all related definitions, standards, rules and instructions and a shortened Alphabetical Index.
Member States intending to produce national language versions of the Tenth Revision should notify WHO of their intentions. Copies of the drafts of the ICD at the three- and four-character levels would be made available from WHO both in printed form and on electronic media.
With respect to the physical appearance of the pages and type formats for both the Tabular List and the Alphabetical Index, the Conference was assured that recommendations from the Centre Heads and complaints from coders would be considered, and every attempt made to improve those aspects as compared with the Ninth Revision.
As with the Ninth Revision, it was intended to develop materials for the reorientation of trained coders, with the help of the Collaborating Centres. The actual training courses would be the responsibility of the WHO regional offices and individual countries. They would be carried out from late 1991 to the end of 1992, to finish before the implementation of the Tenth Revision.
Materials for the basic training of new users of the ICD would also be developed by WHO; it was not, however, planned to begin courses before 1993.
As noted above, WHO would be prepared to provide the Tenth Revision (both the Tabular List and the Alphabetical Index) on electronic media. In future, with the assistance of the Collaborating Centres, other software might also be made available. A key for conversion from the Ninth to the Tenth Revision, and the reverse, should be available before the implementation of the Tenth Revision.
As the development activities that had been endorsed by the Expert Committee were on schedule, the Conference
RECOMMENDED that the Tenth Revision of the International Classification of Diseases should come into effect as from 1 January 1993.
8. Future revision of the ICD
The Conference discussed the difficulties experienced during the extended period of use of the Ninth Revision, related to the emergence of new diseases and the lack of an updating mechanism to accommodate them.
Various suggestions for mechanisms to overcome these difficulties and avoid similar problems with respect to the Tenth Revision were discussed. There was a clear feeling that there was a need for ongoing information exchange to standardize the use of the Tenth Revision between countries, but that any changes introduced during its "lifetime" should be considered very carefully in relation to their impact on analyses and trends. There was discussion on the type of forum in which such changes and the potential for use of the vacant letter "U" in new or temporary code assignments could be discussed. It was agreed that it would not be feasible to hold revision conferences more frequently than every 10 years.
On the basis of the needs expressed, and the fact that it would be inappropriate to attempt to determine or define the exact process to be used, the Conference
RECOMMENDED that the next International Revision Conference should take place in ten years' time, and that WHO should endorse the concept of an updating process between revisions and give consideration as to how an effective updating mechanism could be put in place.
9. Adoption of the Tenth Revision of the ICD
The Conference made the following recommendation:
Having considered the proposals prepared by the Organization on the basis of the recommendations of the Expert Committee on the International Classification of Diseases - Tenth Revision,
Recognizing the need for a few further minor modifications to reflect the comments on points of detail submitted by Member States during the Conference,
RECOMMENDED that the proposed revised chapters, with their three-character categories and four-character subcategories and the Short Tabulation Lists for Morbidity and Mortality, constitute the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems.
References
1. International Classification of Diseases, 1975 Revision, Volume 1. Geneva, World Health Organization, 1977, pp. xiii-xxiv.
2. Report of the Expert Committee on the International Classification of Diseases-10th Revision: First Meeting. Geneva, World Health Organization, 1984 (unpublished document DES/EC/ICD-10/84.34).
3. Report of the Expert Committee on the International Classification of Diseases-10th Revision: Second Meeting. Geneva, World Health Organization. 1987 (unpublished document WHO/DES/EC/ICD-10/87.38).
4. Report of the Preparatory Meeting on ICD-10. Geneva, World Health Organization, 1983 (unpublished document DES/ICD-10/83.19).
5. Lay reporting of health information. Geneva, World Health Organization, 1978.
6. International Conference on Health Statistics for the Year 2000. Budapest, Statistical Publishing House, 1984.
7. Report of the Consultation on Primary Care Classifications. Geneva, World Health Organization, 1985 (unpublished document DES/PHC/85.7).
8. International Classification of Impairments, Disabilities, and Handicaps. Geneva, World Health Organization, 1980.
9. WHO Official Records, No. 233, 1976, p. 18.
10. International Classification of Procedures in Medicine. Geneva, World Health Organization, 1978.
LIST OF THREE-CHARACTER CATEGORIES
Chapter I - Certain infectious and parasitic diseases (A00-B99)
Intestinal infectious diseases (A00-A09)
A00 Cholera
A01 Typhoid and paratyphoid fevers
A02 Other salmonella infections
A03 Shigellosis
A04 Other bacterial intestinal infections
A05 Other bacterial foodborne intoxications
A06 Amoebiasis
A07 Other protozoal intestinal diseases
A08 Viral and other specified intestinal infections
A09 Other gastroenteritis and colitis of infectious and unspecified origin
Tuberculosis (A15-A19)
A15 Respiratory tuberculosis, bacteriologically and histologically confirmed
A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically
A17† Tuberculosis of nervous system
A18 Tuberculosis of other organs
A19 Miliary tuberculosis
Certain zoonotic bacterial diseases (A20-A28)
A20 Plague
A21 Tularaemia
A22 Anthrax
A23 Brucellosis
A24 Glanders and melioidosis
A25 Rat-bite fevers
A26 Erysipeloid
A27 Leptospirosis
A28 Other zoonotic bacterial diseases, not elsewhere classified
Other bacterial diseases (A30-A49)
A30 Leprosy [Hansen disease]
A31 Infection due to other mycobacteria
A32 Listeriosis
A33 Tetanus neonatorum
A34 Obstetrical tetanus
A35 Other tetanus
A36 Diphtheria
A37 Whooping cough
A38 Scarlet fever
A39 Meningococcal infection
A40 Streptococcal septicaemia
A41 Other septicaemia
A42 Actinomycosis
A43 Nocardiosis
A44 Bartonellosis
A46 Erysipelas
A48 Other bacterial diseases, not elsewhere classified
A49 Bacterial infection of unspecified site
Infections with a predominantly sexual mode of transmission (A50-A64)
A50 Congenital syphilis
A51 Early syphilis
A52 Late syphilis
A53 Other and unspecified syphilis
A54 Gonococcal infection
A55 Chlamydial lymphogranuloma (venereum)
A56 Other sexually transmitted chlamydial diseases
A57 Chancroid
A58 Granuloma inguinale
A59 Trichomoniasis
A60 Anogenital herpesviral [herpes simplex] infections
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
A64 Unspecified sexually transmitted disease
Other spirochaetal diseases (A65-A69)
A65 Nonvenereal syphilis
A66 Yaws
A67 Pinta [carate]
A68 Relapsing fevers
A69 Other spirochaetal infections
Other diseases caused by chlamydiae (A70-A74)
A70 Chlamydia psittaci infection
A71 Trachoma
A74 Other diseases caused by chlamydiae
Rickettsioses (A75-A79)
A75 Typhus fever
A77 Spotted fever [tick-borne rickettsioses]
A78 Q fever
A79 Other rickettsioses
Viral infections of the central nervous system (A80-A89)
A80 Acute poliomyelitis
A81 Atypical virus infections of central nervous system
A82 Rabies
A83 Mosquito-borne viral encephalitis
A84 Tick-borne viral encephalitis
A85 Other viral encephalitis, not elsewhere classified
A86 Unspecified viral encephalitis
A87 Viral meningitis
A88 Other viral infections of the central nervous system, not elsewhere classified
A89 Unspecified viral infection of the central nervous system
Arthropod-borne viral fevers and viral haemorrhagic fevers (A90-A99)
A90 Dengue fever [classical dengue]
A91 Dengue haemorrhagic fever
A92 Other mosquito-borne viral fevers
A93 Other arthropod-borne viral fevers, not elsewhere classified
A94 Unspecified arthropod-borne viral fever
A95 Yellow fever
A96 Arenaviral haemorrhagic fever
A98 Other viral haemorrhagic fevers, not elsewhere classified
A99 Unspecified viral haemorrhagic fever
Viral infections characterized by skin and mucous membrane lesions (B00-B09)
B00 Herpesviral [herpes simplex] infections
B01 Varicella [chickenpox]
B02 Zoster [herpes zoster]
B03 Smallpox
B04 Monkeypox
B05 Measles
B06 Rubella [German measles]
B07 Viral warts
B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
B09 Unspecified viral infection characterized by skin and mucous membrane lesions
Viral hepatitis (B15-B19)
B15 Acute hepatitis A
B16 Acute hepatitis B
B17 Other acute viral hepatitis
B18 Chronic viral hepatitis
B19 Unspecified viral hepatitis
Human immunodeficiency virus [HIV] disease (B20-B24)
B20 Human immunodeficiency virus [HIV] disease with infectious and parasitic diseases
B21 Human immunodeficiency virus [HIV] disease with malignant neoplasms
B22 Human immunodeficiency virus [HIV] disease with other specified diseases
B23 Human immunodeficiency virus [HIV] disease with other conditions
B24 Unspecified human immunodeficiency virus [HIV] disease
Other viral diseases (B25-B34)
B25 Cytomegaloviral disease
B26 Mumps
B27 Infectious mononucleosis
B30 Viral conjunctivitis
B33 Other viral diseases, not elsewhere classified
B34 Viral infection of unspecified site
Mycoses (B35-B49)
B35 Dermatophytosis
B36 Other superficial mycoses
B37 Candidiasis
B38 Coccidioidomycosis
B39 Histoplasmosis
B40 Blastomycosis
B41 Paracoccidioidomycosis
B42 Sporotrichosis
B43 Chromomycosis and phaeomycotic abscess
B44 Aspergillosis
B45 Cryptococcosis
B46 Zygomycosis
B47 Mycetoma
B48 Other mycoses, not elsewhere classified
B49 Unspecified mycosis
Protozoal diseases (B50-B64)
B50 Plasmodium falciparum malaria
B51 Plasmodium vivax malaria
B52 Plasmodium malariae malaria
B53 Other parasitologically confirmed malaria
B54 Unspecified malaria
B55 Leishmaniasis
B56 African trypanosomiasis
B57 Chagas disease
B58 Toxoplasmosis
B59 Pneumocystosis
B60 Other protozoal diseases, not elsewhere classified
B64 Unspecified protozoal disease
Helminthiases (B65-B83)
B65 Schistosomiasis [bilharziasis]
B66 Other fluke infections
B67 Echinococcosis
B68 Taeniasis
B69 Cysticercosis
B70 Diphyllobothriasis and sparganosis
B71 Other cestode infections
B72 Dracunculiasis
B73 Onchocerciasis
B74 Filariasis
B75 Trichinellosis
B76 Hookworm diseases
B77 Ascariasis
B78 Strongyloidiasis
B79 Trichuriasis
B80 Enterobiasis
B81 Other intestinal helminthiases, not elsewhere classified
B82 Unspecified intestinal parasitism
B83 Other helminthiases
Pediculosis, acariasis and other infestations (B85-B89)
B85 Pediculosis and phthiriasis
B86 Scabies
B87 Myiasis
B88 Other infestations
B89 Unspecified parasitic disease
Sequelae of infectious and parasitic diseases (B90-B94)
B90 Sequelae of tuberculosis
B91 Sequelae of poliomyelitis
B92 Sequelae of leprosy
B94 Sequelae of other and unspecified infectious and parasitic diseases
Bacterial, viral and other infectious agents (B95-B97)
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters
B96 Other specified bacterial agents as the cause of diseases classified to other chapters
B97 Viral agents as the cause of diseases classified to other chapters
Other infectious diseases (B99)
B99 Other and unspecified infectious diseases
Chapter II - Neoplasms (C00-D48)
Malignant neoplasms (C00-C97)
Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)
C00 Malignant neoplasm of lip
C01 Malignant neoplasm of base of tongue
C02 Malignant neoplasm of other and unspecified parts of tongue
C03 Malignant neoplasm of gum
C04 Malignant neoplasm of floor of mouth
C05 Malignant neoplasm of palate
C06 Malignant neoplasm of other and unspecified parts of mouth
C07 Malignant neoplasm of parotid gland
C08 Malignant neoplasm of other and unspecified major salivary glands
C09 Malignant neoplasm of tonsil
C10 Malignant neoplasm of oropharynx
C11 Malignant neoplasm of nasopharynx
C12 Malignant neoplasm of pyriform sinus
C13 Malignant neoplasm of hypopharynx
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
Malignant neoplasms of digestive organs (C15-C26)
C15 Malignant neoplasm of oesophagus
C16 Malignant neoplasm of stomach
C17 Malignant neoplasm of small intestine
C18 Malignant neoplasm of colon
C19 Malignant neoplasm of rectosigmoid junction
C20 Malignant neoplasm of rectum
C21 Malignant neoplasm of anus and anal canal
C22 Malignant neoplasm of liver and intrahepatic bile ducts
C23 Malignant neoplasm of gallbladder
C24 Malignant neoplasm of other and unspecified parts of biliary tract
C25 Malignant neoplasm of pancreas
C26 Malignant neoplasm of other and ill-defined digestive organs
Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
C30 Malignant neoplasm of nasal cavity and middle ear
C31 Malignant neoplasm of accessory sinuses
C32 Malignant neoplasm of larynx
C33 Malignant neoplasm of trachea
C34 Malignant neoplasm of bronchus and lung
C37 Malignant neoplasm of thymus
C38 Malignant neoplasm of heart, mediastinum and pleura
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
Malignant neoplasms of bone and articular cartilage (C40-C41)
C40 Malignant neoplasm of bone and articular cartilage of limbs
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
Melanoma and other malignant neoplasms of skin (C43-C44)
C43 Malignant melanoma of skin
C44 Other malignant neoplasms of skin
Malignant neoplasms of mesothelial and soft tissue (C45-C49)
C45 Mesothelioma
C46 Kaposi sarcoma
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
C48 Malignant neoplasm of retroperitoneum and peritoneum
C49 Malignant neoplasm of other connective and soft tissue
Malignant neoplasm of breast (C50)
C50 Malignant neoplasm of breast
Malignant neoplasms of female genital organs (C51-C58)
C51 Malignant neoplasm of vulva
C52 Malignant neoplasm of vagina
C53 Malignant neoplasm of cervix uteri
C54 Malignant neoplasm of corpus uteri
C55 Malignant neoplasm of uterus, part unspecified
C56 Malignant neoplasm of ovary
C57 Malignant neoplasm of other and unspecified female genital organs
C58 Malignant neoplasm of placenta
Malignant neoplasms of male genital organs (C60-C63)
C60 Malignant neoplasm of penis
C61 Malignant neoplasm of prostate
C62 Malignant neoplasm of testis
C63 Malignant neoplasm of other and unspecified male genital organs
Malignant neoplasms of urinary tract (C64-C68)
C64 Malignant neoplasm of kidney, except renal pelvis
C65 Malignant neoplasm of renal pelvis
C66 Malignant neoplasm of ureter
C67 Malignant neoplasm of bladder
C68 Malignant neoplasm of other and unspecified urinary organs
Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
C69 Malignant neoplasm of eye and adnexa
C70 Malignant neoplasm of meninges
C71 Malignant neoplasm of brain
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
Malignant neoplasms of thyroid and other endocrine glands (C73-C75)
C73 Malignant neoplasm of thyroid gland
C74 Malignant neoplasm of adrenal gland
C75 Malignant neoplasm of other endocrine glands and related structures
Malignant neoplasms of ill-defined, secondary and unspecified sites (C76-C80)
C76 Malignant neoplasm of other and ill-defined sites
C77 Secondary and unspecified malignant neoplasm of lymph nodes
C78 Secondary malignant neoplasm of respiratory and digestive organs
C79 Secondary malignant neoplasm of other sites
C80 Malignant neoplasm without specification of site
Malignant neoplasms of lymphoid, haematopoietic and related tissue (C81-C96)
C81 Hodgkin disease
C82 Follicular [nodular] non-Hodgkin lymphoma
C83 Diffuse non-Hodgkin lymphoma
C84 Peripheral and cutaneous T-cell lymphomas
C85 Other and unspecified types of non-Hodgkin lymphoma
C88 Malignant immunoproliferative diseases
C90 Multiple myeloma and malignant plasma cell neoplasms
C91 Lymphoid leukaemia
C92 Myeloid leukaemia
C93 Monocytic leukaemia
C94 Other leukaemias of specified cell type
C95 Leukaemia of unspecified cell type
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
Malignant neoplasms of independent (primary) multiple sites (C97)
C97 Malignant neoplasms of independent (primary) multiple sites
In situ neoplasms (D00-D09)
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
D01 Carcinoma in situ of other and unspecified digestive organs
D02 Carcinoma in situ of middle ear and respiratory system
D03 Melanoma in situ
D04 Carcinoma in situ of skin
D05 Carcinoma in situ of breast
D06 Carcinoma in situ of cervix uteri
D07 Carcinoma in situ of other and unspecified genital organs
D09 Carcinoma in situ of other and unspecified sites
Benign neoplasms (D10-D36)
D10 Benign neoplasm of mouth and pharynx
D11 Benign neoplasm of major salivary glands
D12 Benign neoplasm of colon, rectum, anus and anal canal
D13 Benign neoplasm of other and ill-defined parts of digestive system
D14 Benign neoplasm of middle ear and respiratory system
D15 Benign neoplasm of other and unspecified intrathoracic organs
D16 Benign neoplasm of bone and articular cartilage
D17 Benign lipomatous neoplasm
D18 Haemangioma and lymphangioma, any site
D19 Benign neoplasm of mesothelial tissue
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum
D21 Other benign neoplasms of connective and other soft tissue
D22 Melanocytic naevi
D23 Other benign neoplasms of skin
D24 Benign neoplasm of breast
D25 Leiomyoma of uterus
D26 Other benign neoplasms of uterus
D27 Benign neoplasm of ovary
D28 Benign neoplasm of other and unspecified female genital organs
D29 Benign neoplasm of male genital organs
D30 Benign neoplasm of urinary organs
D31 Benign neoplasm of eye and adnexa
D32 Benign neoplasm of meninges
D33 Benign neoplasm of brain and other parts of central nervous system
D34 Benign neoplasm of thyroid gland
D35 Benign neoplasm of other and unspecified endocrine glands
D36 Benign neoplasm of other and unspecified sites
Neoplasms of uncertain or unknown behaviour (D37-D48)
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
D42 Neoplasm of uncertain or unknown behaviour of meninges
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
D45 Polycythaemia vera
D46 Myelodysplastic syndromes
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
Chapter III - Diseases of blood and blood-forming organs and certain disorders involving the immune mechanisms (D50-D89)
Nutritional anaemias (D50-D53)
D50 Iron deficiency anaemia
D51 Vitamin B12 deficiency anaemia
D52 Folate deficiency anaemia
D53 Other nutritional anaemias
Haemolytic anaemias (D55-D59)
D55 Anaemia due to enzyme disorders
D56 Thalassaemia
D57 Sickle-cell disorders
D58 Other hereditary haemolytic anaemias
D59 Acquired haemolytic anaemia
Aplastic and other anaemias (D60-D64)
D60 Acquired pure red cell aplasia [erythroblastopenia]
D61 Other aplastic anaemias
D62 Acute posthaemorrhagic anaemia
D63* Anaemia in chronic diseases classified elsewhere
D64 Other anaemias
Coagulation defects, purpura and other haemorrhagic conditions (D65-D69)
D65 Disseminated intravascular coagulation [defibrination syndrome]
D66 Hereditary factor VIII deficiency
D67 Hereditary factor IX deficiency
D68 Other coagulation defects
D69 Purpura and other haemorrhagic conditions
Other diseases of blood and blood-forming organs (D70-D77)
D70 Agranulocytosis
D71 Functional disorders of polymorphonuclear neutrophils
D72 Other disorders of white blood cells
D73 Diseases of spleen
D74 Methaemoglobinaemia
D75 Other diseases of blood and blood-forming organs
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
D77* Other disorders of blood and blood-forming organs in diseases classified elsewhere
Certain disorders involving the immune mechanism (D80-D89)
D80 Immunodeficiency with predominantly antibody defects
D81 Combined immunodeficiencies
D82 Immunodeficiency associated with other major defects
D83 Common variable immunodeficiency
D84 Other immunodeficiencies
D86 Sarcoidosis
D89 Other disorders involving the immune mechanism, not elsewhere classified
Chapter IV - Endocrine, nutritional and metabolic diseases (E00-E90)
Disorders of thyroid gland (E00-E07)
E00 Congenital iodine-deficiency syndrome
E01 Iodine-deficiency-related thyroid disorders and allied conditions
E02 Subclinical iodine-deficiency hypothyroidism
E03 Other hypothyroidism
E04 Other nontoxic goitre
E05 Thyrotoxicosis [hyperthyroidism]
E06 Thyroiditis
E07 Other disorders of thyroid
Diabetes mellitus (E10-E14)
E10 Type 1 diabetes mellitus
E11 Type 2 diabetes mellitus
E12 Malnutrition-related diabetes mellitus
E13 Other specified diabetes mellitus
E14 Unspecified diabetes mellitus
Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)
E15 Nondiabetic hypoglycaemic coma
E16 Other disorders of pancreatic internal secretion
Disorders of other endocrine glands (E20-E35)
E20 Hypoparathyroidism
E21 Hyperparathyroidism and other disorders of parathyroid gland
E22 Hyperfunction of pituitary gland
E23 Hypofunction and other disorders of pituitary gland
E24 Cushing syndrome
E25 Adrenogenital disorders
E26 Hyperaldosteronism
E27 Other disorders of adrenal gland
E28 Ovarian dysfunction
E29 Testicular dysfunction
E30 Disorders of puberty, not elsewhere classified
E31 Polyglandular dysfunction
E32 Diseases of thymus
E34 Other endocrine disorders
E35* Disorders of endocrine glands in diseases classified elsewhere
Malnutrition (E40-E46)
E40 Kwashiorkor
E41 Nutritional marasmus
E42 Marasmic kwashiorkor
E43 Unspecified severe protein-energy malnutrition
E44 Protein-energy malnutrition of moderate and mild degree
E45 Retarded development following protein-energy malnutrition
E46 Unspecified protein-energy malnutrition
Other nutritional deficiencies (E50-E64)
E50 Vitamin A deficiency
E51 Thiamine deficiency
E52 Niacin deficiency [pellagra]
E53 Deficiency of other B group vitamins
E54 Ascorbic acid deficiency
E55 Vitamin D deficiency
E56 Other vitamin deficiencies
E58 Dietary calcium deficiency
E59 Dietary selenium deficiency
E60 Dietary zinc deficiency
E61 Deficiency of other nutrient elements
E63 Other nutritional deficiencies
E64 Sequelae of malnutrition and other nutritional deficiencies
Obesity and other hyperalimentation (E65-E68)
E65 Localized adiposity
E66 Obesity
E67 Other hyperalimentation
E68 Sequelae of hyperalimentation
Metabolic disorders (E70-E90)
E70 Disorders of aromatic amino-acid metabolism
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
E72 Other disorders of amino-acid metabolism
E73 Lactose intolerance
E74 Other disorders of carbohydrate metabolism
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
E76 Disorders of glycosaminoglycan metabolism
E77 Disorders of glycoprotein metabolism
E78 Disorders of lipoprotein metabolism and other lipidaemias
E79 Disorders of purine and pyrimidine metabolism
E80 Disorders of porphyrin and bilirubin metabolism
E83 Disorders of mineral metabolism
E84 Cystic fibrosis
E85 Amyloidosis
E86 Volume depletion
E87 Other disorders of fluid, electrolyte and acid-base balance
E88 Other metabolic disorders
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
E90* Nutritional and metabolic disorders in diseases classified elsewhere
Chapter V - Mental, behavioural disorders (F00-F99)
Organic, including symptomatic, mental disorders (F00-F09)
F00* Dementia in Alzheimer disease
F01 Vascular dementia
F02* Dementia in other diseases classified elsewhere
F03 Unspecified dementia
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
F05 Delirium, not induced by alcohol and other psychoactive substances
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
F09 Unspecified organic or symptomatic mental disorder
Mental and behavioural disorders due to psychoactive substance use (F10-F19)
F10 Mental and behavioural disorders due to use of alcohol
F11 Mental and behavioural disorders due to use of opioids
F12 Mental and behavioural disorders due to use of cannabinoids
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
F14 Mental and behavioural disorders due to use of cocaine
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
F16 Mental and behavioural disorders due to use of hallucinogens
F17 Mental and behavioural disorders due to use of tobacco
F18 Mental and behavioural disorders due to use of volatile solvents
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
Schizophrenia, schizotypal and delusional disorders (F20-F29)
F20 Schizophrenia
F21 Schizotypal disorder
F22 Persistent delusional disorders
F23 Acute and transient psychotic disorders
F24 Induced delusional disorder
F25 Schizoaffective disorders
F28 Other nonorganic psychotic disorders
F29 Unspecified nonorganic psychosis
Mood [affective] disorders (F30-F39)
F30 Manic episode
F31 Bipolar affective disorder
F32 Depressive episodes
F33 Recurrent depressive disorder
F34 Persistent mood [affective] disorders
F38 Other mood [affective] disorders
F39 Unspecified mood [affective] disorder
Neurotic, stress-related and somatoform disorders (F40-F48)
F40 Phobic anxiety disorders
F41 Other anxiety disorders
F42 Obsessive-compulsive disorder
F43 Reaction to severe stress, and adjustment disorders
F44 Dissociative [conversion] disorders
F45 Somatoform disorders
F48 Other neurotic disorders
Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59)
F50 Eating disorders
F51 Nonorganic sleep disorders
F52 Sexual dysfunction, not caused by organic disorder or disease
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
F55 Abuse of non-dependence-producing substances
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
Disorders of adult personality and behaviour (F60-F69)
F60 Specific personality disorders
F61 Mixed and other personality disorders
F62 Enduring personality changes, not attributable to brain damage and disease
F63 Habit and impulse disorders
F64 Gender identity disorders
F65 Disorders of sexual preference
F66 Psychological and behavioural disorders associated with sexual development and orientation
F68 Other disorders of adult personality and behaviour
F69 Unspecified disorder of adult personality and behaviour
Mental retardation (F70-F79)
F70 Mild mental retardation
F71 Moderate mental retardation
F72 Severe mental retardation
F73 Profound mental retardation
F78 Other mental retardation
F79 Unspecified mental retardation
Disorders of psychological development (F80-F89)
F80 Specific developmental disorders of speech and language
F81 Specific developmental disorders of scholastic skills
F82 Specific developmental disorder of motor function
F83 Mixed specific developmental disorders
F84 Pervasive developmental disorders
F88 Other disorders of psychological development
F89 Unspecified disorder of psychological development
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98)
F90 Hyperkinetic disorders
F91 Conduct disorders
F92 Mixed disorders of conduct and emotions
F93 Emotional disorders with onset specific to childhood
F94 Disorders of social functioning with onset specific to childhood and adolescence
F95 Tic disorders
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
Unspecified mental disorder (F99)
F99 Mental disorder, not otherwise specified
Chapter VI - Diseases of the nervous system (G00-G99)
Inflammatory diseases of the central nervous system (G00-G09)
G00 Bacterial meningitis, not elsewhere classified
G01* Meningitis in bacterial diseases classified elsewhere
G02* Meningitis in other infectious and parasitic diseases classified elsewhere
G03 Meningitis due to other and unspecified causes
G04 Encephalitis, myelitis and encephalomyelitis
G05* Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
G06 Intracranial and intraspinal abscess and granuloma
G07* Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
G09 Sequelae of inflammatory diseases of central nervous system
Systemic atrophies primarily affecting the central nervous system (G10-G14)
G10 Huntington disease
G11 Hereditary ataxia
G12 Spinal muscular atrophy and related syndromes
G13* Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
G14 Postpolio syndrome
Extrapyramidal and movement disorders (G20-G26)
G20 Parkinson disease
G21 Secondary parkinsonism
G22* Parkinsonism in diseases classified elsewhere
G23 Other degenerative diseases of the basal ganglia
G24 Dystonia
G25 Other extrapyramidal and movement disorders
G26* Extrapyramidal and movement disorders in diseases classified elsewhere
Other degenerative diseases of the nervous system (G30-G32)
G30 Alzheimer disease
G31 Other degenerative diseases of nervous system, not elsewhere classified
G32* Other degenerative disorders of nervous system in diseases classified elsewhere
Demyelinating diseases of the central nervous system (G35-G37)
G35 Multiple sclerosis
G36 Other acute disseminated demyelination
G37 Other demyelinating diseases of central nervous system
Episodic and paroxysmal disorders (G40-G47)
G40 Epilepsy
G41 Status epilepticus
G43 Migraine
G44 Other headache syndromes
G45 Transient cerebral ischaemic attacks and related syndromes
G46* Vascular syndromes of brain in cerebrovascular diseases
G47 Sleep disorders
Nerve, nerve root and plexus disorders (G50-G59)
G50 Disorders of trigeminal nerve
G51 Facial nerve disorders
G52 Disorders of other cranial nerves
G53* Cranial nerve disorders in diseases classified elsewhere
G54 Nerve root and plexus disorders
G55* Nerve root and plexus compressions in diseases classified elsewhere
G56 Mononeuropathies of upper limb
G57 Mononeuropathies of lower limb
G58 Other mononeuropathies
G59* Mononeuropathy in diseases classified elsewhere
Polyneuropathies and other disorders of the peripheral nervous system (G60-G64)
G60 Hereditary and idiopathic neuropathy
G61 Inflammatory polyneuropathy
G62 Other polyneuropathies
G63* Polyneuropathy in diseases classified elsewhere
G64 Other disorders of peripheral nervous system
Diseases of myoneural junction and muscle (G70-G73)
G70 Myasthenia gravis and other myoneural disorders
G71 Primary disorders of muscles
G72 Other myopathies
G73* Disorders of myoneural junction and muscle in diseases classified elsewhere
Cerebral palsy and other paralytic syndromes (G80-G83)
G80 Cerebral palsy
G81 Hemiplegia
G82 Paraplegia and tetraplegia
G83 Other paralytic syndromes
Other disorders of the nervous system (G90-G99)
G90 Disorders of autonomic nervous system
G91 Hydrocephalus
G92 Toxic encephalopathy
G93 Other disorders of brain
G94* Other disorders of brain in diseases classified elsewhere
G95 Other diseases of spinal cord
G96 Other disorders of central nervous system
G97 Postprocedural disorders of nervous system, not elsewhere classified
G98 Other disorders of nervous system, not elsewhere classified
G99* Other disorders of nervous system in diseases classified elsewhere
Chapter VII - Diseases of the eye and adnexa (H00-H59)
Disorders of eyelid, lacrimal system and orbit (H00-H06)
H00 Hordeolum and chalazion
H01 Other inflammation of eyelid
H02 Other disorders of eyelid
H03* Disorders of eyelid in diseases classified elsewhere
H04 Disorders of lacrimal system
H05 Disorders of orbit
H06* Disorders of lacrimal system and orbit in diseases classified elsewhere
Disorders of conjunctiva (H10-H13)
H10 Conjunctivitis
H11 Other disorders of conjunctiva
H13* Disorders of conjunctiva in diseases classified elsewhere
Disorders of sclera, cornea, iris and ciliary body (H15-H22)
H15 Disorders of sclera
H16 Keratitis
H17 Corneal scars and opacities
H18 Other disorders of cornea
H19* Disorders of sclera and cornea in diseases classified elsewhere
H20 Iridocyclitis
H21 Other disorders of iris and ciliary body
H22* Disorders of iris and ciliary body in diseases classified elsewhere
Disorders of lens (H25-H28)
H25 Senile cataract
H26 Other cataract
H27 Other disorders of lens
H28* Cataract and other disorders of lens in diseases classified elsewhere
Disorders of choroid and retina (H30-H36)
H30 Chorioretinal inflammation
H31 Other disorders of choroid
H32* Chorioretinal disorders in diseases classified elsewhere
H33 Retinal detachments and breaks
H34 Retinal vascular occlusions
H35 Other retinal disorders
H36* Retinal disorders in diseases classified elsewhere
Glaucoma (H40-H42)
H40 Glaucoma
H42* Glaucoma in diseases classified elsewhere
Disorders of vitreous body and globe (H43-H45)
H43 Disorders of vitreous body
H44 Disorders of globe
H45* Disorders of vitreous body and globe in diseases classified elsewhere
Disorders of optic nerve and visual pathways (H46-H48)
H46 Optic neuritis
H47 Other disorders of optic [2nd] nerve and visual pathways
H48* Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52)
H49 Paralytic strabismus
H50 Other strabismus
H51 Other disorders of binocular movement
H52 Disorders of refraction and accommodation
Visual disturbances and blindness (H53-H54)
H53 Visual disturbances
H54 Visual impairment including blindness (binocular or monocular)
Other disorders of eye and adnexa (H55-H59)
H55 Nystagmus and other irregular eye movements
H57 Other disorders of eye and adnexa
H58* Other disorders of eye and adnexa in diseases classified elsewhere
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
Chapter VIII - Diseases of the ear and mastoid process (H60-H95)
Diseases of external ear (H60-H62)
H60 Otitis externa
H61 Other disorders of external ear
H62* Disorders of external ear in diseases classified elsewhere
Diseases of middle ear and mastoid (H65-H75)
H65 Nonsuppurative otitis media
H66 Suppurative and unspecified otitis media
H67* Otitis media in diseases classified elsewhere
H68 Eustachian salpingitis and obstruction
H69 Other disorders of Eustachian tube
H70 Mastoiditis and related conditions
H71 Cholesteatoma of middle ear
H72 Perforation of tympanic membrane
H73 Other disorders of tympanic membrane
H74 Other disorders of middle ear and mastoid
H75* Other disorders of middle ear and mastoid in diseases classified elsewhere
Diseases of inner ear (H80-H83)
H80 Otosclerosis
H81 Disorders of vestibular function
H82* Vertiginous syndromes in diseases classified elsewhere
H83 Other diseases of inner ear
Other disorders of ear (H90-H95)
H90 Conductive and sensorineural hearing loss
H91 Other hearing loss
H92 Otalgia and effusion of ear
H93 Other disorders of ear, not elsewhere classified
H94* Other disorders of ear in diseases classified elsewhere
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
Chapter IX - Diseases of the circulatory system (I00-I99)
Acute rheumatic fever (I00-I02)
I00 Rheumatic fever without mention of heart involvement
I01 Rheumatic fever with heart involvement
I02 Rheumatic chorea
Chronic rheumatic heart diseases (I05-I09)
I05 Rheumatic mitral valve diseases
I06 Rheumatic aortic valve diseases
I07 Rheumatic tricuspid valve diseases
I08 Multiple valve diseases
I09 Other rheumatic heart diseases
Hypertensive diseases (I10-I15)
I10 Essential (primary) hypertension
I11 Hypertensive heart disease
I12 Hypertensive renal disease
I13 Hypertensive heart and renal disease
I15 Secondary hypertension
Ischaemic heart diseases (I20-I25)
I20 Angina pectoris
I21 Acute myocardial infarction
I22 Subsequent myocardial infarction
I23 Certain current complications following acute myocardial infarction
I24 Other acute ischaemic heart diseases
I25 Chronic ischaemic heart disease
Pulmonary heart disease and diseases of pulmonary circulation (I26-I28)
I26 Pulmonary embolism
I27 Other pulmonary heart diseases
I28 Other diseases of pulmonary vessels
Other forms of heart disease (I30-I52)
I30 Acute pericarditis
I31 Other diseases of pericardium
I32* Pericarditis in diseases classified elsewhere
I33 Acute and subacute endocarditis
I34 Nonrheumatic mitral valve disorders
I35 Nonrheumatic aortic valve disorders
I36 Nonrheumatic tricuspid valve disorders
I37 Pulmonary valve disorders
I38 Endocarditis, valve unspecified
I39* Endocarditis and heart valve disorders in diseases classified elsewhere
I40 Acute myocarditis
I41* Myocarditis in diseases classified elsewhere
I42 Cardiomyopathy
I43* Cardiomyopathy in diseases classified elsewhere
I44 Atrioventricular and left bundle-branch block
I45 Other conduction disorders
I46 Cardiac arrest
I47 Paroxysmal tachycardia
I48 Atrial fibrillation and flutter
I49 Other cardiac arrhythmias
I50 Heart failure
I51 Complications and ill-defined descriptions of heart disease
I52* Other heart disorders in diseases classified elsewhere
Cerebrovascular diseases (I60-I69)
I60 Subarachnoid haemorrhage
I61 Intracerebral haemorrhage
I62 Other nontraumatic intracranial haemorrhage
I63 Cerebral infarction
I64 Stroke, not specified as haemorrhage or infarction
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
I67 Other cerebrovascular diseases
I68* Cerebrovascular disorders in diseases classified elsewhere
I69 Sequelae of cerebrovascular disease
Diseases of arteries, arterioles and capillaries (I70-I79)
I70 Atherosclerosis
I71 Aortic aneurysm and dissection
I72 Other aneurysm and dissection
I73 Other peripheral vascular diseases
I74 Arterial embolism and thrombosis
I77 Other disorders of arteries and arterioles
I78 Diseases of capillaries
I79* Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89)
I80 Phlebitis and thrombophlebitis
I81 Portal vein thrombosis
I82 Other venous embolism and thrombosis
I83 Varicose veins of lower extremities
I84 Haemorrhoids
I85 Oesophageal varices
I86 Varicose veins of other sites
I87 Other disorders of veins
I88 Nonspecific lymphadenitis
I89 Other noninfective disorders of lymphatic vessels and lymph nodes
Other and unspecified disorders of the circulatory system (I95-I99)
I95 Hypotension
I97 Postprocedural disorders of circulatory system, not elsewhere classified
I98* Other disorders of circulatory system in diseases classified elsewhere
I99 Other and unspecified disorders of circulatory system
Chapter X - Diseases of the respiratory system (J00-J99)
Acute upper respiratory infections (J00-J06)
J00 Acute nasopharyngitis [common cold]
J01 Acute sinusitis
J02 Acute pharyngitis
J03 Acute tonsillitis
J04 Acute laryngitis and tracheitis
J05 Acute obstructive laryngitis [croup] and epiglottitis
J06 Acute upper respiratory infections of multiple or unspecified sites
Influenza and pneumonia (J09-J18)
J09 Influenza due to identified zoonotic or pandemic influenza virus
J10 Influenza due to identified seasonal influenza virus
J11 Influenza, virus not identified
J12 Viral pneumonia, not elsewhere classified
J13 Pneumonia due to Streptococcus pneumoniae
J14 Pneumonia due to Haemophilus influenzae
J15 Bacterial pneumonia, not elsewhere classified
J16 Pneumonia due to other infectious organisms, not elsewhere classified
J17* Pneumonia in diseases classified elsewhere
J18 Pneumonia, organism unspecified
Other acute lower respiratory infections (J20-J22)
J20 Acute bronchitis
J21 Acute bronchiolitis
J22 Unspecified acute lower respiratory infection
Other diseases of upper respiratory tract (J30-J39)
J30 Vasomotor and allergic rhinitis
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
J32 Chronic sinusitis
J33 Nasal polyp
J34 Other disorders of nose and nasal sinuses
J35 Chronic diseases of tonsils and adenoids
J36 Peritonsillar abscess
J37 Chronic laryngitis and laryngotracheitis
J38 Diseases of vocal cords and larynx, not elsewhere classified
J39 Other diseases of upper respiratory tract
Chronic lower respiratory diseases (J40-J47)
J40 Bronchitis, not specified as acute or chronic
J41 Simple and mucopurulent chronic bronchitis
J42 Unspecified chronic bronchitis
J43 Emphysema
J44 Other chronic obstructive pulmonary disease
J45 Asthma
J46 Status asthmaticus
J47 Bronchiectasis
Lung diseases due to external agents (J60-J70)
J60 Coalworker pneumoconiosis
J61 Pneumoconiosis due to asbestos and other mineral fibres
J62 Pneumoconiosis due to dust containing silica
J63 Pneumoconiosis due to other inorganic dusts
J64 Unspecified pneumoconiosis
J65 Pneumoconiosis associated with tuberculosis
J66 Airway disease due to specific organic dust
J67 Hypersensitivity pneumonitis due to organic dust
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
J69 Pneumonitis due to solids and liquids
J70 Respiratory conditions due to other external agents
Other respiratory diseases principally affecting the interstitium (J80-J84)
J80 Adult respiratory distress syndrome
J81 Pulmonary oedema
J82 Pulmonary eosinophilia, not elsewhere classified
J84 Other interstitial pulmonary diseases
Suppurative and necrotic conditions of lower respiratory tract (J85-J86)
J85 Abscess of lung and mediastinum
J86 Pyothorax
Other diseases of pleura (J90-J94)
J90 Pleural effusion, not elsewhere classified
J91* Pleural effusion in conditions classified elsewhere
J92 Pleural plaque
J93 Pneumothorax
J94 Other pleural conditions
Other diseases of the respiratory system (J95-J99)
J95 Postprocedural respiratory disorders, not elsewhere classified
J96 Respiratory failure, not elsewhere classified
J98 Other respiratory disorders
J99* Respiratory disorders in diseases classified elsewhere
Chapter XI - Diseases of the digestive system (K00-K93)
Diseases of oral cavity, salivary glands and jaws (K00-K14)
K00 Disorders of tooth development and eruption
K01 Embedded and impacted teeth
K02 Dental caries
K03 Other diseases of hard tissues of teeth
K04 Diseases of pulp and periapical tissues
K05 Gingivitis and periodontal diseases
K06 Other disorders of gingiva and edentulous alveolar ridge
K07 Dentofacial anomalies [including malocclusion]
K08 Other disorders of teeth and supporting structures
K09 Cysts of oral region, not elsewhere classified
K10 Other diseases of jaws
K11 Diseases of salivary glands
K12 Stomatitis and related lesions
K13 Other diseases of lip and oral mucosa
K14 Diseases of tongue
Diseases of oesophagus, stomach and duodenum (K20-K31)
K20 Oesophagitis
K21 Gastro-oesophageal reflux disease
K22 Other diseases of oesophagus
K23* Disorders of oesophagus in diseases classified elsewhere
K25 Gastric ulcer
K26 Duodenal ulcer
K27 Peptic ulcer, site unspecified
K28 Gastrojejunal ulcer
K29 Gastritis and duodenitis
K30 Functional dyspepsia
K31 Other diseases of stomach and duodenum
Diseases of appendix (K35-K38)
K35 Acute appendicitis
K36 Other appendicitis
K37 Unspecified appendicitis
K38 Other diseases of appendix
Hernia (K40-K46)
K40 Inguinal hernia
K41 Femoral hernia
K42 Umbilical hernia
K43 Ventral hernia
K44 Diaphragmatic hernia
K45 Other abdominal hernia
K46 Unspecified hernia of abdominal cavity
Noninfective enteritis and colitis (K50-K52)
K50 Crohn disease [regional enteritis]
K51 Ulcerative colitis
K52 Other noninfective gastroenteritis and colitis
Other diseases of intestines (K55-K63)
K55 Vascular disorders of intestine
K56 Paralytic ileus and intestinal obstruction without hernia
K57 Diverticular disease of intestine
K58 Irritable bowel syndrome
K59 Other functional intestinal disorders
K60 Fissure and fistula of anal and rectal regions
K61 Abscess of anal and rectal regions
K62 Other diseases of anus and rectum
K63 Other diseases of intestine
Diseases of peritoneum (K65-K67)
K65 Peritonitis
K66 Other disorders of peritoneum
K67* Disorders of peritoneum in infectious diseases classified elsewhere
Diseases of liver (K70-K77)
K70 Alcoholic liver disease
K71 Toxic liver disease
K72 Hepatic failure, not elsewhere classified
K73 Chronic hepatitis, not elsewhere classified
K74 Fibrosis and cirrhosis of liver
K75 Other inflammatory liver diseases
K76 Other diseases of liver
K77* Liver disorders in diseases classified elsewhere
Disorders of gallbladder, biliary tract and pancreas (K80-K87)
K80 Cholelithiasis
K81 Cholecystitis
K82 Other diseases of gallbladder
K83 Other diseases of biliary tract
K85 Acute pancreatitis
K86 Other diseases of pancreas
K87* Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
Other diseases of the digestive system (K90-K93)
K90 Intestinal malabsorption
K91 Postprocedural disorders of digestive system, not elsewhere classified
K92 Other diseases of digestive system
K93* Disorders of other digestive organs in diseases classified elsewhere
Chapter XII - Diseases of the skin and subcutaneous tissue (L00-L99)
Infections of the skin and subcutaneous tissue (L00-L08)
L00 Staphylococcal scalded skin syndrome
L01 Impetigo
L02 Cutaneous abscess, furuncle and carbuncle
L03 Cellulitis
L04 Acute lymphadenitis
L05 Pilonidal cyst
L08 Other local infections of skin and subcutaneous tissue
Bullous disorders (L10-L14)
L10 Pemphigus
L11 Other acantholytic disorders
L12 Pemphigoid
L13 Other bullous disorders
L14* Bullous disorders in diseases classified elsewhere
Dermatitis and eczema (L20-L30)
L20 Atopic dermatitis
L21 Seborrhoeic dermatitis
L22 Diaper [napkin] dermatitis
L23 Allergic contact dermatitis
L24 Irritant contact dermatitis
L25 Unspecified contact dermatitis
L26 Exfoliative dermatitis
L27 Dermatitis due to substances taken internally
L28 Lichen simplex chronicus and prurigo
L29 Pruritus
L30 Other dermatitis
Papulosquamous disorders (L40-L45)
L40 Psoriasis
L41 Parapsoriasis
L42 Pityriasis rosea
L43 Lichen planus
L44 Other papulosquamous disorders
L45* Papulosquamous disorders in diseases classified elsewhere
Urticaria and erythema (L50-L54)
L50 Urticaria
L51 Erythema multiforme
L52 Erythema nodosum
L53 Other erythematous conditions
L54* Erythema in diseases classified elsewhere
Radiation-related disorders of the skin and subcutaneous tissue (L55-L59)
L55 Sunburn
L56 Other acute skin changes due to ultraviolet radiation
L57 Skin changes due to chronic exposure to nonionizing radiation
L58 Radiodermatitis
L59 Other disorders of skin and subcutaneous tissue related to radiation
Disorders of skin appendages (L60-L75)
L60 Nail disorders
L62* Nail disorders in diseases classified elsewhere
L63 Alopecia areata
L64 Androgenic alopecia
L65 Other nonscarring hair loss
L66 Cicatricial alopecia [scarring hair loss]
L67 Hair colour and hair shaft abnormalities
L68 Hypertrichosis
L70 Acne
L71 Rosacea
L72 Follicular cysts of skin and subcutaneous tissue
L73 Other follicular disorders
L74 Eccrine sweat disorders
L75 Apocrine sweat disorders
Other disorders of the skin and subcutaneous tissue (L80-L99)
L80 Vitiligo
L81 Other disorders of pigmentation
L82 Seborrhoeic keratosis
L83 Acanthosis nigricans
L84 Corns and callosities
L85 Other epidermal thickening
L86* Keratoderma in diseases classified elsewhere
L87 Transepidermal elimination disorders
L88 Pyoderma gangrenosum
L89 Decubitus ulcer and pressure area
L90 Atrophic disorders of skin
L91 Hypertrophic disorders of skin
L92 Granulomatous disorders of skin and subcutaneous tissue
L93 Lupus erythematosus
L94 Other localized connective tissue disorders
L95 Vasculitis limited to skin, not elsewhere classified
L97 Ulcer of lower limb, not elsewhere classified
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified
L99* Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Chapter XIII - Diseases of the musculoskeletal system and connective tissue (M00-M99)
Arthropathies (M00-M25)
Infectious arthropathies (M00-M03)
M00 Pyogenic arthritis
M01* Direct infections of joint in infectious and parasitic diseases classified elsewhere
M02 Reactive arthropathies
M03* Postinfective and reactive arthropathies in diseases classified elsewhere
Inflammatory polyarthropathies (M05-M14)
M05 Seropositive rheumatoid arthritis
M06 Other rheumatoid arthritis
M07* Psoriatic and enteropathic arthropathies
M08 Juvenile arthritis
M09* Juvenile arthritis in diseases classified elsewhere
M10 Gout
M11 Other crystal arthropathies
M12 Other specific arthropathies
M13 Other arthritis
M14* Arthropathies in other diseases classified elsewhere
Arthrosis (M15-M19)
M15 Polyarthrosis
M16 Coxarthrosis [arthrosis of hip]
M17 Gonarthrosis [arthrosis of knee]
M18 Arthrosis of first carpometacarpal joint
M19 Other arthrosis
Other joint disorders (M20-M25)
M20 Acquired deformities of fingers and toes
M21 Other acquired deformities of limbs
M22 Disorders of patella
M23 Internal derangement of knee
M24 Other specific joint derangements
M25 Other joint disorders, not elsewhere classified
Systemic connective tissue disorders (M30-M36)
M30 Polyarteritis nodosa and related conditions
M31 Other necrotizing vasculopathies
M32 Systemic lupus erythematosus
M33 Dermatopolymyositis
M34 Systemic sclerosis
M35 Other systemic involvement of connective tissue
M36* Systemic disorders of connective tissue in diseases classified elsewhere
Dorsopathies (M40-M54)
Deforming dorsopathies (M40-M43)
M40 Kyphosis and lordosis
M41 Scoliosis
M42 Spinal osteochondrosis
M43 Other deforming dorsopathies
Spondylopathies (M45-M49)
M45 Ankylosing spondylitis
M46 Other inflammatory spondylopathies
M47 Spondylosis
M48 Other spondylopathies
M49* Spondylopathies in diseases classified elsewhere
Other dorsopathies (M50-M54)
M50 Cervical disc disorders
M51 Other intervertebral disc disorders
M53 Other dorsopathies, not elsewhere classified
M54 Dorsalgia
Soft tissue disorders (M60-M79)
Disorders of muscles (M60-M63)
M60 Myositis
M61 Calcification and ossification of muscle
M62 Other disorders of muscle
M63* Disorders of muscle in diseases classified elsewhere
Disorders of synovium and tendon (M65-M68)
M65 Synovitis and tenosynovitis
M66 Spontaneous rupture of synovium and tendon
M67 Other disorders of synovium and tendon
M68* Disorders of synovium and tendon in diseases classified elsewhere
Other soft tissue disorders (M70-M79)
M70 Soft tissue disorders related to use, overuse and pressure
M71 Other bursopathies
M72 Fibroblastic disorders
M73* Soft tissue disorders in diseases classifed elsewhere
M75 Shoulder lesions
M76 Enthesopathies of lower limb, excluding foot
M77 Other enthesopathies
M79 Other soft tissue disorders, not elsewhere classified
Osteopathies and chondropathies (M80-M94)
Disorders of bone density and structure (M80-M85)
M80 Osteoporosis with pathological fracture
M81 Osteoporosis without pathological fracture
M82* Osteoporosis in diseases classified elsewhere
M83 Adult osteomalacia
M84 Disorders of continuity of bone
M85 Other disorders of bone density and structure
Other osteopathies (M86-M90)
M86 Osteomyelitis
M87 Osteonecrosis
M88 Paget disease of bone [osteitis deformans]
M89 Other disorders of bone
M90* Osteopathies in diseases classified elsewhere
Chondropathies (M91-M94)
M91 Juvenile osteochondrosis of hip and pelvis
M92 Other juvenile osteochondrosis
M93 Other osteochondropathies
M94 Other disorders of cartilage
Other disorders of the musculoskeletal system and connective tissue (M95-M99)
M95 Other acquired deformities of musculoskeletal system
M96 Postprocedural muscoloskeletal disorders, not elsewhere classified
M99 Biomechanical lesions, not elsewhere classified
Chapter XIV - Diseases of the genitourinary system (N00-N99)
Glomerular diseases (N00-N08)
N00 Acute nephritic syndrome
N01 Rapidly progressive nephritic syndrome
N02 Recurrent and persistent haematuria
N03 Chronic nephritic syndrome
N04 Nephrotic syndrome
N05 Unspecified nephritic syndrome
N06 Isolated proteinuria with specified morphological lesion
N07 Hereditary nephropathy, not elsewhere classified
N08* Glomerular disorders in diseases classified elsewhere
Renal tubulo-interstitial diseases (N10-N16)
N10 Acute tubulo-interstitial nephritis
N11 Chronic tubulo-interstitial nephritis
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
N13 Obstructive and reflux uropathy
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
N15 Other renal tubulo-interstitial diseases
N16* Renal tubulo-interstitial disorders in diseases classified elsewhere
Renal failure (N17-N19)
N17 Acute renal failure
N18 Chronic kidney disease
N19 Unspecified kidney failure
Urolithiasis (N20-N23)
N20 Calculus of kidney and ureter
N21 Calculus of lower urinary tract
N22* Calculus of urinary tract in diseases classified elsewhere
N23 Unspecified renal colic
Other disorders of kidney and ureter (N25-N29)
N25 Disorders resulting from impaired renal tubular function
N26 Unspecified contracted kidney
N27 Small kidney of unknown cause
N28 Other disorders of kidney and ureter, not elsewhere classified
N29* Other disorders of kidney and ureter in diseases classified elsewhere
Other diseases of urinary system (N30-N39)
N30 Cystitis
N31 Neuromuscular dysfunction of bladder, not elsewhere classified
N32 Other disorders of bladder
N33* Bladder disorders in diseases classified elsewhere
N34 Urethritis and urethral syndrome
N35 Urethral stricture
N36 Other disorders of urethra
N37* Urethral disorders in diseases classified elsewhere
N39 Other disorders of urinary system
Diseases of male genital organs (N40-N51)
N40 Hyperplasia of prostate
N41 Inflammatory diseases of prostate
N42 Other disorders of prostate
N43 Hydrocele and spermatocele
N44 Torsion of testis
N45 Orchitis and epididymitis
N46 Male infertility
N47 Redundant prepuce, phimosis and paraphimosis
N48 Other disorders of penis
N49 Inflammatory disorders of male genital organs, not elsewhere classified
N50 Other disorders of male genital organs
N51* Disorders of male genital organs in diseases classified elsewhere
Disorders of breast (N60-N64)
N60 Benign mammary dysplasia
N61 Inflammatory disorders of breast
N62 Hypertrophy of breast
N63 Unspecified lump in breast
N64 Other disorders of breast
Inflammatory diseases of female pelvic organs (N70-N77)
N70 Salpingitis and oophoritis
N71 Inflammatory disease of uterus, except cervix
N72 Inflammatory disease of cervix uteri
N73 Other female pelvic inflammatory diseases
N74* Female pelvic inflammatory disorders in diseases classified elsewhere
N75 Diseases of Bartholin gland
N76 Other inflammation of vagina and vulva
N77* Vulvovaginal ulceration and inflammation in diseases classified elsewhere
Noninflammatory disorders of female genital tract (N80-N98)
N80 Endometriosis
N81 Female genital prolapse
N82 Fistulae involving female genital tract
N83 Noninflammatory disorders of ovary, fallopian tube and broad ligament
N84 Polyp of female genital tract
N85 Other noninflammatory disorders of uterus, except cervix
N86 Erosion and ectropion of cervix uteri
N87 Dysplasia of cervix uteri
N88 Other noninflammatory disorders of cervix uteri
N89 Other noninflammatory disorders of vagina
N90 Other noninflammatory disorders of vulva and perineum
N91 Absent, scanty and rare menstruation
N92 Excessive, frequent and irregular menstruation
N93 Other abnormal uterine and vaginal bleeding
N94 Pain and other conditions associated with female genital organs and menstrual cycle
N95 Menopausal and other perimenopausal disorders
N96 Habitual aborter
N97 Female infertility
N98 Complications associated with artificial fertilization
Other disorders of the genitourinary tract (N99)
N99 Postprocedural disorders of the genitourinary system, not elsewhere classified
Chapter XV - Pregnancy, childbirth and the puerperium (O00-O99)
Pregnancy with abortive outcome (O00-O08)
O00 Ectopic pregnancy
O01 Hydatidiform mole
O02 Other abnormal products of conception
O03 Spontaneous abortion
O04 Medical abortion
O05 Other abortion
O06 Unspecified abortion
O07 Failed attempted abortion
O08 Complications following abortion and ectopic and molar pregnancy
Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium (O10-O16)
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium
O11 Pre-existing hypertensive disorder with superimposed proteinuria
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria
O15 Eclampsia
O16 Unspecified maternal hypertension
Other maternal disorders predominantly related to pregnancy (O20-O29)
O20 Haemorrhage in early pregnancy
O21 Excessive vomiting in pregnancy
O22 Venous complications in pregnancy
O23 Infections of genitourinary tract in pregnancy
O24 Diabetes mellitus in pregnancy
O25 Malnutrition in pregnancy
O26 Maternal care for other conditions predominantly related to pregnancy
O28 Abnormal findings on antenatal screening of mother
O29 Complications of anaesthesia during pregnancy
Maternal care related to fetus and amniotic cavity and possible delivery problems (O30-O48)
O30 Multiple gestation
O31 Complications specific to multiple gestation
O32 Maternal care for known or suspected malpresentation of fetus
O33 Maternal care for known or suspected disproportion
O34 Maternal care for known or suspected abnormality of pelvic organs
O35 Maternal care for known or suspected fetal abnormality and damage
O36 Maternal care for other known or suspected fetal problems
O40 Polyhydramnios
O41 Other disorders of amniotic fluid and membranes
O42 Premature rupture of membranes
O43 Placental disorders
O44 Placenta praevia
O45 Premature separation of placenta [abruptio placentae]
O46 Antepartum haemorrhage, not elsewhere classified
O47 False labour
O48 Prolonged pregnancy
Complications of labour and delivery (O60-O75)
O60 Preterm labour
O61 Failed induction of labour
O62 Abnormalities of forces of labour
O63 Long labour
O64 Obstructed labour due to malposition and malpresentation of fetus
O65 Obstructed labour due to maternal pelvic abnormality
O66 Other obstructed labour
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified
O68 Labour and delivery complicated by fetal stress [distress]
O69 Labour and delivery complicated by umbilical cord complications
O70 Perineal laceration during delivery
O71 Other obstetric trauma
O72 Postpartum haemorrhage
O73 Retained placenta and membranes, without haemorrhage
O74 Complications of anaesthesia during labour and delivery
O75 Other complications of labour and delivery, not elsewhere classified
Delivery (O80-O84)
O80 Single spontaneous delivery
O81 Single delivery by forceps and vacuum extractor
O82 Single delivery by caesarean section
O83 Other assisted single delivery
O84 Multiple delivery
Complications predominantly related to the puerperium (O85-O92)
O85 Puerperal sepsis
O86 Other puerperal infections
O87 Venous complications in the puerperium
O88 Obstetric embolism
O89 Complications of anaesthesia during the puerperium
O90 Complications of the puerperium, not elsewhere classified
O91 Infections of breast associated with childbirth
O92 Other disorders of breast and lactation associated with childbirth
Other obstetric conditions, not elsewhere classified (O94-O99)
O94 Sequelae of complication of pregnancy, childbirth and the puerperium
O95 Obstetric death of unspecified cause
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery
O97 Death from sequelae of obstetric causes
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
Chapter XVI - Certain conditions originating in the perinatal period (P00-P96)
Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery (P00-P04)
P00 Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy
P01 Fetus and newborn affected by maternal complications of pregnancy
P02 Fetus and newborn affected by complications of placenta, cord and membranes
P03 Fetus and newborn affected by other complications of labour and delivery
P04 Fetus and newborn affected by noxious influences transmitted via placenta or breast milk
Disorders related to length of gestation and fetal growth (P05-P08)
P05 Slow fetal growth and fetal malnutrition
P07 Disorders related to short gestation and low birth weight, not elsewhere classified
P08 Disorders related to long gestation and high birth weight
Birth trauma (P10-P15)
P10 Intracranial laceration and haemorrhage due to birth injury
P11 Other birth injuries to central nervous system
P12 Birth injury to scalp
P13 Birth injury to skeleton
P14 Birth injury to peripheral nervous system
P15 Other birth injuries
Respiratory and cardiovascular disorders specific to the perinatal period (P20-P29)
P20 Intrauterine hypoxia
P21 Birth asphyxia
P22 Respiratory distress of newborn
P23 Congenital pneumonia
P24 Neonatal aspiration syndromes
P25 Interstitial emphysema and related conditions originating in the perinatal period
P26 Pulmonary haemorrhage originating in the perinatal period
P27 Chronic respiratory disease originating in the perinatal period
P28 Other respiratory conditions originating in the perinatal period
P29 Cardiovascular disorders originating in the perinatal period
Infections specific to the perinatal period (P35-P39)
P35 Congenital viral diseases
P36 Bacterial sepsis of newborn
P37 Other congenital infectious and parasitic diseases
P38 Omphalitis of newborn with or without mild haemorrhage
P39 Other infections specific to the perinatal period
Haemorrhagic and haematological disorders of fetus and newborn (P50-P61)
P50 Fetal blood loss
P51 Umbilical haemorrhage of newborn
P52 Intracranial nontraumatic haemorrhage of fetus and newborn
P53 Haemorrhagic disease of fetus and newborn
P54 Other neonatal haemorrhages
P55 Haemolytic disease of fetus and newborn
P56 Hydrops fetalis due to haemolytic disease
P57 Kernicterus
P58 Neonatal jaundice due to other excessive haemolysis
P59 Neonatal jaundice from other and unspecified causes
P60 Disseminated intravascular coagulation of fetus and newborn
P61 Other perinatal haematological disorders
Transitory endocrine and metabolic disorders specific to fetus and newborn (P70-P74)
P70 Transitory disorders of carbohydrate metabolism specific to fetus and newborn
P71 Transitory neonatal disorders of calcium and magnesium metabolism
P72 Other transitory neonatal endocrine disorders
P74 Other transitory neonatal electrolyte and metabolic disturbances
Digestive system disorders of fetus and newborn (P75-P78)
P75* Meconium ileus
P76 Other intestinal obstruction of newborn
P77 Necrotizing enterocolitis of fetus and newborn
P78 Other perinatal digestive system disorders
Conditions involving the integument and temperature regulation of fetus and newborn (P80-P83)
P80 Hypothermia of newborn
P81 Other disturbances of temperature regulation of newborn
P83 Other conditions of integument specific to fetus and newborn
Other disorders originating in the perinatal period (P90-P96)
P90 Convulsions of newborn
P91 Other disturbances of cerebral status of newborn
P92 Feeding problems of newborn
P93 Reactions and intoxications due to drugs administered to fetus and newborn
P94 Disorders of muscle tone of newborn
P95 Fetal death of unspecified cause
P96 Other conditions originating in the perinatal period
Chapter XVII - Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
Congenital malformations of the nervous system (Q00-Q07)
Q00 Anencephaly and similar malformations
Q01 Encephalocele
Q02 Microcephaly
Q03 Congenital hydrocephalus
Q04 Other congenital malformations of brain
Q05 Spina bifida
Q06 Other congenital malformations of spinal cord
Q07 Other congenital malformations of nervous system
Congenital malformations of eye, ear, face and neck (Q10-Q18)
Q10 Congenital malformations of eyelid, lacrimal apparatus and orbit
Q11 Anophthalmos, microphthalmos and macrophthalmos
Q12 Congenital lens malformations
Q13 Congenital malformations of anterior segment of eye
Q14 Congenital malformations of posterior segment of eye
Q15 Other congenital malformations of eye
Q16 Congenital malformations of ear causing impairment of hearing
Q17 Other congenital malformations of ear
Q18 Other congenital malformations of face and neck
Congenital malformations of the circulatory system (Q20-Q28)
Q20 Congenital malformations of cardiac chambers and connections
Q21 Congenital malformations of cardiac septa
Q22 Congenital malformations of pulmonary and tricuspid valves
Q23 Congenital malformations of aortic and mitral valves
Q24 Other congenital malformations of the heart
Q25 Congenital malformations of great arteries
Q26 Congenital malformations of great veins
Q27 Other congenital malformations of peripheral vascular system
Q28 Other congenital malformations of circulatory system
Congenital malformations of the respiratory system (Q30-Q34)
Q30 Congenital malformations of nose
Q31 Congenital malformations of larynx
Q32 Congenital malformations of trachea and bronchus
Q33 Congenital malformations of lung
Q34 Other congenital malformations of respiratory system
Cleft lip and cleft palate (Q35-Q37)
Q35 Cleft palate
Q36 Cleft lip
Q37 Cleft palate with cleft lip
Other congenital malformations of the digestive system (Q38-Q45)
Q38 Other congenital malformations of tongue, mouth and pharynx
Q39 Congenital malformations of oesophagus
Q40 Other congenital malformations of upper alimentary tract
Q41 Congenital absence, atresia and stenosis of small intestine
Q42 Congenital absence, atresia and stenosis of large intestine
Q43 Other congenital malformations of intestine
Q44 Congenital malformations of gallbladder, bile ducts and liver
Q45 Other congenital malformations of digestive system
Congenital malformations of genital organs (Q50-Q56)
Q50 Congenital malformations of ovaries, fallopian tubes and broad ligaments
Q51 Congenital malformations of uterus and cervix
Q52 Other congenital malformations of female genitalia
Q53 Undescended testicle
Q54 Hypospadias
Q55 Other congenital malformations of male genital organs
Q56 Indeterminate sex and pseudohermaphroditism
Congenital malformations of the urinary system (Q60-Q64)
Q60 Renal agenesis and other reduction defects of kidney
Q61 Cystic kidney disease
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
Q63 Other congenital malformations of kidney
Q64 Other congenital malformations of urinary system
Congenital malformations and deformations of the musculoskeletal system (Q65-Q79)
Q65 Congenital deformities of hip
Q66 Congenital deformities of feet
Q67 Congenital musculoskeletal deformities of head, face, spine and chest
Q68 Other congenital musculoskeletal deformities
Q69 Polydactyly
Q70 Syndactyly
Q71 Reduction defects of upper limb
Q72 Reduction defects of lower limb
Q73 Reduction defects of unspecified limb
Q74 Other congenital malformations of limb(s)
Q75 Other congenital malformations of skull and face bones
Q76 Congenital malformations of spine and bony thorax
Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine
Q78 Other osteochondrodysplasias
Q79 Congenital malformations of the musculoskeletal system, not elsewhere classified
Other congenital malformations (Q80-Q89)
Q80 Congenital ichthyosis
Q81 Epidermolysis bullosa
Q82 Other congenital malformations of skin
Q83 Congenital malformations of breast
Q84 Other congenital malformations of integument
Q85 Phakomatoses, not elsewhere classified
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
Q87 Other specified congenital malformation syndromes affecting multiple systems
Q89 Other congenital malformations, not elsewhere classified
Chromosomal abnormalities, not elsewhere classified (Q90-Q99)
Q90 Down syndrome
Q91 Edward syndrome and Patau syndrome
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified
Q93 Monosomies and deletions from the autosomes, not elsewhere classified
Q95 Balanced rearrangements and structural markers, not elsewhere classified
Q96 Turner syndrome
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified
Q99 Other chromosome abnormalities, not elsewhere classified
Chapter XVIII - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
R00 Abnormalities of heart beat
R01 Cardiac murmurs and other cardiac sounds
R02 Gangrene, not elsewhere classified
R03 Abnormal blood-pressure reading, without diagnosis
R04 Haemorrhage from respiratory passages
R05 Cough
R06 Abnormalities of breathing
R07 Pain in throat and chest
R09 Other symptoms and signs involving the circulatory and respiratory systems
Symptoms and signs involving the digestive system and abdomen (R10-R19)
R10 Abdominal and pelvic pain
R11 Nausea and vomiting
R12 Heartburn
R13 Dysphagia
R14 Flatulence and related conditions
R15 Faecal incontinence
R16 Hepatomegaly and splenomegaly, not elsewhere classified
R17 Unspecified jaundice
R18 Ascites
R19 Other symptoms and signs involving the digestive system and abdomen
Symptoms and signs involving the skin and subcutaneous tissue (R20-R23)
R20 Disturbances of skin sensation
R21 Rash and other nonspecific skin eruption
R22 Localized swelling, mass and lump of skin and subcutaneous tissue
R23 Other skin changes
Symptoms and signs involving the nervous and musculoskeletal systems (R25-R29)
R25 Abnormal involuntary movements
R26 Abnormalities of gait and mobility
R27 Other lack of coordination
R29 Other symptoms and signs involving the nervous and musculoskeletal systems
Symptoms and signs involving the urinary system (R30-R39)
R30 Pain associated with micturition
R31 Unspecified haematuria
R32 Unspecified urinary incontinence
R33 Retention of urine
R34 Anuria and oliguria
R35 Polyuria
R36 Urethral discharge
R39 Other symptoms and signs involving the urinary system
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
R40 Somnolence, stupor and coma
R41 Other symptoms and signs involving cognitive functions and awareness
R42 Dizziness and giddiness
R43 Disturbances of smell and taste
R44 Other symptoms and signs involving general sensations and perceptions
R45 Symptoms and signs involving emotional state
R46 Symptoms and signs involving appearance and behaviour
Symptoms and signs involving speech and voice (R47-R49)
R47 Speech disturbances, not elsewhere classified
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified
R49 Voice disturbances
General symptoms and signs (R50-R69)
R50 Fever of other and unknown origin
R51 Headache
R52 Pain, not elsewhere classified
R53 Malaise and fatigue
R54 Senility
R55 Syncope and collapse
R56 Convulsions, not elsewhere classified
R57 Shock, not elsewhere classified
R58 Haemorrhage, not elsewhere classified
R59 Enlarged lymph nodes
R60 Oedema, not elsewhere classified
R61 Hyperhidrosis
R62 Lack of expected normal physiological development
R63 Symptoms and signs concerning food and fluid intake
R64 Cachexia
R68 Other general symptoms and signs
R69 Unknown and unspecified causes of morbidity
Abnormal findings on examination of blood, without diagnosis (R70-R79)
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
R71 Abnormality of red blood cells
R72 Abnormality of white blood cells, not elsewhere classified
R73 Elevated blood glucose level
R74 Abnormal serum enzyme levels
R75 Laboratory evidence of human immunodeficiency virus [HIV]
R76 Other abnormal immunological findings in serum
R77 Other abnormalities of plasma proteins
R78 Findings of drugs and other substances, not normally found in blood
R79 Other abnormal findings of blood chemistry
Abnormal findings on examination of urine, without diagnosis (R80-R82)
R80 Isolated proteinuria
R81 Glycosuria
R82 Other abnormal findings in urine
Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
R83 Abnormal findings in cerebrospinal fluid
R84 Abnormal findings in specimens from respiratory organs and thorax
R85 Abnormal findings in specimens from digestive organs and abdominal cavity
R86 Abnormal findings in specimens from male genital organs
R87 Abnormal findings in specimens from female genital organs
R89 Abnormal findings in specimens from other organs, systems and tissues
Abnormal findings on diagnostic imaging and in function studies, without diagnosis (R90-R94)
R90 Abnormal findings on diagnostic imaging of central nervous system
R91 Abnormal findings on diagnostic imaging of lung
R92 Abnormal findings on diagnostic imaging of breast
R93 Abnormal findings on diagnostic imaging of other body structures
R94 Abnormal results of function studies
Ill-defined and unknown causes of mortality (R95-R99)
R95 Sudden infant death syndrome
R96 Other sudden death, cause unknown
R98 Unattended death
R99 Other ill-defined and unspecified causes of mortality
Chapter XIX - Injury, poisoning and certain other consequences of external causes (S00-T98)
Injuries to the head (S00-S09)
S00 Superficial injury of head
S01 Open wound of head
S02 Fracture of skull and facial bones
S03 Dislocation, sprain and strain of joints and ligaments of head
S04 Injury of cranial nerves
S05 Injury of eye and orbit
S06 Intracranial injury
S07 Crushing injury of head
S08 Traumatic amputation of part of head
S09 Other and unspecified injuries of head
Injuries to the neck (S10-S19)
S10 Superficial injury of neck
S11 Open wound of neck
S12 Fracture of neck
S13 Dislocation, sprain and strain of joints and ligaments at neck level
S14 Injury of nerves and spinal cord at neck level
S15 Injury of blood vessels at neck level
S16 Injury of muscle and tendon at neck level
S17 Crushing injury of neck
S18 Traumatic amputation at neck level
S19 Other and unspecified injuries of neck
Injuries to the thorax (S20-S29)
S20 Superficial injury of thorax
S21 Open wound of thorax
S22 Fracture of rib(s), sternum and thoracic spine
S23 Dislocation, sprain and strain of joints and ligaments of thorax
S24 Injury of nerves and spinal cord at thorax level
S25 Injury of blood vessels of thorax
S26 Injury of heart
S27 Injury of other and unspecified intrathoracic organs
S28 Crushing injury of thorax and traumatic amputation of part of thorax
S29 Other and unspecified injuries of thorax
Injuries to the abdomen, lower back, lumbar spine and pelvis (S30-S39)
S30 Superficial injury of abdomen, lower back and pelvis
S31 Open wound of abdomen, lower back and pelvis
S32 Fracture of lumbar spine and pelvis
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level
S35 Injury of blood vessels at abdomen, lower back and pelvis level
S36 Injury of intra-abdominal organs
S37 Injury of urinary and pelvic organs
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis
S39 Other and unspecified injuries of abdomen, lower back and pelvis
Injuries to the shoulder and upper arm (S40-S49)
S40 Superficial injury of shoulder and upper arm
S41 Open wound of shoulder and upper arm
S42 Fracture of shoulder and upper arm
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle
S44 Injury of nerves at shoulder and upper arm level
S45 Injury of blood vessels at shoulder and upper arm level
S46 Injury of muscle and tendon at shoulder and upper arm level
S47 Crushing injury of shoulder and upper arm
S48 Traumatic amputation of shoulder and upper arm
S49 Other and unspecified injuries of shoulder and upper arm
Injuries to the elbow and forearm (S50-S59)
S50 Superficial injury of forearm
S51 Open wound of forearm
S52 Fracture of forearm
S53 Dislocation, sprain and strain of joints and ligaments of elbow
S54 Injury of nerves at forearm level
S55 Injury of blood vessels at forearm level
S56 Injury of muscle and tendon at forearm level
S57 Crushing injury of forearm
S58 Traumatic amputation of forearm
S59 Other and unspecified injuries of forearm
Injuries to the wrist and hand (S60-S69)
S60 Superficial injury of wrist and hand
S61 Open wound of wrist and hand
S62 Fracture at wrist and hand level
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level
S64 Injury of nerves at wrist and hand level
S65 Injury of blood vessels at wrist and hand level
S66 Injury of muscle and tendon at wrist and hand level
S67 Crushing injury of wrist and hand
S68 Traumatic amputation of wrist and hand
S69 Other and unspecified injuries of wrist and hand
Injuries to the hip and thigh (S70-S79)
S70 Superficial injury of hip and thigh
S71 Open wound of hip and thigh
S72 Fracture of femur
S73 Dislocation, sprain and strain of joint and ligaments of hip
S74 Injury of nerves at hip and thigh level
S75 Injury of blood vessels at hip and thigh level
S76 Injury of muscle and tendon at hip and thigh level
S77 Crushing injury of hip and thigh
S78 Traumatic amputation of hip and thigh
S79 Other and unspecified injuries of hip and thigh
Injuries to the knee and lower leg (S80-S89)
S80 Superficial injury of lower leg
S81 Open wound of lower leg
S82 Fracture of lower leg, including ankle
S83 Dislocation, sprain and strain of joints and ligaments of knee
S84 Injury of nerves at lower leg level
S85 Injury of blood vessels at lower leg level
S86 Injury of muscle and tendon at lower leg level
S87 Crushing injury of lower leg
S88 Traumatic amputation of lower leg
S89 Other and unspecified injuries of lower leg
Injuries to the ankle and foot (S90-S99)
S90 Superficial injury of ankle and foot
S91 Open wound of ankle and foot
S92 Fracture of foot, except ankle
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level
S94 Injury of nerves at ankle and foot level
S95 Injury of blood vessels at ankle and foot level
S96 Injury of muscle and tendon at ankle and foot level
S97 Crushing injuries of ankle and foot
S98 Traumatic amputation of ankle and foot
S99 Other and unspecified injuries of ankle and foot
Injuries involving multiple body regions (T00-T07)
T00 Superficial injuries involving multiple body regions
T01 Open wounds involving multiple body regions
T02 Fractures involving multiple body regions
T03 Dislocations, sprains and strains involving multiple body regions
T04 Crushing injuries involving multiple body regions
T05 Traumatic amputations involving multiple body regions
T06 Other injuries involving multiple body regions, not elsewhere classified
T07 Unspecified multiple injuries
Injuries to unspecified part of trunk, limb or body region (T08-T14)
T08 Fracture of spine, level unspecified
T09 Other injuries of spine and trunk, level unspecified
T10 Fracture of upper limb, level unspecified
T11 Other injuries of upper limb, level unspecified
T12 Fracture of lower limb, level unspecified
T13 Other injuries of lower limb, level unspecified
T14 Injury of unspecified of body
Effects of foreign body entering through natural orifice (T15-T19)
T15 Foreign body on external eye
T16 Foreign body in ear
T17 Foreign body in respiratory tract
T18 Foreign body in alimentary tract
T19 Foreign body in genitourinary tract
Burns and corrosions (T20-T32)
Burns and corrosions of external body surface, specified by site (T20-T25)
T20 Burn and corrosion of head and neck
T21 Burn and corrosion of trunk
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand
T23 Burn and corrosion of wrist and hand
T24 Burn and corrosion of hip and lower limb, except ankle and foot
T25 Burn and corrosion of ankle and foot
Burns and corrosions confined to eye and internal organs (T26-T28)
T26 Burn and corrosion confined to eye and adnexa
T27 Burn and corrosion of respiratory tract
T28 Burn and corrosion of other internal organs
Burns and corrosions of multiple and unspecified body regions (T29-T32)
T29 Burns and corrosions of multiple body regions
T30 Burn and corrosion, body region unspecified
T31 Burns classified according to extent of body surface involved
T32 Corrosions classified according to extent of body surface involved
Frostbite (T33-T35)
T33 Superficial frostbite
T34 Frostbite with tissue necrosis
T35 Frostbite involving multiple body regions and unspecified frostbite
Poisoning by drugs, medicaments and biological substances (T36-T50)
T36 Poisoning by systemic antibiotics
T37 Poisoning by other systemic anti-infectives and antiparasitics
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
T41 Poisoning by anaesthetics and therapeutic gases
T42 Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
T43 Poisoning by psychotropic drugs, not elsewhere classified
T44 Poisoning by drugs primarily affecting the autonomic nervous system
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
T46 Poisoning by agents primarily affecting the cardiovascular system
T47 Poisoning by agents primarily affecting the gastrointestinal system
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
T49 Poisoning by topical agents primarily affecting skin and mucous membrane, and by ophthalmological, otorhinolaryngological and dental drugs
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
Toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
T51 Toxic effect of alcohol
T52 Toxic effect of organic solvents
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons
T54 Toxic effect of corrosive substances
T55 Toxic effect of soaps and detergents
T56 Toxic effect of metals
T57 Toxic effect of other inorganic substances
T58 Toxic effect of carbon monoxide
T59 Toxic effect of other gases, fumes and vapours
T60 Toxic effect of pesticides
T61 Toxic effect of noxious substances eaten as seafood
T62 Toxic effect of other noxious substances eaten as food
T63 Toxic effect of contact with venomous animals
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants
T65 Toxic effect of other and unspecified substances
Other and unspecified effects of external causes (T66-T78)
T66 Unspecified effects of radiation
T67 Effects of heat and light
T68 Hypothermia
T69 Other effects of reduced temperature
T70 Effects of air pressure and water pressure
T71 Asphyxiation
T73 Effects of other deprivation
T74 Maltreatment syndromes
T75 Effects of other external causes
T78 Adverse effects, not elsewhere classified
Certain early complications of trauma (T79)
T79 Certain early complications of trauma, not elsewhere classified
Complications of surgical and medical care, not elsewhere classified (T80-T88)
T80 Complications following infusion, transfusion and therapeutic injection
T81 Complications of procedures, not elsewhere classified
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts
T83 Complications of genitourinary devices, implants and grafts
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts
T85 Complications of other internal prosthetic devices, implants and grafts
T86 Failure and rejection of transplanted organs and tissues
T87 Complications peculiar to reattachment and amputation
T88 Other complications of surgical and medical care, not elsewhere classified
Sequelae of injuries, of poisoning and of other consequences of external causes (T90-T98)
T90 Sequelae of injuries of head
T91 Sequelae of injuries of neck and trunk
T92 Sequelae of injuries of upper limb
T93 Sequelae of injuries of lower limb
T94 Sequelae of injuries involving multiple and unspecified body regions
T95 Sequelae of burns, corrosions and frostbite
T96 Sequelae of poisoning by drugs, medicaments and biological substances
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
T98 Sequelae of other and unspecified effects of external causes
Chapter XX - External causes of morbidity and mortality (V01-Y98)
Transport accidents (VO1-V99)
Pedestrian injured in transport accident (V01-V09)
V01 Pedestrian injured in collision with pedal cycle
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle
V03 Pedestrian injured in collision with car, pick-up truck or van
V04 Pedestrian injured in collision with heavy transport vehicle or bus
V05 Pedestrian injured in collision with railway train or railway vehicle
V06 Pedestrian injured in collision with other nonmotor vehicle
V09 Pedestrian injured in other and unspecified transport accidents
Pedal cyclist injured in transport accident (Vl0-Vl9)
V10 Pedal cyclist injured in collision with pedestrian or animal
V11 Pedal cyclist injured in collision with other pedal cycle
V12 Pedal cyclist injured in collision with two-or three-wheeled motor vehicle
V13 Pedal cyclist injured in collision with car, pick-up truck or van
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus
V15 Pedal cyclist injured in collision with railway train or railway vehicle
V16 Pedal cyclist injured in collision with other nonmotor vehicle
V17 Pedal cyclist injured in collision with fixed or stationary object
V18 Pedal cyclist injured in noncollision transport accident
V19 Pedal cyclist injured in other and unspecified transport accidents
Motorcycle rider injured in transport accident (V20-V29)
V20 Motorcyle rider injured in collision with pedestrian or animal
V21 Motorcyle rider injured in collision with pedal cycle
V22 Motorcyle rider injured in collision with two-or three-wheeled motor vehicle
V23 Motorcyle rider injured in collision with car, pick-up truck or van
V24 Motorcyle rider injured in collision with heavy transport vehicle or bus
V25 Motorcyle rider injured in collision with railway train or railway vehicle
V26 Motorcyle rider injured in collision with other nonmotor vehicle
V27 Motorcyle rider injured in collision with fixed or stationary object
V28 Motorcyle rider injured in noncollision transport accident
V29 Motorcyle rider injured in other and unspecified transport accidents
Occupant of three-wheeled motor vehicle injured in transport accident (V30-V39)
V30 Occupant of three-wheeled motor vehicle injured in collision with pedestrian or animal
V31 Occupant of three-wheeled motor vehicle injured in collision with pedal cycle
V32 Occupant of three-wheeled motor vehicle injured in collision with two-or three-wheeled motor vehicle
V33 Occupant of three-wheeled motor vehicle injured in collision with car, pick-up truck or van
V34 Occupant of three-wheeled motor vehicle injured in collision with heavy transport vehicle or bus
V35 Occupant of three-wheeled motor vehicle injured in collision with railway train or railway vehicle
V36 Occupant of three-wheeled motor vehicle injured in collision with other nonmotor vehicle
V37 Occupant of three-wheeled motor vehicle injured in collision with fixed or stationary object
V38 Occupant of three-wheeled motor vehicle injured in noncollision transport accident
V39 Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents
Car occupant injured in transport accident (V40-V49)
V40 Car occupant injured in collision with pedestrian or animal
V41 Car occupant injured in collision with pedal cycle
V42 Car occupant injured in collision with two-or three-wheeled motor vehicle
V43 Car occupant injured in collision with car, pick-up truck or van
V44 Car occupant injured in collision with heavy transport vehicle or bus
V45 Car occupant injured in collision with railway train or railway vehicle
V46 Car occupant injured in collision with other nonmotor vehicle
V47 Car occupant injured in collision with fixed or stationary object
V48 Car occupant injured in noncollision transport accident
V49 Car occupant injured in other and unspecified transport accidents
Occupant of pick-up truck or van injured in transport accident (V50-V59)
V50 Occupant of pick-up truck or van injured in collision with pedestrian or animal
V51 Occupant of pick-up truck or van injured in collision with pedal cycle
V52 Occupant of pick-up truck or van injured in collision with two-or three-wheeled motor vehicle
V53 Occupant of pick-up truck or van injured in collision with car, pick-up truck or van
V54 Occupant of pick-up truck or van injured in collision with heavy transport vehicle or bus
V55 Occupant of pick-up truck or van injured in collision with railway train or railway vehicle
V56 Occupant of pick-up truck or van injured in collision with other nonmotor vehicle
V57 Occupant of pick-up truck or van injured in collision with fixed or stationary object
V58 Occupant of pick-up truck or van injured in noncollision transport accident
V59 Occupant of pick-up truck or van injured in other and unspecified transport accidents
Occupant of heavy transport vehicle injured in transport accident (V60-V69)
V60 Occupant of heavy transport vehicle injured in collision with pedestrian or animal
V61 Occupant of heavy transport vehicle injured in collision with pedal cycle
V62 Occupant of heavy transport vehicle injured in collision with two-or three-wheeled motor vehicle
V63 Occupant of heavy transport vehicle injured in collision with car, pick-up truck or van
V64 Occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus
V65 Occupant of heavy transport vehicle injured in collision with railway train or railway vehicle
V66 Occupant of heavy transport vehicle injured in collision with other nonmotor vehicle
V67 Occupant of heavy transport vehicle injured in collision with fixed or stationary object
V68 Occupant of heavy transport vehicle injured in noncollision transport accident
V69 Occupant of heavy transport vehicle injured in other and unspecified transport accidents
Bus occupant injured in transport accident (V70-V79)
V70 Bus occupant injured in collision with pedestrian or animal
V71 Bus occupant injured in collision with pedal cycle
V72 Bus occupant injured in collision with two-or three-wheeled motor vehicle
V73 Bus occupant injured in collision with car, pick-up truck or van
V74 Bus occupant injured in collision with heavy transport vehicle or bus
V75 Bus occupant injured in collision with railway train or railway vehicle
V76 Bus occupant injured in collision with other nonmotor vehicle
V77 Bus occupant injured in collision with fixed or stationary object
V78 Bus occupant injured in noncollision transport accident
V79 Bus occupant injured in other and unspecified transport accidents
Other land transport accidents (V80-V89)
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident
V81 Occupant of railway train or railway vehicle injured in transport accident
V82 Occupant of streetcar injured in transport accident
V83 Occupant of special vehicle mainly used on industrial premises injured in transport accident
V84 Occupant of special vehicle mainly used in agriculture injured in transport accident
V85 Occupant of special construction vehicle injured in transport accident
V86 Occupant of special all-terrain or other motor vehicles designed primarily for off-road use, injured in transport accident
V87 Traffic accident of specified type but victim's mode of transport unknown
V88 Nontraffic accident of specified type but victim's mode of transport unknown
V89 Motor-or nonmotor-vehicle accident, type of vehicle unspecified
Water transport accidents (V90-V94)
V90 Accident to watercraft causing drowning and submersion
V91 Accident to watercraft causing other injury
V92 Water-transport-related drowning and submersion without accident to watercraft
V93 Accident on board watercraft without accident to watercraft, not causing drowning and submersion
V94 Other and unspecified water transport accidents
Air and space transport accidents (V95-V97)
V95 Accident to powered aircraft causing injury to occupant
V96 Accident to nonpowered aircraft causing injury to occupant
V97 Other specified air transport accidents
Other and unspecified transport accidents (V98-V99)
V98 Other specified transport accidents
V99 Unspecified transport accident
Other external causes of accidental injury (W00-X59)
Falls (W00-W19)
W00 Fall on same level involving ice and snow
W01 Fall on same level from slipping, tripping and stumbling
W02 Fall involving ice-skates, skis, roller-skates or skateboards
W03 Other fall on same level due to collision with, or pushing by, another person
W04 Fall while being carried or supported by other persons
W05 Fall involving wheelchair
W06 Fall involving bed
W07 Fall involving chair
W08 Fall involving other furniture
W09 Fall involving playground equipment
W10 Fall on and from stairs and steps
W11 Fall on and from ladder
W12 Fall on and from scaffolding
W13 Fall from, out of or through building or structure
W14 Fall from tree
W15 Fall from cliff
W16 Diving or jumping into water causing injury other than drowning or submersion
W17 Other fall from one level to another
W18 Other fall on same level
W19 Unspecified fall
Exposure to inanimate mechanical forces (W20-W49)
W20 Struck by thrown, projected or falling object
W21 Striking against or struck by sports equipment
W22 Striking against or struck by other objects
W23 Caught, crushed, jammed or pinched in or between objects
W24 Contact with lifting and transmission devices, not elsewhere classified
W25 Contact with sharp glass
W26 Contact with knife, sword or dagger
W27 Contact with nonpowered hand tool
W28 Contact with powered lawnmower
W29 Contact with other powered hand tools and household machinery
W30 Contact with agricultural machinery
W31 Contact with other and unspecified machinery
W32 Handgun discharge
W33 Rifle, shotgun and larger firearm discharge
W34 Discharge from other and unspecified firearms
W35 Explosion and rupture of boiler
W36 Explosion and rupture of gas cylinder
W37 Explosion and rupture of pressurized tire, pipe or hose
W38 Explosion and rupture of other specified pressurized devices
W39 Discharge of firework
W40 Explosion of other materials
W41 Exposure to high-pressure jet
W42 Exposure to noise
W43 Exposure to vibration
W44 Foreign body entering into or through eye or natural orifice
W45 Foreign body or object entering through skin
W46 Contact with hypodermic needle
W49 Exposure to other and unspecified inanimate mechanical forces
Exposure to animate mechanical forces (W50-W64)
W50 Hit, struck, kicked, twisted, bitten or scratched by another person
W51 Striking against or bumped into by another person
W52 Crushed, pushed and stepped on by crowd or human stampede
W53 Bitten by rat
W54 Bitten or struck by dog
W55 Bitten or struck by other mammals
W56 Contact with marine animal
W57 Bitten or stung by nonvenomous insects and other nonvenomous arthropods
W58 Bitten or struck by crocodile or alligator
W59 Bitten or crushed by other reptiles
W60 Contact with plant thorns and spines and sharp leaves
W64 Exposure to other and unspecified animate mechanical forces
Accidental drowning and submersion (W65-W74)
W65 Drowning and submersion while in bath-tub
W66 Drowning and submersion following fall into bath-tub
W67 Drowning and submersion while in swimming-pool
W68 Drowning and submersion following fall into swimming-pool
W69 Drowning and submersion while in natural water
W70 Drowning and submersion following fall into natural water
W73 Other specified drowning and submersion
W74 Unspecified drowning and submersion
Other accidental threats to breathing (W75-W84)
W75 Accidental suffocation and strangulation in bed
W76 Other accidental hanging and strangulation
W77 Threat to breathing due to cave-in, falling earth and other substances
W78 Inhalation of gastric contents
W79 Inhalation and ingestion of food causing obstruction of respiratory tract
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract
W81 Confined to or trapped in a low oxygen-environment
W83 Other specified threats to breathing
W84 Unspecified threat to breathing
Exposure to electric current, radiation and extreme ambient air temperature and pressure (W85-W99)
W85 Exposure to electric transmission lines
W86 Exposure to other specified electric current
W87 Exposure to unspecified electric current
W88 Exposure to ionizing radiation
W89 Exposure to man-made visible and ultraviolet light
W90 Exposure to other nonionizing radiation
W91 Exposure to unspecified type of radiation
W92 Exposure to excessive heat of man-made origin
W93 Exposure to excessive cold of man-made origin
W94 Exposure to high and low air pressure and changes in air pressure
W99 Exposure to other and unspecified man-made environmental factors
Exposure to smoke, fire and flames (X00-X09)
X00 Exposure to uncontrolled fire in building or structure
X01 Exposure to uncontrolled fire, not in building or structure
X02 Exposure to controlled fire in building or structure
X03 Exposure to controlled fire, not in building or structure
X04 Exposure to ignition of highly flammable material
X05 Exposure to ignition or melting of nightwear
X06 Exposure to ignition or melting of other clothing and apparel
X08 Exposure to other specified smoke, fire and flames
X09 Exposure to unspecified smoke, fire and flames
Contact with heat and hot substances (X10-X19)
X10 Contact with hot drinks, food, fats and cooking oils
X11 Contact with hot tap-water
X12 Contact with other hot fluids
X13 Contact with steam and hot vapours
X14 Contact with hot air and gases
X15 Contact with hot household appliances
X16 Contact with hot heating appliances, radiators and pipes
X17 Contact with hot engines, machinery and tools
X18 Contact with other hot metals
X19 Contact with other and unspecified heat and hot substances
Contact with venomous animals and plants (X20-X29)
X20 Contact with venomous snakes and lizards
X21 Contact with venomous spiders
X22 Contact with scorpions
X23 Contact with hornets, wasps and bees
X24 Contact with centipedes and venomous millipedes (tropical)
X25 Contact with other venomous arthropods
X26 Contact with venomous marine animals and plants
X27 Contact with other specified venomous animals
X28 Contact with other specified venomous plants
X29 Contact with unspecified venomous animal or plant
Exposure to forces of nature (X30-X39)
X30 Exposure to excessive natural heat
X31 Exposure to excessive natural cold
X32 Exposure to sunlight
X33 Victim of lightning
X34 Victim of earthquake
X35 Victim of volcanic eruption
X36 Victim of avalanche, landslide and other earth movements
X37 Victim of cataclysmic storm
X38 Victim of flood
X39 Exposure to other and unspecified forces of nature
Accidental poisoning by and exposure to noxious substances (X40-X49)
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X45 Accidental poisoning by and exposure to alcohol
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
X47 Accidental poisoning by and exposure to other gases and vapours
X48 Accidental poisoning by and exposure to pesticides
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
Overexertion, travel and privation (X50-X57)
X50 Overexertion and strenuous or repetitive movements
X51 Travel and motion
X52 Prolonged stay in weightless environment
X53 Lack of food
X54 Lack of water
X57 Unspecified privation
Accidental exposure to other and unspecified factors (X58-X59)
X58 Exposure to other specified factors
X59 Exposure to unspecified factor
Intentional self-harm (X60-X84)
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X65 Intentional self-poisoning by and exposure to alcohol
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
X67 Intentional self-poisoning by and exposure to other gases and vapours
X68 Intentional self-poisoning by and exposure to pesticides
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X70 Intentional self-harm by hanging, strangulation and suffocation
X71 Intentional self-harm by drowning and submersion
X72 Intentional self-harm by handgun discharge
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge
X74 Intentional self-harm by other and unspecified firearm discharge
X75 Intentional self-harm by explosive material
X76 Intentional self-harm by smoke, fire and flames
X77 Intentional self-harm by steam, hot vapours and hot objects
X78 Intentional self-harm by sharp object
X79 Intentional self-harm by blunt object
X80 Intentional self-harm by jumping from a high place
X81 Intentional self-harm by jumping or lying before moving object
X82 Intentional self-harm by crashing of motor vehicle
X83 Intentional self-harm by other specified means
X84 Intentional self-harm by unspecified means
Assault (X85-Y09)
X85 Assault by drugs, medicaments and biological substances
X86 Assault by corrosive substance
X87 Assault by pesticides
X88 Assault by gases and vapours
X89 Assault by other specified chemicals and noxious substances
X90 Assault by unspecified chemical or noxious substance
X91 Assault by hanging, strangulation and suffocation
X92 Assault by drowning and submersion
X93 Assault by handgun discharge
X94 Assault by rifle, shotgun and larger firearm discharge
X95 Assault by other and unspecified firearm discharge
X96 Assault by explosive material
X97 Assault by fire and flames
X98 Assault by steam, hot vapours and hot objects
X99 Assault by sharp object
Y00 Assault by blunt object
Y01 Assault by pushing from high place
Y02 Assault by pushing or placing victim before moving object
Y03 Assault by crashing of motor vehicle
Y04 Assault by bodily force
Y05 Sexual assault by bodily force
Y06 Neglect and abandonment
Y07 Other maltreatment syndromes
Y08 Assault by other specified means
Y09 Assault by unspecified means
Event of undetermined intent (Y10-Y34)
Y10 Poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, undetermined intent
Y11 Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, undetermined intent
Y12 Poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified, undetermined intent
Y13 Poisoning by and exposure to other drugs acting on the autonomic nervous system, undetermined intent
Y14 Poisoning by and exposure to other and unspecified drugs, medicaments and biological substances, undetermined intent
Y15 Poisoning by and exposure to alcohol, undetermined intent
Y16 Poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours, undetermined intent
Y17 Poisoning by and exposure to other gases and vapours, undetermined intent
Y18 Poisoning by and exposure to pesticides, undetermined intent
Y19 Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
Y20 Hanging, strangulation and suffocation, undetermined intent
Y21 Drowning and submersion, undetermined intent
Y22 Handgun discharge, undetermined intent
Y23 Rifle, shotgun and larger firearm discharge, undetermined intent
Y24 Other and unspecified firearm discharge, undetermined intent
Y25 Contact with explosive material, undetermined intent
Y26 Exposure to smoke, fire and flames, undetermined intent
Y27 Contact with steam, hot vapours and hot objects, undetermined intent
Y28 Contact with sharp object, undetermined intent
Y29 Contact with blunt object, undetermined intent
Y30 Falling, jumping or pushed from a high place, undetermined intent
Y31 Falling, lying or running before or into moving object, undetermined intent
Y32 Crashing of motor vehicle, undetermined intent
Y33 Other specified events, undetermined intent
Y34 Unspecified event, undetermined intent
Legal intervention and operations of war (Y35-Y36)
Y35 Legal intervention
Y36 Operations of war
Complications of medical and surgical care (Y40-Y84)
Drugs, medicaments and biological substances causing adverse effects in therapeutic use (Y40-Y59)
Y40 Systemic antibiotics
Y41 Other systemic anti-infectives and antiparasitics
Y42 Hormones, and their synthetic substitutes and antagonists, not elsewhere classified
Y43 Primarily systemic agents
Y44 Agents primarily affecting blood constituents
Y45 Analgesics, antipyretics and anti-inflammatory drugs
Y46 Antiepileptics and antiparkinsonism drugs
Y47 Sedatives, hypnotics and antianxiety drugs
Y48 Anaesthetics and therapeutic gases
Y49 Psychotropic drugs, not elsewhere classified
Y50 Central nervous system stimulants, not elsewhere classified
Y51 Drugs primarily affecting the autonomic nervous system
Y52 Agents primarily affecting the cardiovascular system
Y53 Agents primarily affecting the gastrointestinal system
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
Y57 Other and unspecified drugs and medicaments
Y58 Bacterial vaccines
Y59 Other and unspecified vaccines and biological substances
Misadventures to patients during surgical and medical care (Y60-Y69)
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
Y61 Foreign object accidentally left in body during surgical and medical care
Y62 Failure of sterile precautions during surgical and medical care
Y63 Failure in dosage during surgical and medical care
Y64 Contaminated medical or biological substances
Y65 Other misadventures during surgical and medical care
Y66 Nonadministration of surgical and medical care
Y69 Unspecified misadventure during surgical and medical care
Medical devices associated with adverse incidents in diagnostic and therapeutic use (Y70-Y82)
Y70 Anaesthesiology devices associated with adverse incidents
Y71 Cardiovascular devices associated with adverse incidents
Y72 Otorhinolaryngological devices associated with adverse incidents
Y73 Gastroenterology and urology devices associated with adverse incidents
Y74 General hospital and personal-use devices associated with adverse incidents
Y75 Neurological devices associated with adverse incidents
Y76 Obstetric and gynaecological devices associated with adverse incidents
Y77 Ophthalmic devices associated with adverse incidents
Y78 Radiological devices associated with adverse incidents
Y79 Orthopaedic devices associated with adverse incidents
Y80 Physical medicine devices associated with adverse incidents
Y81 General-and plastic-surgery devices associated with adverse incidents
Y82 Other and unspecified medical devices associated with adverse incidents
Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure (Y83-Y84)
Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of procedure
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Sequelae of external causes of morbidity and mortality (Y85-Y89)
Y85 Sequelae of transport accidents
Y86 Sequelae of other accidents
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent
Y88 Sequelae of surgical and medical care as external cause
Y89 Sequelae of other external causes
Supplementary factors related to causes of morbidity and mortality classified elsewhere (Y90-Y98)
Y90 Evidence of alcohol involvement determined by blood alcohol level
Y91 Evidence of alcohol involvement determined by level of intoxication
Y95 Nosocomial condition
Y96 Work-related condition
Y97 Environmental-pollution-related condition
Y98 Lifestyle-related condition
Chapter XXI - Factors influencing health status and contact with health services (Z00-Z99)
Persons encountering health services for examination and investigation (Z00-Z13)
[i]Z00 General examination and investigation of persons without complaint and reported diagnosis
[i]Z01 Other special examinations and investigations of persons without complaint and reported diagnosis
[i]Z02 Examination and encounter for administrative purposes
[i]Z03 Medical observation and evaluation for suspected diseases and conditions, ruled out
[i]Z04 Examination and observation for other reasons
[i]Z08 Follow-up examination after treatment for malignant neoplasms
[i]Z09 Follow-up examination after treatment for conditions other than malignant neoplasms
[i]Z10 Routine general health check-up of defined subpopulation
[i]Z11 Special screening examination for infectious and parasitic diseases
[i]Z12 Special screening examination for neoplasms
[i]Z13 Special screening examination for other diseases and disorders
Persons with potential health hazards related to communicable diseases (Z20-Z29)
[i]Z20 Contact with and exposure to communicable diseases
[i]Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
[i]Z22 Carrier of infectious disease
[i]Z23 Need for immunization against single bacterial diseases
[i]Z24 Need for immunization against certain single viral diseases
[i]Z25 Need for immunization against other single viral diseases
[i]Z26 Need for immunization against other single infectious diseases
[i]Z27 Need for immunization against combinations of infectious diseases
[i]Z28 Immunization not carried out
[i]Z29 Need for other prophylactic measures
Persons encountering health services in circumstances related to reproduction (Z30-Z39)
[i]Z30 Contraceptive management
[i]Z31 Procreative management
[i]Z32 Pregnancy examination and test
[i]Z33 Pregnant state, incidental
[i]Z34 Supervision of normal pregnancy
[i]Z35 Supervision of high-risk pregnancy
[i]Z36 Antenatal screening
[i]Z37 Outcome of delivery
[i]Z38 Liveborn infants according to place of birth
[i]Z39 Postpartum care and examination
Persons encountering health services for specific procedures and health care (Z40-Z54)
[i]Z40 Prophylactic surgery
[i]Z41 Procedures for purposes other than remedying health state
[i]Z42 Follow-up care involving plastic surgery
[i]Z43 Attention to artificial openings
[i]Z44 Fitting and adjustment of external prosthetic device
[i]Z45 Adjustment and management of implanted device
[i]Z46 Fitting and adjustment of other devices
[i]Z47 Other orthopaedic follow-up care
[i]Z48 Other surgical follow-up care
[i]Z49 Care involving dialysis
[i]Z50 Care involving use of rehabilitation procedures
[i]Z51 Other medical care
[i]Z52 Donors of organs and tissues
[i]Z53 Persons encountering health services for specific procedures, not carried out
[i]Z54 Convalescence
Persons with potential health hazards related to socioeconomic and psychosocial circumstances (Z55-Z65)
[i]Z55 Problems related to education and literacy
[i]Z56 Problems related to employment and unemployment
[i]Z57 Occupational exposure to risk-factors
[i]Z58 Problems related to physical environment
[i]Z59 Problems related to housing and economic circumstances
[i]Z60 Problems related to social environment
[i]Z61 Problems related to negative life events in childhood
[i]Z62 Other problems related to upbringing
[i]Z63 Other problems related to primary support group, including family circumstances
[i]Z64 Problems related to certain psychosocial circumstances
[i]Z65 Problems related to other psychosocial circumstances
Persons encountering health services in other circumstances (Z70-Z76)
[i]Z70 Counselling related to sexual attitude, behaviour and orientation
[i]Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified
[i]Z72 Problems related to lifestyle
[i]Z73 Problems related to life-management difficulty
[i]Z74 Problems related to care-provider dependency
[i]Z75 Problems related to medical facilities and other health care
[i]Z76 Persons encountering health services in other circumstances
Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z80-Z99)
[i]Z80 Family history of malignant neoplasm
[i]Z81 Family history of mental and behavioural disorders
[i]Z82 Family history of certain disabilities and chronic diseases leading to disablement
[i]Z83 Family history of other specific disorders
[i]Z84 Family history of other conditions
[i]Z85 Personal history of malignant neoplasm
[i]Z86 Personal history of certain other diseases
[i]Z87 Personal history of other diseases and conditions
[i]Z88 Personal history of allergy to drugs, medicaments and biological substances
[i]Z89 Acquired absence of limb
[i]Z90 Acquired absence of organs, not elsewhere classified
[i]Z91 Personal history of risk-factors, not elsewhere classified
[i]Z92 Personal history of medical treatment
[i]Z93 Artificial opening status
[i]Z94 Transplanted organ and tissue status
[i]Z95 Presence of cardiac and vascular implants and grafts
[i]Z96 Presence of other functional implants
[i]Z97 Presence of other devices
[i]Z98 Other postsurgical states
[i]Z99 Dependence on enabling machines and devices, not elsewhere classified
TABULAR LIST OF INCLUSIONS AND FOUR-CHARACTER SUBCATEGORIES
CHAPTER I - Certain infectious and parasitic diseases (A00-B99)
Includes: diseases generally recognized as communicable or transmissible
Excludes: carrier or suspected carrier of infectious disease ([i]Z22.-)
certain localized infections - see body system-related chapters
infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium [except obstetrical tetanus] (O98-)
infectious and parasitic diseases specific to the perinatal period [except tetanus neonatorum, whooping cough, congenital syphilis, perinatal gonococcal infection and perinatal human immunodeficiency virus [HIV] disease] (P35-P39)
influenza and other acute respiratory infections (J00-J22)
This chapter contains the following blocks:
A00-A09 Intestinal infectious diseases
A15-A19 Tuberculosis
A20-A28 Certain zoonotic bacterial diseases
A30-A49 Other bacterial diseases
A50-A64 Infections with a predominantly sexual mode of transmission
A65-A69 Other spirochaetal diseases
A70-A74 Other diseases caused by chlamydiae
A75-A79 Rickettsioses
A80-A89 Viral infections of the central nervous system
A90-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
B00-B09 Viral infections characterized by skin and mucous membrane lesions
B15-B19 Viral hepatitis
B20-B24 Human immunodeficiency virus [HIV] disease
B25-B34 Other viral diseases
B35-B49 Mycoses
B50-B64 Protozoal diseases
B65-B83 Helminthiases
B85-B89 Pediculosis, acariasis and other infestations
B90-B94 Sequelae of infectious and parasitic diseases
B95-B97 Bacterial, viral and other infectious agents
B99 Other infectious diseases
Intestinal infectious diseases (A00-A09)
A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae
Classical cholera
A00.1 Cholera due to Vibrio cholerae 01, biovar eltor
Cholera eltor
A01 Typhoid and paratyphoid fevers
Infection due to Salmonella typhi
A01.4 Paratyphoid fever, unspecified
Infection due to Salmonella paratyphi NOS
A02 Other salmonella infections
Includes: infection or foodborne intoxication due to any Salmonella species other than S. typhi and S. paratyphi
Salmonellosis
A02.2 Localized salmonella infections
Salmonella:
• arthritis† (M01.3*)
• meningitis† (G01*)
• osteomyelitis† (M90.2*)
• pneumonia† (J17.0*)
• renal tubulo-interstitial disease† (N16.0*)
A02.8 Other specified salmonella infections
A02.9 Salmonella infection, unspecified
A03.0 Shigellosis due to Shigella dysenteriae
Group A shigellosis [Shiga-Kruse dysentery]
A03.1 Shigellosis due to Shigella flexneri
Group B shigellosis
A03.2 Shigellosis due to Shigella boydii
Group C shigellosis
A03.3 Shigellosis due to Shigella sonnei
Group D shigellosis
A03.9 Shigellosis, unspecified
Bacillary dysentery NOS
A04 Other bacterial intestinal infections
Excludes: foodborne intoxications, elsewhere classified tuberculous enteritis (A18.3)
A04.0 Enteropathogenic Escherichia coli infection
A04.1 Enterotoxigenic Escherichia coli infection
A04.2 Enteroinvasive Escherichia coli infection
A04.3 Enterohaemorrhagic Escherichia coli infection
A04.4 Other intestinal Escherichia coli infections
Escherichia coli enteritis NOS
A04.6 Enteritis due to Yersinia enterocolitica
Excludes: extraintestinal yersiniosis (A28.2)
A04.7 Enterocolitis due to Clostridium difficile
Foodborne intoxication by Clostridium difficile
Pseudomembranous colitis
A04.8 Other specified bacterial intestinal infections
A04.9 Bacterial intestinal infection, unspecified
Bacterial enteritis NOS
A05 Other bacterial foodborne intoxications, not elsewhere classified
Excludes: Clostridium difficile foodborne intoxication and infection (A04.7)
Escherichia coli infection (A04.0-A04.4)
listeriosis (A32-)
salmonella foodborne intoxication and infection (A02-)
toxic effect of noxious foodstuffs (T61-T62)
A05.0 Foodborne staphylococcal intoxication
Classical foodborne intoxication due to Clostridium botulinum
A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication
Enteritis necroticans
Pig-bel
A05.3 Foodborne Vibrio parahaemolyticus intoxication
A05.4 Foodborne Bacillus cereus intoxication
A05.8 Other specified bacterial foodborne intoxications
A05.9 Bacterial foodborne intoxication, unspecified
Includes: infection due to Entamoeba histolytica
Excludes: other protozoal intestinal diseases (A07-)
Acute amoebiasis
Intestinal amoebiasis NOS
A06.1 Chronic intestinal amoebiasis
A06.2 Amoebic nondysenteric colitis
Amoeboma NOS
Hepatic amoebiasis
Amoebic abscess of lung (and liver) (J99.8*)
Amoebic abscess of lung (and liver) with pneumonia (J17.3*)
A06.6† Amoebic brain abscess (G07*)
Amoebic abscess of brain (and liver)(and lung)
A06.8 Amoebic infection of other sites
Amoebic:
• appendicitis
• balanitis† (N51.2*)
A07 Other protozoal intestinal diseases
Balantidial dysentery
Infection due to Isospora belli and Isospora hominis
Intestinal coccidiosis
Isosporosis
A07.8 Other specified protozoal intestinal diseases
Intestinal trichomoniasis
Sarcocystosis
Sarcosporidiosis
A07.9 Protozoal intestinal disease, unspecified
Flagellate diarrhoea
Protozoal:
• colitis
• diarrhoea
• dysentery
A08 Viral and other specified intestinal infections
Excludes: influenza with involvement of gastrointestinal tract (J09, J10.8, J11.8)
A08.1 Acute gastroenteropathy due to Norovirus
Noroviral enteritis
Small round structured virus enteritis
A08.4 Viral intestinal infection, unspecified
Viral:
• enteritis NOS
• gastroenteritis NOS
• gastroenteropathy NOS
A08.5 Other specified intestinal infections
A09 Other gastroenteritis and colitis of infectious and unspecified origin
Excludes: due to bacterial, protozoal, viral and other specified infectious agents (A00-A08)
noninfective (see noninfectious) diarrhoea (K52.9)
• neonatal (P78.3)
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin
Catarrh, enteric or intestinal
Diarrhoea:
• acute bloody
• acute haemorrhagic
• acute watery
• dysenteric
• epidemic
Infectious or septic:
• colitis
• enteritis NOS haemorrhagic
• gastroenteritis
Infectious (neonatal) diarrhoea NOS
A09.9 Gastroenteritis and colitis of unspecified origin
Excludes: indeterminate colitis (K52.3)
Tuberculosis (A15-A19)
Includes: infections due to Mycobacterium tuberculosis and Mycobacterium bovis
Excludes: congenital tuberculosis (P37.0)
human immunodeficiency [HIV] disease resulting in tuberculosis (B20.0)
pneumoconiosis associated with tuberculosis (J65)
sequelae of tuberculosis (B90-)
silicotuberculosis (J65)
A15 Respiratory tuberculosis, bacteriologically and histologically confirmed
A15.0 Tuberculosis of lung, confirmed by sputum microscopy with or without culture
Tuberculosis of lung, bacteriologically confirmed
Tuberculous:
• bronchiectasis
• fibrosis of lung confirmed bacteriologically with or
• pneumonia without culture
• pneumothorax
Excludes: confirmed by culture only (A15.1)
A15.1 Tuberculosis of lung, confirmed by culture only
Conditions listed in A15.0, confirmed by culture only
A15.2 Tuberculosis of lung, confirmed histologically
Conditions listed in A15.0, confirmed histologically
A15.3 Tuberculosis of lung, confirmed by unspecified means
Conditions listed in A15.0, confirmed but unspecified whether bacteriologically or histologically
A15.4 Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically
Tuberculosis of lymph nodes:
• hilar
• mediastinal confirmed bacteriologically and
• tracheobronchial histologically
Excludes: specified as primary (A15.7)
A15.5 Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically
Tuberculosis of:
• bronchus
• glottis confirmed bacteriologically and
• larynx histologically
• trachea
A15.6 Tuberculous pleurisy, confirmed bacteriologically and histologically
Tuberculosis of pleura confirmed bacteriologically and
Tuberculous empyema histologically
Excludes: in primary respiratory tuberculosis, confirmed bacteriologically and histologically (A15.7)
A15.7 Primary respiratory tuberculosis, confirmed bacteriologically and histologically
A15.8 Other respiratory tuberculosis, confirmed bacteriologically and histologically
Mediastinal tuberculosis
Nasopharyngeal tuberculosis confirmed bacteriologically and
Tuberculosis of: histologically
• nose
• sinus [any nasal]
A15.9 Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically
Includes: 5TH DIGIT TO IDENTIFY TUBERCULOSIS NOT QUALIFIED AS RESPIRATORY OR PULMONARY
A16.0 Tuberculosis of lung, bacteriologically and histologically negative
Tuberculous:
• bronchiectasis
• fibrosis of lung bacteriologically and histologically
• pneumonia negative
• pneumothorax
A16.1 Tuberculosis of lung, bacteriological and histological examination not done
Conditions listed in A16.0, bacteriological and histological examination not done
A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation
Tuberculosis of lung
Tuberculous:
• bronchiectasis NOS (without mention of bacteriological
• fibrosis of lung or histological confirmation)
• pneumonia
• pneumothorax
A16.3 Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation
Tuberculosis of lymph nodes:
• hilar
• intrathoracic NOS (without mention of bacteriological
• mediastinal or histological confirmation)
• tracheobronchial
Excludes: when specified as primary (A16.7)
A16.4 Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation
Tuberculosis of:
• bronchus
• glottis NOS (without mention of bacteriological
• larynx or histological confirmation)
• trachea
A16.5 Tuberculous pleurisy, without mention of bacteriological or histological confirmation
Tuberculosis of pleura
Tuberculous: NOS (without mention of bacteriological
• empyema or histological confirmation)
• pleurisy
Excludes: in primary respiratory tuberculosis (A16.7)
A16.7 Primary respiratory tuberculosis without mention of bacteriological or histological confirmation
Primary:
• respiratory tuberculosis NOS
• tuberculous complex
A16.8 Other respiratory tuberculosis, without mention of bacteriological or histological confirmation
Mediastinal tuberculosis
Nasopharyngeal tuberculosis NOS (without mention of bacteriological
Tuberculosis of: or histological confirmation)
• nose
• sinus [any nasal]
A16.9 Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation
Respiratory tuberculosis NOS
Tuberculosis NOS
A17 Tuberculosis of nervous system
A17.0† Tuberculous meningitis (G01*)
Tuberculosis of meninges (cerebral) (spinal)
Tuberculous leptomeningitis
A17.1† Meningeal tuberculoma (G07*)
Tuberculoma of meninges
A17.8† Other tuberculosis of nervous system
Tuberculoma Tuberculosis |
|
of |
|
brain (G07*) spinal cord (G07*) |
Tuberculous:
• abscess of brain (G07*)
• meningoencephalitis (G05.0*)
• myelitis (G05.0*)
• polyneuropathy (G63.0*)
A17.9† Tuberculosis of nervous system, unspecified (G99.8*)
A18 Tuberculosis of other organs
A18.0† Tuberculosis of bones and joints
Tuberculosis of:
• hip (M01.1*)
• knee (M01.1*)
• vertebral column (M49.0*)
Tuberculous:
• arthritis (M01.1*)
• mastoiditis (H75.0*)
• necrosis of bone (M90.0*)
• osteitis (M90.0*)
• osteomyelitis (M90.0*)
• synovitis (M68.0*)
• tenosynovitis (M68.0*)
A18.1 Tuberculosis of genitourinary system
Tuberculosis of:
• bladder† (N33.0*)
• cervix† (N74.0*)
• kidney† (N29.1*)
• male genital organs† (N51*)
• ureter† (N29.1*)
Tuberculous female pelvic inflammatory disease† (N74.1*)
A18.2 Tuberculous peripheral lymphadenopathy
Tuberculous adenitis
Excludes: tuberculosis of lymph nodes:
• intrathoracic (A15.4, A16.3)
• mesenteric and retroperitoneal (A18.3)
tuberculous tracheobronchial adenopathy (A15.4, A16.3)
A18.3 Tuberculosis of intestines, peritoneum and mesenteric glands
Tuberculosis (of):
• anus and rectum† (K93.0*)
• intestine (large) (small)† (K93.0*)
• retroperitoneal (lymph nodes)
Tuberculous:
• ascites
• enteritis† (K93.0*)
• peritonitis† (K67.3*)
A18.4 Tuberculosis of skin and subcutaneous tissue
Erythema induratum, tuberculous
Lupus:
• exedens
• vulgaris
• NOS
• of eyelid† (H03.1*)
Scrofuloderma
Excludes: lupus erythematosus (L93-)
• systemic (M32-)
Tuberculous:
• chorioretinitis† (H32.0*)
• episcleritis† (H19.0*)
• interstitial keratitis† (H19.2*)
• iridocyclitis† (H22.0*)
• keratoconjunctivitis (interstitial) (phlyctenular)† (H19.2*)
Excludes: lupus vulgaris of eyelid (A18.4)
Tuberculous otitis media† (H67.0*)
Excludes: tuberculous mastoiditis (A18.0†)
A18.7† Tuberculosis of adrenal glands (E35.1*)
Addison disease, tuberculous
A18.8 Tuberculosis of other specified organs
Tuberculosis of:
• endocardium† (I39.8*)
• myocardium† (I41.0*)
• oesophagus† (K23.0*)
• pericardium† (I32.0*)
• thyroid gland† (E35.0*)
Tuberculous cerebral arteritis† (I68.1*)
Includes: tuberculosis:
• disseminated
• generalized
tuberculous polyserositis
A19.0 Acute miliary tuberculosis of a single specified site
A19.1 Acute miliary tuberculosis of multiple sites
A19.2 Acute miliary tuberculosis, unspecified
A19.8 Other miliary tuberculosis
A19.9 Miliary tuberculosis, unspecified
Certain zoonotic bacterial diseases (A20-A28)
Includes: infection due to Yersinia pestis
Abortive plague
Asymptomatic plague
Pestis minor
Includes: deer-fly fever
infection due to Francisella tularensis
rabbit fever
A21.0 Ulceroglandular tularaemia
A21.1 Oculoglandular tularaemia
Ophthalmic tularaemia
A21.3 Gastrointestinal tularaemia
Abdominal tularaemia
A21.8 Other forms of tularaemia
Includes: infection due to Bacillus anthracis
Malignant:
• carbuncle
• pustule
Inhalation anthrax
Ragpicker disease
Woolsorter disease
A22.2 Gastrointestinal anthrax
Anthrax meningitis† (G01*)
Includes: fever:
• Malta
• Mediterranean
• Undulant
A23.0 Brucellosis due to Brucella melitensis
A23.1 Brucellosis due to Brucella abortus
A23.2 Brucellosis due to Brucella suis
A23.3 Brucellosis due to Brucella canis
A23.9 Brucellosis, unspecified
Infection due to Burkholderia mallei
Infection due to Pseudomonas mallei
Malleus
A24.1 Acute and fulminating melioidosis
Melioidosis:
• pneumonia
• sepsis
• septicaemia
A24.2 Subacute and chronic melioidosis
A24.4 Melioidosis, unspecified
Infection due to Burkholderia pseudomallei NOS
Infection due to Pseudomonas pseudomallei NOS
Whitmore disease
Sodoku
Epidemic arthritic erythema
Haverhill fever
Streptobacillary rat-bite fever
A25.9 Rat-bite fever, unspecified
Erythema migrans
A26.7 Erysipelothrix septicaemia
A26.8 Other forms of erysipeloid
A26.9 Erysipeloid, unspecified
A27.0 Leptospirosis icterohaemorrhagica
Leptospirosis due to Leptospira interrogans serovar icterohaemorrhagiae
A27.8 Other forms of leptospirosis
A27.9 Leptospirosis, unspecified
A28 Other zoonotic bacterial diseases, not elsewhere classified
Cat-scratch fever
A28.2 Extraintestinal yersiniosis
Excludes: enteritis due to Yersinia enterocolitica (A04.6)
plague (A20-)
A28.8 Other specified zoonotic bacterial diseases, not elsewhere classified
A28.9 Zoonotic bacterial disease, unspecified
Other bacterial diseases (A30-A49)
Includes: infection due to Mycobacterium leprae
Excludes: sequelae of leprosy (B92)
I leprosy
TT leprosy
A30.2 Borderline tuberculoid leprosy
BT leprosy
BB leprosy
A30.4 Borderline lepromatous leprosy
BL leprosy
LL leprosy
A31 Infection due to other mycobacteria
Excludes: leprosy (A30-)
tuberculosis (A15-A19)
A31.0 Pulmonary mycobacterial infection
Infection due to Mycobacterium:
• avium
• intracellulare [Battey bacillus]
• kansasii
A31.1 Cutaneous mycobacterial infection
Buruli ulcer
Infection due to Mycobacterium:
• marinum
• ulcerans
A31.8 Other mycobacterial infections
A31.9 Mycobacterial infection, unspecified
Atypical mycobacterium infection NOS
Mycobacteriosis NOS
Includes: listerial foodborne infection
Excludes: neonatal (disseminated) listeriosis (P37.2)
A32.1† Listerial meningitis and meningoencephalitis
Listerial:
• meningitis (G01*)
• meningoencephalitis (G05.0*)
A32.8 Other forms of listeriosis
Listerial:
• cerebral arteritis† (I68.1*)
• endocarditis† (I39.8*)
Oculoglandular listeriosis
A32.9 Listeriosis, unspecified
Tetanus NOS
Excludes: tetanus:
• neonatorum (A33)
• obstetrical (A34)
Diphtheritic membranous angina
Tonsillar diphtheria
A36.1 Nasopharyngeal diphtheria
Diphtheritic laryngotracheitis
Excludes: erythrasma (L08.1)
Diphtheritic:
• conjunctivitis† (H13.1*)
• myocarditis† (I41.0*)
• polyneuritis† (G63.0*)
A37.0 Whooping cough due to Bordetella pertussis
A37.1 Whooping cough due to Bordetella parapertussis
A37.8 Whooping cough due to other Bordetella species
A37.9 Whooping cough, unspecified
Scarlatina
Excludes: streptococcal sore throat (J02.0)
A39.0† Meningococcal meningitis (G01*)
A39.1† Waterhouse-Friderichsen syndrome (E35.1*)
Meningococcal haemorrhagic adrenalitis
Meningococcic adrenal syndrome
A39.3 Chronic meningococcaemia
A39.4 Meningococcaemia, unspecified
Meningococcal bacteraemia NOS
A39.5† Meningococcal heart disease
Meningococcal:
• carditis NOS (I52.0*)
• endocarditis (I39.8*)
• myocarditis (I41.0*)
• pericarditis (I32.0*)
A39.8 Other meningococcal infections
Meningococcal:
• arthritis† (M01.0*)
• conjunctivitis† (H13.1*)
• encephalitis† (G05.0*)
• retrobulbar neuritis† (H48.1*)
Postmeningococcal arthritis† (M03.0*)
A39.9 Meningococcal infection, unspecified
Meningococcal disease NOS
Excludes: during labour (O75.3)
following:
• abortion or ectopic or molar pregnancy (O03-O07, O08.0)
• immunization (T88.0)
• infusion, transfusion or therapeutic injection (T80.2)
neonatal (P36.0-P36.1)
postprocedural (T81.4)
puerperal (O85)
A40.0 Septicaemia due to streptococcus, group A
A40.1 Septicaemia due to streptococcus, group B
A40.2 Septicaemia due to streptococcus, group D and enterococcus
A40.3 Septicaemia due to Streptococcus pneumoniae
Pneumococcal septicaemia
A40.8 Other streptococcal septicaemia
A40.9 Streptococcal septicaemia, unspecified
Excludes: bacteraemia NOS (A49.9)
during labour (O75.3)
following:
• abortion or ectopic or molar pregnancy (O03-O07, O08.0)
• immunization (T88.0)
• infusion, transfusion or therapeutic injection (T80.2)
septicaemia (due to) (in):
• actinomycotic (A42.7)
• anthrax (A22.7)
• candidal (B37.7)
• Erysipelothrix (A26.7)
• extraintestinal yersiniosis (A28.2)
• gonococcal (A54.8)
• herpesviral (B00.7)
• listerial (A32.7)
• meningococcal (A39.2-A39.4)
• neonatal (P36-)
• postprocedural (T81.4)
• puerperal (O85)
• streptococcal (A40-)
• tularaemia (A21.7)
septicaemic:
• melioidosis (A24.1)
• plague (A20.7)
toxic shock syndrome (A48.3)
A41.0 Septicaemia due to Staphylococcus aureus
A41.1 Septicaemia due to other specified staphylococcus
Septicaemia due to coagulase-negative staphylococcus
A41.2 Septicaemia due to unspecified staphylococcus
A41.3 Septicaemia due to Haemophilus influenzae
A41.4 Septicaemia due to anaerobes
Excludes: gas gangrene (A48.0)
A41.5 Septicaemia due to other Gram-negative organisms
Gram-negative septicaemia NOS
A41.8 Other specified septicaemia
A41.9 Septicaemia, unspecified
Septic shock
Excludes: actinomycetoma (B47.1)
A42.2 Cervicofacial actinomycosis
A42.7 Actinomycotic septicaemia
A42.8 Other forms of actinomycosis
A42.9 Actinomycosis, unspecified
A43.8 Other forms of nocardiosis
A43.9 Nocardiosis, unspecified
Oroya fever
A44.1 Cutaneous and mucocutaneous bartonellosis
Verruga peruana
A44.8 Other forms of bartonellosis
A44.9 Bartonellosis, unspecified
Excludes: postpartum or puerperal erysipelas (O86.8)
A48 Other bacterial diseases, not elsewhere classified
Excludes: actinomycetoma (B47.1)
Clostridial:
• cellulitis
• myonecrosis
A48.2 Nonpneumonic Legionnaires disease [Pontiac fever]
Excludes: endotoxic shock NOS (R57.8)
septicaemia NOS (A41.9)
A48.4 Brazilian purpuric fever
Systemic Haemophilus aegyptius infection
A48.8 Other specified bacterial diseases
A49 Bacterial infection of unspecified site
Excludes: bacterial agents as the cause of diseases classified to other chapters (B95-B96)
chlamydial infection NOS (A74.9)
meningococcal infection NOS (A39.9)
rickettsial infection NOS (A79.9)
spirochaetal infection NOS (A69.9)
A49.0 Staphylococcal infection, unspecified site
A49.1 Streptococcal infection, unspecified site
A49.2 Haemophilus influenzae infection, unspecified site
A49.3 Mycoplasma infection, unspecified site
A49.8 Other bacterial infections of unspecified site
A49.9 Bacterial infection, unspecified
Bacteraemia NOS
Infections with a predominantly sexual mode of transmission (A50-A64)
Excludes: human immunodeficiency virus [HIV] disease (B20-B24)
nonspecific and nongonococcal urethritis (N34.1)
Reiter disease (M02.3)
A50.0 Early congenital syphilis, symptomatic
Any congenital syphilitic condition specified as early or manifest less than two years after birth.
Early congenital syphilis:
• cutaneous
• mucocutaneous
• visceral
Early congenital syphilitic:
• laryngitis
• oculopathy
• osteochondropathy
• pharyngitis
• pneumonia
• rhinitis
A50.1 Early congenital syphilis, latent
Congenital syphilis without clinical manifestations, with positive serological reaction and negative spinal fluid test, less than two years after birth.
A50.2 Early congenital syphilis, unspecified
Congenital syphilis NOS less than two years after birth.
A50.3 Late congenital syphilitic oculopathy
Late congenital syphilitic interstitial keratitis† (H19.2*)
Late congenital syphilitic oculopathy NEC† (H58.8*)
Excludes: Hutchinson triad (A50.5)
A50.4 Late congenital neurosyphilis [juvenile neurosyphilis]
Dementia paralytica juvenilis
Juvenile:
• general paresis
• tabes dorsalis
• taboparetic neurosyphilis
Late congenital syphilitic:
• encephalitis† (G05.0*)
• meningitis† (G01*)
• polyneuropathy† (G63.0*)
Use additional code, if desired, to identify any associated mental disorder.
Excludes: Hutchinson triad (A50.5)
A50.5 Other late congenital syphilis, symptomatic
Any congenital syphilitic condition specified as late or manifest two years or more after birth.
Clutton joints† (M03.1*)
Hutchinson:
• teeth
• triad
Late congenital:
• cardiovascular syphilis† (I98.0*)
• syphilitic:
• arthropathy† (M03.1*)
• osteochondropathy† (M90.2*)
Syphilitic saddle nose
A50.6 Late congenital syphilis, latent
Congenital syphilis without clinical manifestations, with positive serological reaction and negative spinal fluid test, two years or more after birth.
A50.7 Late congenital syphilis, unspecified
Congenital syphilis NOS two years or more after birth.
A50.9 Congenital syphilis, unspecified
A51.0 Primary genital syphilis
Syphilitic chancre NOS
A51.2 Primary syphilis of other sites
A51.3 Secondary syphilis of skin and mucous membranes
Condyloma latum
Syphilitic:
• alopecia† (L99.8*)
• leukoderma† (L99.8*)
• mucous patch
A51.4 Other secondary syphilis
Secondary syphilitic:
• female pelvic inflammatory disease† (N74.2*)
• iridocyclitis† (H22.0*)
• lymphadenopathy
• meningitis† (G01*)
• myositis† (M63.0*)
• oculopathy NEC† (H58.8*)
• periostitis† (M90.1*)
Syphilis (acquired) without clinical manifestations, with positive serological reaction and negative spinal fluid test, less than two years after infection.
A51.9 Early syphilis, unspecified
A52.0† Cardiovascular syphilis
Cardiovascular syphilis NOS (I98.0*)
Syphilitic:
• aneurysm of aorta (I79.0*)
• aortic incompetence (I39.1*)
• aortitis (I79.1*)
• arteritis, cerebral (I68.1*)
• endocarditis NOS (I39.8*)
• myocarditis (I41.0*)
• pericarditis (I32.0*)
• pulmonary regurgitation (I39.3*)
A52.1 Symptomatic neurosyphilis
Charcot arthropathy† (M14.6*)
Late syphilitic:
• acoustic neuritis† (H94.0*)
• encephalitis† (G05.0*)
• meningitis† (G01*)
• optic atrophy† (H48.0*)
• polyneuropathy† (G63.0*)
• retrobulbar neuritis† (H48.1*)
Syphilitic parkinsonism† (G22*)
Tabes dorsalis
A52.2 Asymptomatic neurosyphilis
A52.3 Neurosyphilis, unspecified
Gumma (syphilitic)
Syphilis (late) of central nervous system NOS
Syphiloma
A52.7 Other symptomatic late syphilis
Glomerular disease in syphilis† (N08.0*)
Gumma (syphilitic)any sites, except those late or tertiary syphilis classified to A52.0-A52.3
Late syphilitic:
• bursitis† (M73.1*)
• chorioretinitis† (H32.0*)
• episcleritis† (H19.0*)
• female pelvic inflammatory disease† (N74.2*)
• leukoderma† (L99.8*)
• oculopathy NEC† (H58.8*)
• peritonitis† (K67.2*)
Syphilis [stage unspecified] of:
• bone† (M90.2*)
• liver† (K77.0*)
• lung† (J99.8*)
• muscle† (M63.0*)
• synovium† (M68.0*)
Syphilis (acquired) without clinical manifestations, with positive serological reaction and negative spinal fluid test, two years or more after infection.
A52.9 Late syphilis, unspecified
A53 Other and unspecified syphilis
A53.0 Latent syphilis, unspecified as early or late
Latent syphilis NOS
Positive serological reaction for syphilis
Infection due to Treponema pallidum NOS
Syphilis (acquired) NOS
Excludes: syphilis NOS causing death under two years of age (A50.2)
A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
Gonococcal:
• cervicitis NOS
• cystitis NOS
• urethritis NOS
• vulvovaginitis NOS
Excludes: with:
• genitourinary gland abscess (A54.1)
• periurethral abscess (A54.1)
A54.1 Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess
Gonococcal Bartholin gland abscess
A54.2 Gonococcal pelviperitonitis and other gonococcal genitourinary infections
Gonococcal:
• epididymitis† (N51.1*)
• female pelvic inflammatory disease† (N74.3*)
• orchitis† (N51.1*)
• prostatitis† (N51.0*)
Excludes: gonococcal peritonitis (A54.8)
A54.3 Gonococcal infection of eye
Gonococcal:
• conjunctivitis† (H13.1*)
• iridocyclitis† (H22.0*)
Ophthalmia neonatorum due to gonococcus
A54.4† Gonococcal infection of musculoskeletal system
Gonococcal:
• arthritis (M01.3*)
• bursitis (M73.0*)
• osteomyelitis (M90.2*)
• synovitis (M68.0*)
• tenosynovitis (M68.0*)
A54.6 Gonococcal infection of anus and rectum
A54.8 Other gonococcal infections
Gonococcal:
• brain abscess† (G07*)
• endocarditis† (I39.8*)
• meningitis† (G01*)
• myocarditis† (I41.0*)
• pericarditis† (I32.0*)
• peritonitis† (K67.1*)
• pneumonia† (J17.0*)
• septicaemia
• skin lesions
Excludes: gonococcal pelviperitonitis (A54.2)
A54.9 Gonococcal infection, unspecified
A55 Chlamydial lymphogranuloma (venereum)
Climatic or tropical bubo
Durand-Nicolas-Favre disease
Esthiomene
Lymphogranuloma inguinale
A56 Other sexually transmitted chlamydial diseases
Includes: sexually transmitted diseases due to Chlamydia trachomatis
Excludes: chlamydial:
• lymphogranuloma (A55)
• neonatal:
• conjunctivitis (P39.1)
• pneumonia (P23.1)
conditions classified to A74-
A56.0 Chlamydial infection of lower genitourinary tract
Chlamydial:
• cervicitis
• cystitis
• urethritis
• vulvovaginitis
A56.1 Chlamydial infection of pelviperitoneum and other genitourinary organs
Chlamydial:
• epididymitis† (N51.1*)
• female pelvic inflammatory disease† (N74.4*)
• orchitis† (N51.1*)
A56.2 Chlamydial infection of genitourinary tract, unspecified
A56.3 Chlamydial infection of anus and rectum
A56.4 Chlamydial infection of pharynx
A56.8 Sexually transmitted chlamydial infection of other sites
Ulcus molle
Donovanosis
Excludes: intestinal trichomoniasis (A07.8)
A59.0 Urogenital trichomoniasis
Leukorrhoea (vaginalis) } due to Trichomonas (vaginalis)
Prostatitis† (N51.0*)
A59.8 Trichomoniasis of other sites
A59.9 Trichomoniasis, unspecified
A60 Anogenital herpesviral [herpes simplex] infection
A60.0 Herpesviral infection of genitalia and urogenital tract
Herpesviral infection of genital tract:
• female† (N77.0-N77.1*)
• male† (N51*)
A60.1 Herpesviral infection of perianal skin and rectum
A60.9 Anogenital herpesviral infection, unspecified
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
Excludes: molluscum contagiosum (B08.1)
papilloma of cervix (D26.0)
A63.0 Anogenital (venereal) warts
A63.8 Other specified predominantly sexually transmitted diseases
A64 Unspecified sexually transmitted disease
Venereal disease NOS
Other spirochaetal diseases (A65-A69)
Excludes: leptospirosis (A27-)
syphilis (A50-A53)
Bejel
Endemic syphilis
Njovera
Includes: bouba
framboesia (tropica)
pian
Chancre of yaws
Framboesia, initial or primary
Initial framboesial ulcer
Mother yaw
A66.1 Multiple papillomata and wet crab yaws
Framboesioma
Pianoma
Plantar or palmar papilloma of yaws
A66.2 Other early skin lesions of yaws
Cutaneous yaws, less than five years after infection
Early yaws (cutaneous) (macular) (maculopapular) (micropapular) (papular)
Framboeside of early yaws
Ghoul hand
Hyperkeratosis, palmar or plantar (early)(late) due to yaws
Worm-eaten soles
A66.4 Gummata and ulcers of yaws
Gummatous framboeside
Nodular late yaws (ulcerated)
Rhinopharyngitis mutilans
A66.6 Bone and joint lesions of yaws
Ganglion
Hydrarthrosis
Osteitis of yaws (early) (late)
Periostitis (hypertrophic)
Goundou
Gumma, bone of yaws (late)
Gummatous osteitis or periostitis
A66.7 Other manifestations of yaws
Juxta-articular nodules of yaws
Mucosal yaws
Yaws without clinical manifestations, with positive serology
A67.0 Primary lesions of pinta
Chancre (primary)
Papule (primary) of pinta [carate]
A67.1 Intermediate lesions of pinta
Erythematous plaques
Hyperchromic lesions
Hyperkeratosis of pinta [carate]
Pintids
Cardiovascular lesions† (I98.1*)
Skin lesions:
• achromic of pinta [carate]
• cicatricial
• dyschromic
Achromic with hyperchromic skin lesions of pinta [carate]
Includes: recurrent fever
Excludes: Lyme disease (A69.2)
A68.0 Louse-borne relapsing fever
Relapsing fever due to Borrelia recurrentis
A68.1 Tick-borne relapsing fever
Relapsing fever due to any Borrelia species other than Borrelia recurrentis
A68.9 Relapsing fever, unspecified
A69 Other spirochaetal infections
A69.0 Necrotizing ulcerative stomatitis
Cancrum oris
Fusospirochaetal gangrene
Noma
Stomatitis gangrenosa
A69.1 Other Vincent infections
Fusospirochaetal pharyngitis
Necrotizing ulcerative (acute):
• gingivitis
• gingivostomatitis
Spirochaetal stomatitis
Trench mouth
Vincent:
• angina
• gingivitis
Erythema chronicum migrans due to Borrelia burgdorferi
A69.8 Other specified spirochaetal infections
A69.9 Spirochaetal infection, unspecified
Other diseases caused by chlamydiae (A70-A74)
Ornithosis
Parrot fever
Psittacosis
Excludes: sequelae of trachoma (B94.0)
A71.0 Initial stage of trachoma
Trachoma dubium
A71.1 Active stage of trachoma
Granular conjunctivitis (trachomatous)
Trachomatous:
• follicular conjunctivitis
• pannus
A74 Other diseases caused by chlamydiae
Excludes: chlamydial pneumonia (J16.0)
neonatal chlamydial:
• conjunctivitis (P39.1)
• pneumonia (P23.1)
sexually transmitted chlamydial diseases (A55-A56)
A74.0† Chlamydial conjunctivitis (H13.1*)
Paratrachoma
A74.8 Other chlamydial diseases
Chlamydial peritonitis† (K67.0*)
A74.9 Chlamydial infection, unspecified
Chlamydiosis NOS
Rickettsioses (A75-A79)
Excludes: rickettsiosis due to Neorickettsia sennetsu [Ehrlichia sennetsu](A79.8)
A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii
Classical typhus (fever)
Epidemic (louse-borne) typhus
A75.1 Recrudescent typhus [Brill disease]
Brill-Zinsser disease
A75.2 Typhus fever due to Rickettsia typhi
Murine (flea-borne) typhus
A75.3 Typhus fever due to Rickettsia tsutsugamushi
Scrub (mite-borne) typhus
Tsutsugamushi fever
A75.9 Typhus fever, unspecified
Typhus (fever) NOS
A77 Spotted fever [tick-borne rickettsioses]
A77.0 Spotted fever due to Rickettsia rickettsii
Rocky Mountain spotted fever
Sao Paulo fever
A77.1 Spotted fever due to Rickettsia conorii
African tick typhus
Boutonneuse fever
India tick typhus
Kenya tick typhus
Marseilles fever
Mediterranean tick fever
A77.2 Spotted fever due to Rickettsia sibirica
North Asian tick fever
Siberian tick typhus
A77.3 Spotted fever due to Rickettsia australis
Queensland tick typhus
A77.9 Spotted fever, unspecified
Tick-borne typhus NOS
Infection due to Coxiella burnetii
Nine Mile fever
Quadrilateral fever
Quintan fever
Wolhynian fever
A79.1 Rickettsialpox due to Rickettsia akari
Kew Garden fever
Vesicular rickettsiosis
A79.8 Other specified rickettsioses
Rickettsiosis due to Neorickettsia sennetsu [Ehrlichia sennetsu]
A79.9 Rickettsiosis, unspecified
Rickettsial infection NOS
Viral infections of the central nervous system (A80-A89)
Excludes: sequelae of:
• poliomyelitis (B91)
• viral encephalitis (B94.1)
A80.0 Acute paralytic poliomyelitis, vaccine-associated
A80.1 Acute paralytic poliomyelitis, wild virus, imported
A80.2 Acute paralytic poliomyelitis, wild virus, indigenous
A80.3 Acute paralytic poliomyelitis, other and unspecified
A80.4 Acute nonparalytic poliomyelitis
A80.9 Acute poliomyelitis, unspecified
A81 Atypical virus infections of central nervous system
Includes: prion diseases of the central nervous system
A81.0 Creutzfeldt-Jakob disease
Subacute spongiform encephalopathy
A81.1 Subacute sclerosing panencephalitis
Dawson inclusion body encephalitis
Van Bogaert sclerosing leukoencephalopathy
A81.2 Progressive multifocal leukoencephalopathy
Multifocal leukoencephalopathy NOS
A81.8 Other atypical virus infections of central nervous system
Kuru
A81.9 Atypical virus infection of central nervous system, unspecified
Prion disease of central nervous system NOS
A83 Mosquito-borne viral encephalitis
Includes: mosquito-borne viral meningoencephalitis
Excludes: Venezuelan equine encephalitis (A92.2)
A83.1 Western equine encephalitis
A83.2 Eastern equine encephalitis
Kunjin virus disease
California meningoencephalitis
La Crosse encephalitis
A83.8 Other mosquito-borne viral encephalitis
A83.9 Mosquito-borne viral encephalitis, unspecified
A84 Tick-borne viral encephalitis
Includes: tick-borne viral meningoencephalitis
A84.0 Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis]
A84.1 Central European tick-borne encephalitis
A84.8 Other tick-borne viral encephalitis
Louping ill
Powassan virus disease
A84.9 Tick-borne viral encephalitis, unspecified
A85 Other viral encephalitis, not elsewhere classified
Includes: specified viral:
• encephalomyelitis NEC
• meningoencephalitis NEC
Excludes: myalgic encephalomyelitis (G93.3)
encephalitis due to:
• herpesvirus [herpes simplex] (B00.4)
• measles virus (B05.0)
• mumps virus (B26.2)
• poliomyelitis virus (A80-)
• zoster (B02.0)
lymphocytic choriomeningitis (A87.2)
A85.0† Enteroviral encephalitis (G05.1*)
Enteroviral encephalomyelitis
A85.1† Adenoviral encephalitis (G05.1*)
Adenoviral meningoencephalitis
A85.2 Arthropod-borne viral encephalitis, unspecified
A85.8 Other specified viral encephalitis
Encephalitis lethargica
Von Economo-Cruchet disease
A86 Unspecified viral encephalitis
Viral:
• encephalomyelitis NOS
• meningoencephalitis NOS
Excludes: meningitis due to:
• herpesvirus [herpes simplex] (B00.3)
• measles virus (B05.1)
• mumps virus (B26.1)
• poliomyelitis virus (A80-)
• zoster (B02.1)
A87.0† Enteroviral meningitis (G02.0*)
Coxsackievirus meningitis
Echovirus meningitis
A87.1† Adenoviral meningitis (G02.0*)
A87.2 Lymphocytic choriomeningitis
Lymphocytic meningoencephalitis
A87.9 Viral meningitis, unspecified
A88 Other viral infections of central nervous system, not elsewhere classified
Excludes: viral:
• encephalitis NOS (A86)
• meningitis NOS (A87.9)
A88.0 Enteroviral exanthematous fever [Boston exanthem]
A88.8 Other specified viral infections of central nervous system
A89 Unspecified viral infection of central nervous system
Arthropod-borne viral fevers and viral haemorrhagic fevers (A90-A99)
A90 Dengue fever [classical dengue]
Excludes: dengue haemorrhagic fever (A91)
A92 Other mosquito-borne viral fevers
Excludes: Ross River disease (B33.1)
A92.0 Chikungunya virus disease
Chikungunya (haemorrhagic) fever
Venezuelan equine:
• encephalitis
• encephalomyelitis virus disease
A92.3 West Nile virus infection
West Nile fever
A92.8 Other specified mosquito-borne viral fevers
A92.9 Mosquito-borne viral fever, unspecified
A93 Other arthropod-borne viral fevers, not elsewhere classified
Oropouche fever
Pappataci fever
Phlebotomus fever
A93.8 Other specified arthropod-borne viral fevers
Piry virus disease
Vesicular stomatitis virus disease [Indiana fever]
A94 Unspecified arthropod-borne viral fever
Arboviral fever NOS
Arbovirus infection NOS
Jungle yellow fever
A95.9 Yellow fever, unspecified
A96 Arenaviral haemorrhagic fever
A96.0 Junin haemorrhagic fever
Argentinian haemorrhagic fever
A96.1 Machupo haemorrhagic fever
Bolivian haemorrhagic fever
A96.8 Other arenaviral haemorrhagic fevers
A96.9 Arenaviral haemorrhagic fever, unspecified
A98 Other viral haemorrhagic fevers, not elsewhere classified
Excludes: chikungunya haemorrhagic fever (A92.0)
dengue haemorrhagic fever (A91)
A98.0 Crimean-Congo haemorrhagic fever
Central Asian haemorrhagic fever
A98.5 Haemorrhagic fever with renal syndrome
Haemorrhagic fever:
• epidemic
• Korean
• Russian
Hantaan virus disease
Hantavirus disease with renal manifestations
Nephropathia epidemica
Excludes: hantavirus (cardio)-pulmonary syndrome (B33.4† J17.1*)
A98.8 Other specified viral haemorrhagic fevers
A99 Unspecified viral haemorrhagic fever
Viral infections characterized by skin and mucous membrane lesions (B00-B09)
B00 Herpesviral [herpes simplex] infections
Excludes: anogenital herpesviral infection (A60-)
congenital herpesviral infection (P35.2)
gammaherpesviral mononucleosis (B27.0)
herpangina (B08.5)
Kaposi varicelliform eruption
B00.1 Herpesviral vesicular dermatitis
Herpes simplex:
• facialis
• labialis
Vesicular dermatitis of:
• ear } due to human (alpha) herpesvirus 2
• lip
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis
Herpesviral pharyngitis
B00.3† Herpesviral meningitis (G02.0*)
B00.4† Herpesviral encephalitis (G05.1*)
Herpesviral meningoencephalitis
Simian B disease
B00.5 Herpesviral ocular disease
Herpesviral:
• conjunctivitis† (H13.1*)
• dermatitis of eyelid† (H03.1*)
• iridocyclitis† (H22.0*)
• iritis† (H22.0*)
• keratitis† (H19.1*)
• keratoconjunctivitis† (H19.1*)
• uveitis, anterior† (H22.0*)
B00.7 Disseminated herpesviral disease
Herpesviral septicaemia
B00.8 Other forms of herpesviral infection
Herpesviral:
• hepatitis† (K77.0*)
• whitlow† (L99.8*)
B00.9 Herpesviral infection, unspecified
Herpes simplex infection NOS
B01.0† Varicella meningitis (G02.0*)
B01.1† Varicella encephalitis (G05.1*)
Postchickenpox encephalitis
Varicella encephalomyelitis
B01.2† Varicella pneumonia (J17.1*)
B01.8 Varicella with other complications
B01.9 Varicella without complication
Varicella NOS
Includes: shingles
zona
B02.0† Zoster encephalitis (G05.1*)
Zoster meningoencephalitis
B02.1† Zoster meningitis (G02.0*)
B02.2† Zoster with other nervous system involvement
Postherpetic:
• geniculate ganglionitis (G53.0*)
• polyneuropathy (G63.0*)
• trigeminal neuralgia (G53.0*)
Zoster:
• blepharitis† (H03.1*)
• conjunctivitis† (H13.1*)
• iridocyclitis† (H22.0*)
• iritis† (H22.0*)
• keratitis† (H19.2*)
• keratoconjunctivitis† (H19.2*)
• scleritis† (H19.0*)
B02.8 Zoster with other complications
B02.9 Zoster without complication
Zoster NOS
Includes: morbilli
Excludes: subacute sclerosing panencephalitis (A81.1)
B05.0† Measles complicated by encephalitis (G05.1*)
Postmeasles encephalitis
B05.1† Measles complicated by meningitis (G02.0*)
Postmeasles meningitis
B05.2† Measles complicated by pneumonia (J17.1*)
Postmeasles pneumonia
B05.3† Measles complicated by otitis media (H67.1*)
Postmeasles otitis media
B05.4 Measles with intestinal complications
B05.8 Measles with other complications
Measles keratitis and keratoconjunctivitis† (H19.2*)
B05.9 Measles without complication
Excludes: congenital rubella (P35.0)
B06.0† Rubella with neurological complications
Rubella:
• encephalitis (G05.1*)
• meningitis (G02.0*)
• meningoencephalitis (G05.1*)
B06.8 Rubella with other complications
Rubella:
• arthritis† (M01.4*)
• pneumonia† (J17.1*)
B06.9 Rubella without complication
Rubella NOS
Verruca:
• simplex
• vulgaris
Excludes: anogenital (venereal) warts (A63.0)
papilloma of:
• bladder (D41.4)
• cervix (D26.0)
• larynx (D14.1)
B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
Excludes: vesicular stomatitis virus disease (A93.8)
B08.0 Other orthopoxvirus infections
Cowpox
Orf virus disease
Pseudocowpox [milker node]
Vaccinia
Excludes: monkeypox (B04)
B08.2 Exanthema subitum [sixth disease]
B08.3 Erythema infectiosum [fifth disease]
B08.4 Enteroviral vesicular stomatitis with exanthem
Hand, foot and mouth disease
B08.5 Enteroviral vesicular pharyngitis
Herpangina
B08.8 Other specified viral infections characterized by skin and mucous membrane lesions
Enteroviral lymphonodular pharyngitis
Foot-and-mouth disease
Tanapox virus disease
Yaba pox virus disease
B09 Unspecified viral infection characterized by skin and mucous membrane lesions
Viral:
• enanthema NOS
• exanthema NOS
Viral hepatitis (B15-B19)
Excludes: cytomegaloviral hepatitis (B25.1)
herpesviral [herpes simplex] hepatitis (B00.8)
sequelae of viral hepatitis (B94.2)
Use additional code (Chapter XX), if desired, to identify drug, if post-transfusion hepatitis.
B15.0 Hepatitis A with hepatic coma
B15.9 Hepatitis A without hepatic coma
Hepatitis A (acute)(viral) NOS
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma
B16.2 Acute hepatitis B without delta-agent with hepatic coma
B16.9 Acute hepatitis B without delta-agent and without hepatic coma
Hepatitis B (acute)(viral) NOS
B17 Other acute viral hepatitis
B17.0 Acute delta-(super) infection of hepatitis B carrier
B17.8 Other specified acute viral hepatitis
Hepatitis non-A non-B (acute)(viral) NEC
B17.9 Acute viral hepatitis, unspecified
Acute hepatitis NOS
Acute infectious hepatitis NOS
B18.0 Chronic viral hepatitis B with delta-agent
B18.1 Chronic viral hepatitis B without delta-agent
Chronic (viral) hepatitis B
B18.2 Chronic viral hepatitis C
B18.8 Other chronic viral hepatitis
B18.9 Chronic viral hepatitis, unspecified
B19 Unspecified viral hepatitis
B19.0 Unspecified viral hepatitis with hepatic coma
B19.9 Unspecified viral hepatitis without hepatic coma
Viral hepatitis NOS
Human immunodeficiency virus [HIV] disease (B20-B24)
Excludes: asymptomatic human immunodeficiency virus [HIV] infection status ([i]Z21)
complicating pregnancy, childbirth and the puerperium (O98.7)
B20 Human immunodeficiency virus [HIV] disease with infectious and parasitic diseases
Excludes: acute HIV infection syndrome (B23.0)
B20.0 HIV disease with mycobacterial infection
HIV disease with tuberculosis
B20.1 HIV disease with other bacterial infections
B20.2 HIV disease with cytomegaloviral disease
B20.3 HIV disease with other viral infections
B20.4 HIV disease with candidiasis
B20.5 HIV disease with other mycoses
B20.6 HIV disease with Pneumocystis jirovecii pneumonia
HIV disease resulting in Pneumocystis carinii pneumonia
B20.7 HIV disease with multiple infections
B20.8 HIV disease with other infectious and parasitic diseases
B20.9 HIV disease with unspecified infectious or parasitic disease
HIV disease with infection NOS
B21 Human immunodeficiency virus [HIV] disease with malignant neoplasms
B21.0 HIV disease with Kaposi sarcoma
B21.1 HIV disease with Burkitt lymphoma
B21.2 HIV disease with other types of non-Hodgkin lymphoma
B21.3 HIV disease with other malignant neoplasms of lymphoid, haematopoietic and related tissue
B21.7 HIV disease with multiple malignant neoplasms
B21.8 HIV disease with other malignant neoplasms
B21.9 HIV disease with unspecified malignant neoplasm
B22 Human immunodeficiency virus [HIV] disease with other specified diseases
B22.0 HIV disease with encephalopathy
HIV dementia
B22.1 HIV disease with lymphoid interstitial pneumonitis
B22.2 HIV disease with wasting syndrome
HIV disease with failure to thrive
Slim disease
B22.7 HIV disease with multiple diseases classified elsewhere
Note: For use of this category, reference should be made to the morbidity coding rules and guidelines in Volume 2 or mortality coding rules and guidelines in Part 2a Instruction Manual (NCHS).
B23 Human immunodeficiency virus [HIV] disease with other conditions
B23.0 Acute HIV infection syndrome
B23.1 HIV disease with (persistent) generalized lymphadenopathy
B23.2 HIV disease with haematological and immunological abnormalities, not elsewhere classified
B23.8 HIV disease with other specified conditions
B24 Unspecified human immunodeficiency virus [HIV] disease
Acquired immunodeficiency syndrome [AIDS] NOS
AIDS-related complex [ARC] NOS
Other viral diseases (B25-B34)
Excludes: congenital cytomegalovirus infection (P35.1)
cytomegaloviral mononucleosis (B27.1)
B25.0† Cytomegaloviral pneumonitis (J17.1*)
B25.1† Cytomegaloviral hepatitis (K77.0*)
B25.2† Cytomegaloviral pancreatitis (K87.1*)
B25.8 Other cytomegaloviral diseases
B25.9 Cytomegaloviral disease, unspecified
Includes: parotitis:
• epidemic
• infectious
B26.0† Mumps orchitis (N51.1*)
B26.1† Mumps meningitis (G02.0*)
B26.2† Mumps encephalitis (G05.1*)
B26.3† Mumps pancreatitis (K87.1*)
B26.8 Mumps with other complications
Mumps:
• arthritis† (M01.5*)
• myocarditis† (I41.1*)
• nephritis† (N08.0*)
• polyneuropathy† (G63.0*)
B26.9 Mumps without complication
Mumps:
• NOS
• parotitis NOS
Includes: glandular fever
monocytic angina
Pfeiffer disease
B27.0 Gammaherpesviral mononucleosis
Mononucleosis due to Epstein-Barr virus
B27.1 Cytomegaloviral mononucleosis
B27.8 Other infectious mononucleosis
B27.9 Infectious mononucleosis, unspecified
Excludes: ocular disease:
• herpesviral [herpes simplex] (B00.5)
• zoster (B02.3)
B30.0† Keratoconjunctivitis due to adenovirus (H19.2*)
Epidemic keratoconjunctivitis
Shipyard eye
B30.1† Conjunctivitis due to adenovirus (H13.1*)
Acute adenoviral follicular conjunctivitis
Swimming-pool conjunctivitis
B30.2 Viral pharyngoconjunctivitis
B30.3† Acute epidemic haemorrhagic conjunctivitis (enteroviral) (H13.1*)
Conjunctivitis due to:
• coxsackievirus 24
• enterovirus 70
Haemorrhagic conjunctivitis (acute)(epidemic)
B30.8† Other viral conjunctivitis (H13.1*)
Newcastle conjunctivitis
B30.9 Viral conjunctivitis, unspecified
B33 Other viral diseases, not elsewhere classified
Bornholm disease
Epidemic polyarthritis and exanthema
Ross River fever
B33.3 Retrovirus infections, not elsewhere classified
Retrovirus infection NOS
B33.4† Hantavirus (cardio)-pulmonary syndrome [HPS] [HCPS] (J17.1*)
Hantavirus disease with pulmonary manifestations
Sin Nombre virus disease
Use additional code (N17.9), if desired, to identify any renal failure associated with HPS caused by the Andes, Bayou and Black Creek Canal hantavirus aetiologies.
Excludes: haemorrhagic fever with renal manifestations (A98.5† N08.0*)
B33.8 Other specified viral diseases
B34 Viral infection of unspecified site
Excludes: cytomegaloviral disease NOS (B25.9)
herpesvirus [herpes simplex] infection NOS (B00.9)
retrovirus infection NOS (B33.3)
viral agents as the cause of diseases classified to other chapters (B97-)
B34.0 Adenovirus infection, unspecified site
B34.1 Enterovirus infection, unspecified site
Coxsackievirus infection NOS
Echovirus infection NOS
B34.2 Coronavirus infection, unspecified site
B34.3 Parvovirus infection, unspecified site
B34.4 Papovavirus infection, unspecified site
B34.8 Other viral infections of unspecified site
B34.9 Viral infection, unspecified
Viraemia NOS
Mycoses (B35-B49)
Excludes: hypersensitivity pneumonitis due to organic dust (J67-)
mycosis fungoides (C84.0)
Includes: favus
infections due to species of Epidermophyton, Microsporum and Trichophyton
tinea, any type except those in B36-
B35.0 Tinea barbae and tinea capitis
Beard ringworm
Kerion
Scalp ringworm
Sycosis, mycotic
Dermatophytic onychia
Dermatophytosis of nail
Onychomycosis
Ringworm of nails
Dermatophytosis of hand
Hand ringworm
Athlete foot
Dermatophytosis of foot
Foot ringworm
Ringworm of the body
Tokelau
B35.6 Tinea inguinalis [Tinea cruris]
Dhobi itch
Groin ringworm
Jock itch
Dermatophytosis:
• disseminated
• granulomatous
B35.9 Dermatophytosis, unspecified
Ringworm NOS
Tinea:
• flava
• versicolor
Keratomycosis nigricans palmaris
Microsporosis nigra
Pityriasis nigra
Tinea blanca
B36.8 Other specified superficial mycoses
B36.9 Superficial mycosis, unspecified
Includes: candidosis
moniliasis
Excludes: neonatal candidiasis (P37.5)
Oral thrush
B37.2 Candidiasis of skin and nail
Candidal:
• onychia
• paronychia
Excludes: diaper [napkin] dermatitis (L22)
B37.3† Candidiasis of vulva and vagina (N77.1*)
Candidal vulvovaginitis
Monilial vulvovaginitis
Vaginal thrush
B37.4 Candidiasis of other urogenital sites
Candidal:
• balanitis† (N51.2*)
• urethritis† (N37.0*)
B37.5† Candidal meningitis (G02.1*)
B37.6† Candidal endocarditis (I39.8*)
B37.8 Candidiasis of other sites
Candidal:
• cheilitis
• enteritis
B37.9 Candidiasis, unspecified
Thrush NOS
B38.0 Acute pulmonary coccidioidomycosis
B38.1 Chronic pulmonary coccidioidomycosis
B38.2 Pulmonary coccidioidomycosis, unspecified
B38.3 Cutaneous coccidioidomycosis
B38.4† Coccidioidomycosis meningitis (G02.1*)
B38.7 Disseminated coccidioidomycosis
Generalized coccidioidomycosis
B38.8 Other forms of coccidioidomycosis
B38.9 Coccidioidomycosis, unspecified
B39.0 Acute pulmonary histoplasmosis capsulati
B39.1 Chronic pulmonary histoplasmosis capsulati
B39.2 Pulmonary histoplasmosis capsulati, unspecified
B39.3 Disseminated histoplasmosis capsulati
Generalized histoplasmosis capsulati
B39.4 Histoplasmosis capsulati, unspecified
American histoplasmosis
African histoplasmosis
B39.9 Histoplasmosis, unspecified
Excludes: Brazilian blastomycosis (B41-)
keloidal blastomycosis (B48.0)
B40.0 Acute pulmonary blastomycosis
B40.1 Chronic pulmonary blastomycosis
B40.2 Pulmonary blastomycosis, unspecified
B40.7 Disseminated blastomycosis
Generalized blastomycosis
B40.8 Other forms of blastomycosis
B40.9 Blastomycosis, unspecified
Includes: Brazilian blastomycosis
Lutz disease
B41.0 Pulmonary paracoccidioidomycosis
B41.7 Disseminated paracoccidioidomycosis
Generalized paracoccidioidomycosis
B41.8 Other forms of paracoccidioidomycosis
B41.9 Paracoccidioidomycosis, unspecified
B42.0† Pulmonary sporotrichosis (J99.8*)
B42.1 Lymphocutaneous sporotrichosis
B42.7 Disseminated sporotrichosis
Generalized sporotrichosis
B42.8 Other forms of sporotrichosis
B42.9 Sporotrichosis, unspecified
B43 Chromomycosis and phaeomycotic abscess
Dermatitis verrucosa
B43.1 Phaeomycotic brain abscess
Cerebral chromomycosis
B43.2 Subcutaneous phaeomycotic abscess and cyst
B43.8 Other forms of chromomycosis
B43.9 Chromomycosis, unspecified
Includes: aspergilloma
B44.0 Invasive pulmonary aspergillosis
B44.1 Other pulmonary aspergillosis
B44.7 Disseminated aspergillosis
Generalized aspergillosis
B44.8 Other forms of aspergillosis
B44.9 Aspergillosis, unspecified
B45.0 Pulmonary cryptococcosis
Cryptococcal meningitis† (G02.1*)
Cryptococcosis meningocerebralis
B45.2 Cutaneous cryptococcosis
B45.7 Disseminated cryptococcosis
Generalized cryptococcosis
B45.8 Other forms of cryptococcosis
B45.9 Cryptococcosis, unspecified
B46.1 Rhinocerebral mucormycosis
B46.2 Gastrointestinal mucormycosis
Subcutaneous mucormycosis
B46.4 Disseminated mucormycosis
Generalized mucormycosis
B46.5 Mucormycosis, unspecified
Entomophthoromycosis
B46.9 Zygomycosis, unspecified
Phycomycosis NOS
Madura foot, mycotic
Maduromycosis
Madura foot NOS
B48 Other mycoses, not elsewhere classified
Keloidal blastomycosis
Lobo disease
Infection due to Pseudallescheria boydii
Excludes: eumycetoma (B47.0)
Geotrichum stomatitis
Mycoses caused by fungi of low virulence that can establish an infection only as a consequence of factors such as the presence of debilitating disease or the administration of immunosuppressive and other therapeutic agents or radiation therapy. Most of the causal fungi are normally saprophytic in soil and decaying vegetation.
Adiaspiromycosis
Fungaemia NOS
Protozoal diseases (B50-B64)
Excludes: amoebiasis (A06-)
other protozoal intestinal diseases (A07-)
Includes: mixed infections of Plasmodium falciparum with any other Pasmodium species
B50.0 Plasmodium falciparum malaria with cerebral complications
Cerebral malaria NOS
B50.8 Other severe and complicated Plasmodium falciparum malaria
Severe or complicated Plasmodium falciparum malaria NOS
B50.9 Plasmodium falciparum malaria, unspecified
Includes: mixed infections of Plasmodium vivax with other Plasmodium species, except Plasmodium falciparum
Excludes: mixed with Plasmodium falciparum (B50-)
B51.0 Plasmodium vivax malaria with rupture of spleen
B51.8 Plasmodium vivax malaria with other complications
B51.9 Plasmodium vivax malaria without complication
Plasmodium vivax malaria NOS
Includes: mixed infections of Plasmodium malariae with other Plasmodium species, except Plasmodium falciparum and Plasmodium vivax
Excludes: when mixed with Plasmodium:
• falciparum (B50-)
• vivax (B51-)
B52.0 Plasmodium malariae malaria with nephropathy
B52.8 Plasmodium malariae malaria with other complications
B52.9 Plasmodium malariae malaria without complication
Plasmodium malariae malaria NOS
B53 Other parasitologically confirmed malaria
B53.0 Plasmodium ovale malaria
Excludes: when mixed with Plasmodium:
• falciparum (B50-)
• malariae (B52-)
• vivax (B51-)
B53.1 Malaria due to simian plasmodia
Excludes: when mixed with Plasmodium:
• falciparum (B50-)
• malariae (B52-)
• ovale (B53.0)
• vivax (B51-)
B53.8 Other parasitologically confirmed malaria, not elsewhere classified
Parasitologically confirmed malaria NOS
Clinically diagnosed malaria without parasitological confirmation
Kala-azar
Post-kala-azar dermal leishmaniasis
B55.2 Mucocutaneous leishmaniasis
B55.9 Leishmaniasis, unspecified
B56.0 Gambiense trypanosomiasis
Infection due to Trypanosoma brucei gambiense
West African sleeping sickness
B56.1 Rhodesiense trypanosomiasis
East African sleeping sickness
Infection due to Trypanosoma brucei rhodesiense
B56.9 African trypanosomiasis, unspecified
Sleeping sickness NOS
Trypanosomiasis NOS, in places where African trypanosomiasis is prevalent
Includes: American trypanosomiasis
infection due to Trypanosoma cruzi
B57.0† Acute Chagas disease with heart involvement (I41.2*, I98.1*)
Acute Chagas disease with:
• cardiovascular involvement NEC (I98.1*)
• myocarditis (I41.2*)
B57.1 Acute Chagas disease without heart involvement
Acute Chagas disease NOS
B57.2 Chagas disease (chronic) with heart involvement
American trypanosomiasis NOS
Chagas disease (chronic) (with):
• NOS
• cardiovascular involvement NEC† (I98.1*)
• myocarditis† (I41.2*)
Trypanosomiasis NOS, in places where Chagas disease is prevalent
B57.3 Chagas disease (chronic) with digestive system involvement
B57.4 Chagas disease (chronic) with nervous system involvement
B57.5 Chagas disease (chronic) with other organ involvement
Includes: infection due to Toxoplasma gondii
Excludes: congenital toxoplasmosis (P37.1)
Toxoplasma chorioretinitis (H32.0*)
B58.1† Toxoplasma hepatitis (K77.0*)
B58.2† Toxoplasma meningoencephalitis (G05.2*)
B58.3† Pulmonary toxoplasmosis (J17.3*)
B58.8 Toxoplasmosis with other organ involvement
Toxoplasma:
• myocarditis† (I41.2*)
• myositis† (M63.1*)
B58.9 Toxoplasmosis, unspecified
B59 Pneumocystosis (J17.3*)
Pneumonia due to:
• Pneumocystis carinii
• Pneumocystis jirovecii
B60 Other protozoal diseases, not elsewhere classified
Excludes: cryptosporidiosis (A07.2)
intestinal microsporidiosis (A07.8)
isosporiasis (A07.3)
Piroplasmosis
Conjunctivitis due to Acanthamoeba† (H13.1*)
Keratoconjunctivitis due to Acanthamoeba† (H19.2*)
Primary amoebic meningoencephalitis† (G05.2*)
B60.8 Other specified protozoal diseases
Microsporidiosis
B64 Unspecified protozoal disease
Helminthiases (B65-B83)
B65 Schistosomiasis [bilharziasis]
Includes: snail fever
B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis]
B65.1 Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis]
B65.2 Schistosomiasis due to Schistosoma japonicum
Asiatic schistosomiasis
Swimmer itch
Infection due to Schistosoma:
• intercalatum
• mattheei
• mekongi
B65.9 Schistosomiasis, unspecified
Infection due to:
• cat liver fluke
• Opisthorchis (felineus) (viverrini)
Chinese liver fluke disease
Infection due to Clonorchis sinensis
Oriental liver fluke disease
Infection due to Dicrocoelium dendriticum
Lancet fluke infection
Infection due to Fasciola:
• gigantica
• hepatica
• indica
Sheep liver fluke disease
Infection due to Paragonimus species
Lung fluke disease
Pulmonary distomiasis
Infection due to Fasciolopsis buski
Intestinal distomiasis
B66.8 Other specified fluke infections
Echinostomiasis
Heterophyiasis
Metagonimiasis
Nanophyetiasis
Watsoniasis
B66.9 Fluke infection, unspecified
Includes: hydatidosis
B67.0 Echinococcus granulosus infection of liver
B67.1 Echinococcus granulosus infection of lung
B67.2 Echinococcus granulosus infection of bone
B67.3 Echinococcus granulosus infection, other and multiple sites
B67.4 Echinococcus granulosus infection, unspecified
Dog tapeworm (infection)
B67.5 Echinococcus multilocularis infection of liver
B67.6 Echinococcus multilocularis infection, other and multiple sites
B67.7 Echinococcus multilocularis infection, unspecified
B67.8 Echinococcosis, unspecified, of liver
B67.9 Echinococcosis, other and unspecified
Echinococcosis NOS
Excludes: cysticercosis (B69-)
Pork tapeworm (infection)
B68.1 Taenia saginata taeniasis
Beef tapeworm (infection)
Infection due to adult tapeworm Taenia saginata
Includes: cysticerciasis infection due to larval form of Taenia solium
B69.0 Cysticercosis of central nervous system
B69.8 Cysticercosis of other sites
B69.9 Cysticercosis, unspecified
B70 Diphyllobothriasis and sparganosis
Diphyllobothrium (adult) (latum) (pacificum) infection
Fish tapeworm (infection)
Excludes: larval diphyllobothriasis (B70.1)
Infection due to:
• Sparganum (mansoni) (proliferum)
• Spirometra larvae
Larval diphyllobothriasis
Spirometrosis
Dwarf tapeworm (infection)
Rat tapeworm (infection)
B71.8 Other specified cestode infections
Coenurosis
B71.9 Cestode infection, unspecified
Tapeworm (infection) NOS
Guinea worm infection
Infection due to Dracunculus medinensis
Onchocerca volvulus infection
Onchocercosis
River blindness
Excludes: onchocerciasis (B73)
tropical (pulmonary) eosinophilia NOS (J82)
B74.0 Filariasis due to Wuchereria bancrofti
Bancroftian:
• elephantiasis
• filariasis
B74.1 Filariasis due to Brugia malayi
B74.2 Filariasis due to Brugia timori
Calabar swelling
Eyeworm disease of Africa
Loa loa infection
Infection due to Mansonella:
• ozzardi
• perstans
• streptocerca
Dirofilariasis
Infection due to Trichinella species
Trichiniasis
Includes: uncinariasis
Infection due to Ancylostoma species
Infection due to Necator americanus
B76.9 Hookworm disease, unspecified
Cutaneous larva migrans NOS
Includes: ascaridiasis
roundworm infection
B77.0 Ascariasis with intestinal complications
B77.8 Ascariasis with other complications
Excludes: trichostrongyliasis (B81.2)
B78.0 Intestinal strongyloidiasis
B78.1 Cutaneous strongyloidiasis
B78.7 Disseminated strongyloidiasis
B78.9 Strongyloidiasis, unspecified
Trichocephaliasis
Whipworm (disease) (infection)
Oxyuriasis
Pinworm infection
Threadworm infection
B81 Other intestinal helminthiases, not elsewhere classified
Excludes: angiostrongyliasis due to:
• Angiostrongylus cantonensis (B83.2)
• Parastrongylus cantonensis (B83.2)
Infection due to Anisakis larvae
B81.1 Intestinal capillariasis
Capillariasis NOS
Infection due to Capillaria philippinensis
Excludes: hepatic capillariasis (B83.8)
B81.3 Intestinal angiostrongyliasis
Angiostrongyliasis due to:
• Angiostrongylus costaricensis
• Parastrongylus costaricensis
B81.4 Mixed intestinal helminthiases
Infection due to intestinal helminths classifiable to more than one of the categories B65.0-B81.3 and B81.8
Mixed helminthiasis NOS
B81.8 Other specified intestinal helminthiases
Infection due to:
• Oesophagostomum species [oesophagostomiasis]
• Ternidens deminutus [ternidensiasis]
• Ternidens diminutus [ternidensiasis]
B82 Unspecified intestinal parasitism
B82.0 Intestinal helminthiasis, unspecified
B82.9 Intestinal parasitism, unspecified
Excludes: capillariasis:
• NOS (B81.1)
• intestinal (B81.1)
Toxocariasis
Wandering swelling
B83.2 Angiostrongyliasis due to Parastrongylus cantonensis
Angiostrongyliasis due to Angiostrongylus cantonensis
Eosinophilic meningoencephalitis† (G05.2*)
Excludes: intestinal angiostrongyliasis (B81.3)
Syngamosis
Excludes: external hirudiniasis (B88.3)
B83.8 Other specified helminthiases
Acanthocephaliasis
Gongylonemiasis
Hepatic capillariasis
Metastrongyliasis
Thelaziasis
B83.9 Helminthiasis, unspecified
Worms NOS
Excludes: intestinal helminthiasis NOS (B82.0)
Pediculosis, acariasis and other infestations (B85-B89)
B85 Pediculosis and phthiriasis
B85.0 Pediculosis due to Pediculus humanus capitis
Head-louse infestation
B85.1 Pediculosis due to Pediculus humanus corporis
Body-louse infestation
B85.2 Pediculosis, unspecified
Infestation by:
• crab-louse
• Phthirus pubis
B85.4 Mixed pediculosis and phthiriasis
Infestation classifiable to more than one of the categories B85.0-B85.3
Sarcoptic itch
Includes: infestation by larvae of flies
Creeping myiasis
Traumatic myiasis
Laryngeal myiasis
Genitourinary myiasis
Intestinal myiasis
Acarine dermatitis
Dermatitis due to:
• Demodex species
• Dermanyssus gallinae
• Liponyssoides sanguineus
Trombiculosis
Excludes: scabies (B86)
B88.1 Tungiasis [sandflea infestation]
B88.2 Other arthropod infestations
Scarabiasis
Leech infestation NOS
Excludes: internal hirudiniasis (B83.4)
B88.8 Other specified infestations
Ichthyoparasitism due to Vandellia cirrhosa
Linguatulosis
Porocephaliasis
B88.9 Infestation, unspecified
Infestation (skin) NOS
Infestation by mites NOS
Skin parasites NOS
B89 Unspecified parasitic disease
Sequelae of infectious and parasitic diseases (B90-B94)
Note: Categories B90-B94 are to be used to indicate conditions in categories A00-B89 as the cause of sequelae, which are themselves classified elsewhere. The "sequelae" include conditions specified as such; they also include late effects of diseases classifiable to the above categories if there is evidence that the disease itself is no longer present. For use of these categories, reference should be made to the morbidity coding rules and guidelines in Volume 2 or mortality coding rules and guidelines in Part 2a Instruction Manual (NCHS).
Not to be used for chronic infections. Code current infections to chronic or active infectious disease as appropriate.
B90.0 Sequelae of central nervous system tuberculosis
B90.1 Sequelae of genitourinary tuberculosis
B90.2 Sequelae of tuberculosis of bones and joints
B90.8 Sequelae of tuberculosis of other organs
B90.9 Sequelae of respiratory and unspecified tuberculosis
Sequelae of tuberculosis NOS
Excludes: postpolio syndrome (G14)
B94 Sequelae of other and unspecified infectious and parasitic diseases
B94.1 Sequelae of viral encephalitis
B94.2 Sequelae of viral hepatitis
B94.8 Sequelae of other specified infectious and parasitic diseases
B94.9 Sequelae of unspecified infectious or parasitic disease
Bacterial, viral and other infectious agents (B95-B97)
Note: These categories should never be used in primary coding. They are provided for use as supplementary or additional codes when it is desired to identify the infectious agent(s) in diseases classified elsewhere.
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters
B95.4 Other streptococcus as the cause of diseases classified to other chapters
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters
B95.7 Other staphylococcus as the cause of diseases classified to other chapters
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters
B96 Other specified bacterial agents as the cause of diseases classified to other chapters
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters
Pleuro-pneumonia-like-organism [PPLO]
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters
B96.4 Proteus (mirabilis) (morganii) as the cause of diseases classified to other chapters
B96.5 Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified to other chapters
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters
B97 Viral agents as the cause of diseases classified to other chapters
B97.0 Adenovirus as the cause of diseases classified to other chapters
B97.1 Enterovirus as the cause of diseases classified to other chapters
Coxsackievirus
Echovirus
B97.2 Coronavirus as the cause of diseases classified to other chapters
B97.3 Retrovirus as the cause of diseases classified to other chapters
Lentivirus
Oncovirus
B97.4 Respiratory syncytial virus as the cause of diseases classified to other chapters
B97.5 Reovirus as the cause of diseases classified to other chapters
B97.6 Parvovirus as the cause of diseases classified to other chapters
B97.7 Papillomavirus as the cause of diseases classified to other chapters
B97.8 Other viral agents as the cause of diseases classified to other chapters
Human metapneumovirus
Other infectious diseases (B99)
B99 Other and unspecified infectious diseases
CHAPTER II - Neoplasms (C00-D48)
This chapter contains the following broad groups of neoplasms:
C00-C97 Malignant neoplasms
C00-C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
C00-C14 Lip, oral cavity and pharynx
C15-C26 Digestive organs
C30-C39 Respiratory and intrathoracic organs
C40-C41 Bone and articular cartilage
C43-C44 Skin
C45-C49 Mesothelial and soft tissue
C50 Breast
C51-C58 Female genital organs
C60-C63 Male genital organs
C64-C68 Urinary tract
C69-C72 Eye, brain and other parts of central nervous system
C73-C75 Thyroid and other endocrine glands
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
C97 Malignant neoplasms of independent (primary) multiple sites
D00-D09 In situ neoplasms
D10-D36 Benign neoplasms
D37-D48 Neoplasms of uncertain or unknown behaviour [see note preceding D37 category]
Notes
1. Primary, ill-defined, secondary and unspecified sites of malignant neoplasms
Categories C76-C80 include malignant neoplasms for which there is no clear indication of the original site of the cancer or the cancer is stated to be "disseminated", "scattered" or "spread" without mention of the primary site. In both cases the primary site is considered to be unknown.
2. Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter IV may be used, if desired, to identify functional activity associated with any neoplasm. For example, catecholamine-producing malignant phaeochromocytoma of adrenal gland should be coded to C74 with additional code E27.5; basophil adenoma of pituitary gland with Cushing syndrome should be coded to D35.2 with additional code E24.0.
3. Morphology
There are a number of major morphological (histological) groups of malignant neoplasms: carcinomas including squamous (cell) and adeno-carcinomas; sarcomas; other soft tissue tumours including mesotheliomas; lymphomas (Hodgkin and non-Hodgkin); leukaemia; other specified and site-specific types; and unspecified cancers. Cancer is a generic term and may be used for any of the above groups, although it is rarely applied to the malignant neoplasms of lymphatic, haematopoietic and related tissue. "Carcinoma" is sometimes used incorrectly as a synonym for "cancer".
In Chapter II neoplasms are classified predominantly by site within broad groupings for behaviour. In a few exceptional cases morphology is indicated in the category and subcategory titles.
For those wishing to identify the histological type of neoplasm, comprehensive separate morphology codes are provided within the Morphology chapter. These morphology codes are derived from the second edition of International Classification of Diseases for Oncology (ICD-O), which is a dual-axis classification providing independent coding systems for topography and morphology. Morphology codes have six digits: the first four digits identify the histological type; the fifth digit is the behaviour code (malignant primary, malignant secondary (metastatic), in situ, benign, uncertain whether malignant or benign); and the sixth digit is a grading code (differentiation) for solid tumours, and is also used as a special code for lymphomas and leukaemias.
4. Use of subcategories in Chapter II
Attention is drawn to the special use of subcategory .8 in this chapter [see note 5]. Where it has been necessary to provide subcategories for "other", these have generally been designated as subcategory .7.
5. Malignant neoplasms overlapping site boundaries and the use of subcategory .8 (overlapping lesion)
Categories C00-C75 classify primary malignant neoplasms according to their point of origin. Many three-character categories are further divided into named parts or subcategories of the organ in question. A neoplasm that overlaps two or more contiguous sites within a three-character category and whose point of origin cannot be determined should be classified to the subcategory .8 ("overlapping lesion"), unless the combination is specifically indexed elsewhere.
For example, carcinoma of oesophagus and stomach is specifically indexed to C16.0 (cardia), while carcinoma of the tip and ventral surface of the tongue should be assigned to C02.8. On the other hand, carcinoma of the tip of the tongue extending to involve the ventral surface should be coded to C02.1 as the point of origin, the tip, is known. "Over-lapping" implies that the sites involved are contiguous (next to each other). Numerically consecutive subcategories are frequently anatomically contiguous, but this is not invariably so (e.g. bladder C67-) and the coder may need to consult anatomical texts to determine the topographical relationships.
Sometimes a neoplasm overlaps the boundaries of three-character categories within certain systems. To take care of this the following subcategories have been designated:
C02.8 Overlapping lesion of tongue
C08.8 Overlapping lesion of major salivary glands
C14.8 Overlapping lesion of lip, oral cavity and pharynx
C21.8 Overlapping lesion of rectum, anus and anal canal
C24.8 Overlapping lesion of biliary tract
C26.8 Overlapping lesion of digestive system
C39.8 Overlapping lesion of respiratory and intrathoracic organs
C41.8 Overlapping lesion of bone and articular cartilage
C49.8 Overlapping lesion of connective and soft tissue
C57.8 Overlapping lesion of female genital organs
C63.8 Overlapping lesion of male genital organs
C68.8 Overlapping lesion of urinary organs
C72.8 Overlapping lesion of central nervous system
An example of this is a carcinoma of the stomach and small intestine, which should be coded to C26.8 (Overlapping lesion of digestive system).
6. Malignant neoplasms of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g. ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
7. Use of the Alphabetical Index in coding neoplasms
In addition to site, morphology and behaviour must also be taken into consideration when coding neoplasms, and reference should always be made first to the Alphabetical Index entry for the morphological description.
The introductory pages of Volume 3 include general instructions about the correct use of the Alphabetical Index. The specific instructions and examples pertaining to neoplasms should be consulted to ensure correct use of the categories and subcategories in Chapter II.
8. Use of the second edition of International Classification of Diseases for Oncology (ICD-O)
For certain morphological types, Chapter II provides a rather restricted topographical classification, or none at all. The topography codes of ICD-O use for all neoplasms essentially the same three- and four-character categories that Chapter II uses for malignant neoplasms (C00-C77, C80), thus providing increased specificity of site for other neoplasms (malignant secondary (metastatic), benign, in situ and uncertain or unknown).
It is therefore recommended that agencies interested in identifying both the site and morphology of tumours, e.g. cancer registries, cancer hospitals, pathology departments and other agencies specializing in cancer, use ICD-O.
Malignant neoplasms (C00-C97)
Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)
Excludes: skin of lip (C43.0, C44.0)
Upper lip:
• NOS
• lipstick area
• vermilion border
Lower lip:
• NOS
• lipstick area
• vermilion border
C00.2 External lip, unspecified
Vermilion border NOS
Upper lip:
• buccal aspect
• frenulum
• mucosa
• oral aspect
Lower lip:
• buccal aspect
• frenulum
• mucosa
• oral aspect
C00.5 Lip, unspecified, inner aspect
Lip, not specified whether upper or lower:
• buccal aspect
• frenulum
• mucosa
• oral aspect
C00.8 Overlapping lesion of lip
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C01 Malignant neoplasm of base of tongue
Dorsal surface of base of tongue
Fixed part of tongue NOS
Posterior third of tongue
C02 Malignant neoplasm of other and unspecified parts of tongue
C02.0 Dorsal surface of tongue
Anterior two-thirds of tongue, dorsal surface
Excludes: dorsal surface of base of tongue (C01)
Tip of tongue
C02.2 Ventral surface of tongue
Anterior two-thirds of tongue, ventral surface
Frenulum linguae
C02.3 Anterior two-thirds of tongue, part unspecified
Middle third of tongue NOS
Mobile part of tongue NOS
Excludes: tonsil NOS (C09.9)
C02.8 Overlapping lesion of tongue
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Malignant neoplasm of tongue whose point of origin cannot be classified to any one of the categories C01-C02.4
Includes: alveolar (ridge) mucosa
gingiva
Excludes: malignant odontogenic neoplasms (C41.0-C41.1)
C04 Malignant neoplasm of floor of mouth
Anterior to the premolar-canine junction
C04.8 Overlapping lesion of floor of mouth
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C04.9 Floor of mouth, unspecified
C05 Malignant neoplasm of palate
Excludes: nasopharyngeal surface of soft palate (C11.3)
C05.8 Overlapping lesion of palate
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Roof of mouth
C06 Malignant neoplasm of other and unspecified parts of mouth
Buccal mucosa NOS
Internal cheek
Buccal sulcus (upper)(lower)
Labial sulcus (upper)(lower)
C06.8 Overlapping lesion of other and unspecified parts of mouth
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Minor salivary gland, unspecified site
Oral cavity NOS
C07 Malignant neoplasm of parotid gland
C08 Malignant neoplasm of other and unspecified major salivary glands
Excludes: malignant neoplasms of specified minor salivary which are classified according to their anatomical location
malignant neoplasms of minor salivary glands NOS (C06.9)
parotid gland (C07)
Submaxillary gland
C08.8 Overlapping lesion of major salivary glands
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Malignant neoplasm of major salivary glands whose point of origin cannot be classified to any one of the categories C07-C08.1
C08.9 Major salivary gland, unspecified
Salivary gland (major) NOS
C09 Malignant neoplasm of tonsil
Excludes: lingual tonsil (C02.4)
pharyngeal tonsil (C11.1)
C09.1 Tonsillar pillar (anterior)(posterior)
C09.8 Overlapping lesion of tonsil
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Tonsil:
• NOS
• faucial
• palatine
C10 Malignant neoplasm of oropharynx
Excludes: tonsil (C09-)
C10.1 Anterior surface of epiglottis
Epiglottis, free border [margin]
Glossoepiglottic fold(s)
Excludes: epiglottis (suprahyoid portion) NOS (C32.1)
C10.2 Lateral wall of oropharynx
C10.3 Posterior wall of oropharynx
Branchial cyst [site of neoplasm]
C10.8 Overlapping lesion of oropharynx
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Junctional region of oropharynx
C11 Malignant neoplasm of nasopharynx
C11.0 Superior wall of nasopharynx
Roof of nasopharynx
C11.1 Posterior wall of nasopharynx
Adenoid
Pharyngeal tonsil
C11.2 Lateral wall of nasopharynx
Fossa of Rosenmuller
Opening of auditory tube
Pharyngeal recess
C11.3 Anterior wall of nasopharynx
Floor of nasopharynx
Nasopharyngeal (anterior) (posterior) surface of soft palate
Posterior margin of nasal:
• choana
• septum
C11.8 Overlapping lesion of nasopharynx
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C11.9 Nasopharynx, unspecified
Nasopharyngeal wall NOS
C12 Malignant neoplasm of pyriform sinus
Pyriform fossa
C13 Malignant neoplasm of hypopharynx
Excludes: pyriform sinus (C12)
C13.1 Aryepiglottic fold, hypopharyngeal aspect
Aryepiglottic fold:
• NOS
• marginal zone
Excludes: aryepiglottic fold, laryngeal aspect (C32.1)
C13.2 Posterior wall of hypopharynx
C13.8 Overlapping lesion of hypopharynx
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C13.9 Hypopharynx, unspecified
Hypopharyngeal wall NOS
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
Excludes: oral cavity NOS (C06.9)
C14.8 Overlapping lesion of lip, oral cavity and pharynx
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Malignant neoplasm of lip, oral cavity and pharynx whose point of origin cannot be classified to any one of the categories C00-C14.2
Malignant neoplasms of digestive organs (C15-C26)
C15 Malignant neoplasm of oesophagus
Note: Two alternative subclassifications are given:
.0-.2 by anatomical description
.3-.5 by thirds
This departure from the principle that categories should be mutually exclusive is deliberate, since both forms of terminology are in use but the resulting anatomical divisions are not analogous.
C15.0 Cervical part of oesophagus
C15.1 Thoracic part of oesophagus
C15.2 Abdominal part of oesophagus
C15.3 Upper third of oesophagus
C15.4 Middle third of oesophagus
C15.5 Lower third of oesophagus
C15.8 Overlapping lesion of oesophagus
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C16 Malignant neoplasm of stomach
Cardiac orifice
Cardio-oesophageal junction
Gastro-oesophageal junction
Oesophagus and stomach
Gastric antrum
Prepylorus
Pyloric canal
C16.5 Lesser curvature of stomach, unspecified
Lesser curvature of stomach, not classifiable to C16.1-C16.4
C16.6 Greater curvature of stomach, unspecified
Greater curvature of stomach, not classifiable to C16.0-C16.4
C16.8 Overlapping lesion of stomach
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Gastric cancer NOS
C17 Malignant neoplasm of small intestine
Excludes: ileocaecal valve (C18.0)
C17.8 Overlapping lesion of small intestine
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C17.9 Small intestine, unspecified
C18 Malignant neoplasm of colon
Ileocaecal valve
Sigmoid (flexure)
Excludes: rectosigmoid junction (C19)
C18.8 Overlapping lesion of colon
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Large intestine NOS
C19 Malignant neoplasm of rectosigmoid junction
Colon with rectum
Rectosigmoid (colon)
C20 Malignant neoplasm of rectum
Rectal ampulla
C21 Malignant neoplasm of anus and anal canal
Excludes: anal:
Anal sphincter
C21.8 Overlapping lesion of rectum, anus and anal canal
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Anorectal junction
Anorectum
Malignant neoplasm of rectum, anus and anal canal whose point of origin cannot be classified to any one of the categories C20-C21.2
C22 Malignant neoplasm of liver and intrahepatic bile ducts
Excludes: biliary tract NOS (C24.9)
secondary malignant neoplasm of liver (C78.7)
Hepatocellular carcinoma
Hepatoma
C22.1 Intrahepatic bile duct carcinoma
Cholangiocarcinoma
Kupffer cell sarcoma
C22.7 Other specified carcinomas of liver
C23 Malignant neoplasm of gallbladder
C24 Malignant neoplasm of other and unspecified parts of biliary tract
Excludes: intrahepatic bile duct (C22.1)
Biliary duct or passage NOS
Common bile duct
Cystic duct
Hepatic duct
C24.8 Overlapping lesion of biliary tract
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Malignant neoplasm involving both intrahepatic and extrahepatic bile ducts
Malignant neoplasm of biliary tract whose point of origin cannot be classified to any one of the categories C22.0-C24.1
C24.9 Biliary tract, unspecified
C25 Malignant neoplasm of pancreas
Islets of Langerhans
Neck of pancreas
C25.8 Overlapping lesion of pancreas
[See note 5 preceding Malignant Neoplasms (C00-C97)]
C26 Malignant neoplasm of other and ill-defined digestive organs
Excludes: peritoneum and retroperitoneum (C48-)
C26.0 Intestinal tract, part unspecified
Intestine NOS
Excludes: Hodgkin disease (C81-)
non-Hodgkin lymphoma (C82-C85)
C26.8 Overlapping lesion of digestive system
[See note 5 preceding Malignant Neoplasms (C00-C97)]
Malignant neoplasm of digestive organs whose point of origin cannot be classified to any one of the categories C15-C26.1
Excludes: cardio-oesophageal junction (C16.0)
C26.9 Ill-defined sites within the digestive system
Alimentary canal or tract NOS
Gastrointestinal tract NOS
Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
Includes: middle ear
Excludes: mesothelioma (C45-)
C30 Malignant neoplasm of nasal cavity and middle ear
Cartilage of nose
Concha, nasal
Internal nose
Septum of nose
Vestibule of nose
Excludes: nasal bone (C41.0)
nose NOS (C76.0)
olfactory bulb (C72.2)
posterior margin of nasal septum and choana (C11.3)
Eustachian tube
Inner ear
Mastoid air cells
Excludes: auricular canal (external) (C43.2, C44.2)
bone of ear (meatus) (C41.0)
cartilage of ear (C49.0)
skin of (external) ear (C43.2, C44.2)
C31 Malignant neoplasm of accessory sinuses
Antrum (Highmore) (maxillary)
C31.8 Overlapping lesion of accessory sinuses
[See note 5 preceding Malignant Neoplasms C00-C97]
C31.9 Accessory sinus, unspecified
C32 Malignant neoplasm of larynx
Intrinsic larynx
Vocal cord (true) NOS
Aryepiglottic fold, laryngeal aspect
Epiglottis (suprahyoid portion) NOS
Extrinsic larynx
False vocal cord
Posterior (laryngeal) surface of epiglottis
Ventricular bands
Excludes: anterior surface of epiglottis (C10.1)
aryepiglottic fold:
• NOS (C13.1)
• hypopharyngeal aspect (C13.1)
• marginal zone (C13.1)
C32.8 Overlapping lesion of larynx
[See note 5 preceding Malignant Neoplasms C00-C97]
C33 Malignant neoplasm of trachea
C34 Malignant neoplasm of bronchus and lung
Carina
Hilus (of lung)
C34.1 Upper lobe, bronchus or lung
C34.2 Middle lobe, bronchus or lung
C34.3 Lower lobe, bronchus or lung
C34.8 Overlapping lesion of bronchus and lung
[See note 5 preceding Malignant Neoplasms C00-C97]
C34.9 Bronchus or lung, unspecified
C37 Malignant neoplasm of thymus
C38 Malignant neoplasm of heart, mediastinum and pleura
Excludes: mesothelioma (C45-)
Pericardium
Excludes: great vessels (C49.3)
C38.3 Mediastinum, part unspecified
C38.8 Overlapping lesion of heart, mediastinum and pleura
[See note 5 preceding Malignant Neoplasms C00-C97]
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
Excludes: intrathoracic NOS (C76.1)
thoracic NOS (C76.1)
C39.0 Upper respiratory tract, part unspecified
C39.8 Overlapping lesion of respiratory and intrathoracic organs
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of respiratory and intrathoracic organs whose point of origin cannot be classified to any one of the categories C30-C39.0
C39.9 Ill-defined sites within the respiratory system
Respiratory tract NOS
Malignant neoplasms of bone and articular cartilage (C40-C41)
Excludes: bone marrow NOS (C96.7)
synovia (C49-)
C40 Malignant neoplasm of bone and articular cartilage of limbs
C40.0 Scapula and long bones of upper limb
C40.1 Short bones of upper limb
C40.2 Long bones of lower limb
C40.3 Short bones of lower limb
C40.8 Overlapping lesion of bone and articular cartilage of limbs
[See note 5 preceding Malignant Neoplasms C00-C97]
C40.9 Bone and articular cartilage of limb, unspecified
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
Excludes: bones of limbs (C40-)
cartilage of:
• ear (C49.0)
• larynx (C32.3)
• limbs (C40-)
• nose (C30.0)
Maxilla (superior)
Orbital bone
Excludes: carcinoma, any type except intraosseous or odontogenic of:
• maxillary sinus (C31.0)
• upper jaw (C03.0)
jaw bone (lower) (C41.1)
Lower jaw bone
Excludes: carcinoma, any type except intraosseous or odontogenic of:
• jaw NOS (C03.9)
• lower (C03.1)
upper jaw bone (C41.0)
Excludes: sacrum and coccyx (C41.4)
C41.3 Ribs, sternum and clavicle
C41.4 Pelvic bones, sacrum and coccyx
C41.8 Overlapping lesion of bone and articular cartilage
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of bone and articular cartilage whose point of origin cannot be classified to any one of the categories C40-C41.4
C41.9 Bone and articular cartilage, unspecified
Melanoma and other malignant neoplasms of skin (C43-C44)
C43 Malignant melanoma of skin
Includes: morphology codes M872-M879 with behaviour code /3
Excludes: malignant melanoma of skin of genital organs (C51-C52, C60-, C63-)
C43.0 Malignant melanoma of lip
Excludes: vermilion border of lip (C00.0-C00.2)
C43.1 Malignant melanoma of eyelid, including canthus
C43.2 Malignant melanoma of ear and external auricular canal
C43.3 Malignant melanoma of other and unspecified parts of face
C43.4 Malignant melanoma of scalp and neck
C43.5 Malignant melanoma of trunk
Anal:
• margin
• skin
Perianal skin
Skin of breast
Excludes: anus NOS (C21.0)
C43.6 Malignant melanoma of upper limb, including shoulder
C43.7 Malignant melanoma of lower limb, including hip
C43.8 Overlapping malignant melanoma of skin
[See note 5 preceding Malignant Neoplasms C00-C97]
C43.9 Malignant melanoma of skin, unspecified
Melanoma (malignant) NOS
C44 Other malignant neoplasms of skin
Includes: malignant neoplasm of:
• sebaceous glands
• sweat glands
Excludes: Kaposi sarcoma (C46-)
malignant melanoma of skin (C43-)
skin of genital organs (C51-C52, C60-, C63-)
Basal cell carcinoma of lip
Excludes: malignant neoplasm of lip (C00-)
C44.1 Skin of eyelid, including canthus
Excludes: connective tissue of eyelid (C49.0)
C44.2 Skin of ear and external auricular canal
Excludes: connective tissue of ear (C49.0)
C44.3 Skin of other and unspecified parts of face
Anal:
• margin
• skin
Perianal skin
Skin of breast
Excludes: anus NOS (C21.0)
C44.6 Skin of upper limb, including shoulder
C44.7 Skin of lower limb, including hip
C44.8 Overlapping lesion of skin
[See note 5 preceding Malignant Neoplasms C00-C97]
C44.9 Malignant neoplasm of skin, unspecified
Malignant neoplasms of mesothelial and soft tissue (C45-C49)
Includes: morphology code M905 with behaviour code /3
Excludes: other malignant neoplasms of pleura (C38.4)
C45.1 Mesothelioma of peritoneum
Mesentery
Mesocolon
Omentum
Peritoneum (parietal) (pelvic)
Excludes: other malignant neoplasms of peritoneum (C48-)
C45.2 Mesothelioma of pericardium
Excludes: other malignant neoplasms of pericardium (C38.0)
C45.7 Mesothelioma of other sites
C45.9 Mesothelioma, unspecified
Includes: morphology code M9140 with behaviour code /3
C46.1 Kaposi sarcoma of soft tissue
C46.2 Kaposi sarcoma of palate
C46.3 Kaposi sarcoma of lymph nodes
C46.7 Kaposi sarcoma of other sites
C46.8 Kaposi sarcoma of multiple organs
C46.9 Kaposi sarcoma, unspecified
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
Includes: sympathetic and parasympathetic nerves and ganglia
C47.0 Peripheral nerves of head, face and neck
Excludes: peripheral nerves of orbit (C69.6)
C47.1 Peripheral nerves of upper limb, including shoulder
C47.2 Peripheral nerves of lower limb, including hip
C47.3 Peripheral nerves of thorax
C47.4 Peripheral nerves of abdomen
C47.5 Peripheral nerves of pelvis
C47.6 Peripheral nerves of trunk, unspecified
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
[See note 5 preceding Malignant Neoplasms C00-C97]
C47.9 Peripheral nerves and autonomic nervous system, unspecified
C48 Malignant neoplasm of retroperitoneum and peritoneum
Excludes: Kaposi sarcoma (C46.1)
mesothelioma (C45-)
C48.1 Specified parts of peritoneum
Mesentery
Mesocolon
Omentum
Peritoneum:
• parietal
• pelvic
C48.8 Overlapping lesion of retroperitoneum and peritoneum
[See note 5 preceding Malignant Neoplasms C00-C97]
C49 Malignant neoplasm of other connective and soft tissue
Includes: blood vessel
bursa
cartilage
fascia
fat
ligament, except uterine
lymphatic vessel
muscle
synovia
tendon (sheath)
Excludes: cartilage (of):
• articular (C40-C41)
• larynx (C32.3)
• nose (C30.0)
connective tissue of breast (C50-)
Kaposi sarcoma (C46-)
mesothelioma (C45-)
peripheral nerves and autonomic nervous system (C47-)
peritoneum (C48-)
retroperitoneum (C48.0)
C49.0 Connective and soft tissue of head, face and neck
Connective tissue of:
• ear
• eyelid
Excludes: connective tissue of orbit (C69.6)
C49.1 Connective and soft tissue of upper limb, including shoulder
C49.2 Connective and soft tissue of lower limb, including hip
C49.3 Connective and soft tissue of thorax
Axilla
Diaphragm
Great vessels
Excludes: breast (C50-)
heart (C38.0)
mediastinum (C38.1-C38.3)
thymus (C37)
C49.4 Connective and soft tissue of abdomen
Abdominal wall
Hypochondrium
C49.5 Connective and soft tissue of pelvis
Buttock
Groin
Perineum
C49.6 Connective and soft tissue of trunk, unspecified
Back NOS
C49.8 Overlapping lesion of connective and soft tissue
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of connective and soft tissue whose point of origin cannot be classified to any one of the categories C47-C49.6
C49.9 Connective and soft tissue, unspecified
Malignant neoplasm of breast (C50)
C50 Malignant neoplasm of breast
Includes: connective tissue of breast
Excludes: skin of breast (C43.5, C44.5)
C50.1 Central portion of breast
C50.2 Upper-inner quadrant of breast
C50.3 Lower-inner quadrant of breast
C50.4 Upper-outer quadrant of breast
C50.5 Lower-outer quadrant of breast
C50.8 Overlapping lesion of breast
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasms of female genital organs (C51-C58)
Includes: skin of female genital organs
C51 Malignant neoplasm of vulva
Bartholin [greater vestibular] gland
C51.8 Overlapping lesion of vulva
[See note 5 preceding Malignant Neoplasms C00-C97]
External female genitalia NOS
Pudendum
C52 Malignant neoplasm of vagina
C53 Malignant neoplasm of cervix uteri
C53.8 Overlapping lesion of cervix uteri
[See note 5 preceding Malignant Neoplasms C00-C97]
C53.9 Cervix uteri, unspecified
C54 Malignant neoplasm of corpus uteri
Lower uterine segment
C54.8 Overlapping lesion of corpus uteri
[See note 5 preceding Malignant Neoplasms C00-C97]
C54.9 Corpus uteri, unspecified
C55 Malignant neoplasm of uterus, part unspecified
C56 Malignant neoplasm of ovary
C57 Malignant neoplasm of other and unspecified female genital organs
Oviduct
Uterine tube
Uterine ligament NOS
C57.4 Uterine adnexa, unspecified
C57.7 Other specified female genital organs
Wolffian body or duct
C57.8 Overlapping lesion of female genital organs
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of female genital organs whose point of origin cannot be classified to any one of the categories C51-C57.7, C58
Tubo-ovarian
Utero-ovarian
C57.9 Female genital organ, unspecified
Female genitourinary tract NOS
C58 Malignant neoplasm of placenta
Choriocarcinoma NOS
Chorionepithelioma NOS
Excludes: chorioadenoma (destruens) (D39.2)
hydatidiform mole:
• NOS (O01.9)
• invasive (D39.2)
• malignant (D39.2)
Malignant neoplasms of male genital organs (C60-C63)
Includes: skin of male genital organs
C60 Malignant neoplasm of penis
Foreskin
Corpus cavernosum
C60.8 Overlapping lesion of penis
[See note 5 preceding Malignant Neoplasms C00-C97]
Skin of penis NOS
C61 Malignant neoplasm of prostate
C62 Malignant neoplasm of testis
Ectopic testis [site of neoplasm]
Retained testis [site of neoplasm]
Scrotal testis
C63 Malignant neoplasm of other and unspecified male genital organs
Skin of scrotum
C63.7 Other specified male genital organs
Seminal vesicle
Tunica vaginalis
C63.8 Overlapping lesion of male genital organs
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of male genital organs whose point of origin cannot be classified to any one of the categories C60-C63.7
C63.9 Male genital organ, unspecified
Male genitourinary tract NOS
Malignant neoplasms of urinary tract (C64-C68)
C64 Malignant neoplasm of kidney, except renal pelvis
Excludes: renal:
• calyces (C65)
• pelvis (C65)
C65 Malignant neoplasm of renal pelvis
Pelviureteric junction
Renal calyces
C66 Malignant neoplasm of ureter
Excludes: ureteric orifice of bladder (C67.6)
C67 Malignant neoplasm of bladder
C67.3 Anterior wall of bladder
C67.4 Posterior wall of bladder
Internal urethral orifice
C67.8 Overlapping lesion of bladder
[See note 5 preceding Malignant Neoplasms C00-C97]
C68 Malignant neoplasm of other and unspecified urinary organs
Excludes: genitourinary tract NOS:
• female (C57.9)
• male (C63.9)
Excludes: urethral orifice of bladder (C67.5)
C68.8 Overlapping lesion of urinary organs
[See note 5 preceding Malignant Neoplasms C00-C97
Malignant neoplasm of urinary organs whose point of origin cannot be classified to any one of the categories C64-C68.1
C68.9 Urinary organ, unspecified
Urinary system NOS
Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
C69 Malignant neoplasm of eye and adnexa
Excludes: connective tissue of eyelid (C49.0)
optic nerve (C72.3)
Lacrimal sac
Nasolacrimal duct
Connective tissue of orbit
Extraocular muscle
Peripheral nerves of orbit
Retrobulbar tissue
Retro-ocular tissue
Excludes: orbital bone (C41.0)
C69.8 Overlapping lesion of eye and adnexa
[See note 5 preceding Malignant Neoplasms C00-C97]
Eyeball
C70 Malignant neoplasm of meninges
C71 Malignant neoplasm of brain
Excludes: cranial nerves (C72.2-C72.5)
retrobulbar tissue (C69.6)
C71.0 Cerebrum, except lobes and ventricles
Supratentorial NOS
Excludes: fourth ventricle (C71.7)
Fourth ventricle
Infratentorial NOS
C71.8 Overlapping lesion of brain
[See note 5 preceding Malignant Neoplasms C00-C97]
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
Excludes: meninges (C70-)
peripheral nerves and autonomic nervous system (C47-)
Olfactory bulb
C72.5 Other and unspecified cranial nerves
Cranial nerve NOS
C72.8 Overlapping lesion of brain and other parts of central nervous system
[See note 5 preceding Malignant Neoplasms C00-C97]
Malignant neoplasm of brain and other parts of central nervous system whose point of origin cannot be classified to any one of the categories C70-C72.5
C72.9 Central nervous system, unspecified
Nervous system NOS
Malignant neoplasms of thyroid and other endocrine glands (C73-C75)
C73 Malignant neoplasm of thyroid gland
C74 Malignant neoplasm of adrenal gland
C74.1 Medulla of adrenal gland
C74.9 Adrenal gland, unspecified
C75 Malignant neoplasm of other endocrine glands and related structures
Excludes: adrenal gland (C74-)
endocrine pancreas (C25.4)
ovary (C56)
testis (C62-)
thymus (C37)
thyroid gland (C73)
C75.5 Aortic body and other paraganglia
C75.8 Pluriglandular involvement, unspecified
Note: If the sites of multiple involvement are known, they should be coded separately.
C75.9 Endocrine gland, unspecified
Malignant neoplasms of ill-defined, secondary and unspecified sites (C76-C80)
C76 Malignant neoplasm of other and ill-defined sites
Excludes: malignant neoplasm of:
• genitourinary tract NOS:
• female (C57.9)
• male (C63.9)
• lymphoid, haematopoietic and related tissue (C81-C96)
• unspecified site (C80)
Cheek NOS
Nose
Axilla NOS
Intrathoracic NOS
Thoracic NOS
Groin NOS
Sites overlapping systems within the pelvis, such as:
• rectovaginal (septum)
• rectovesical (septum)
C76.8 Overlapping lesion of other and ill-defined sites
[See note 5 preceding Malignant Neoplasms C00-C97]
C77 Secondary and unspecified malignant neoplasm of lymph nodes
Excludes: malignant neoplasm of lymph nodes, specified as primary (C81-C87, C96-)
C77.0 Lymph nodes of head, face and neck
Supraclavicular lymph nodes
C77.1 Intrathoracic lymph nodes
C77.2 Intra-abdominal lymph nodes
C77.3 Axillary and upper limb lymph nodes
Pectoral lymph nodes
C77.4 Inguinal and lower limb lymph nodes
C77.8 Lymph nodes of multiple regions
C78 Secondary malignant neoplasm of respiratory and digestive organs
C78.0 Secondary malignant neoplasm of lung
C78.1 Secondary malignant neoplasm of mediastinum
C78.2 Secondary malignant neoplasm of pleura
Malignant pleural effusion NOS
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
C78.4 Secondary malignant neoplasm of small intestine
C78.5 Secondary malignant neoplasm of large intestine and rectum
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
Malignant ascites NOS
C78.7 Secondary malignant neoplasm of liver
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
C79 Secondary malignant neoplasm of other sites
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
C79.2 Secondary malignant neoplasm of skin
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
C79.5 Secondary malignant neoplasm of bone and bone marrow
C79.6 Secondary malignant neoplasm of ovary
C79.7 Secondary malignant neoplasm of adrenal gland
C79.8 Secondary malignant neoplasm of other specified sites
C80 Malignant neoplasm without specification of site
Cancer
Carcinoma
Carcinomatosis
Generalized:
• cancer unspecified site (primary) (secondary)
• malignancy
Malignancy
Multiple cancer
Malignant neoplasms of lymphoid, haematopoietic and related tissue (C81-C96)
Note: The terms used in categories C82-C85 for non-Hodgkin lymphomas are those of the Working Formulation, which attempted to find common ground among several major classification schemes. The terms used in these schemes are not given in the Tabular List but appear in the Alphabetical Index; exact equivalence with the terms appearing in the Tabular List is not always possible.
Includes: morphology codes M959-M994 with behaviour code /3
Excludes: secondary and unspecified neoplasm of lymph nodes (C77-)
Includes: morphology codes M965-M966 with behaviour code /3
C81.0 Lymphocytic predominance
Lymphocytic-histiocytic predominance
C81.9 Hodgkin disease, unspecified
C82 Follicular [nodular] non-Hodgkin lymphoma
Includes: follicular non-Hodgkin lymphoma with or without diffuse areas
morphology code M969 with behaviour code /3
C82.0 Small cleaved cell, follicular
C82.1 Mixed small cleaved and large cell, follicular
C82.7 Other types of follicular non-Hodgkin lymphoma
C82.9 Follicular non-Hodgkin lymphoma, unspecified
Nodular non-Hodgkin lymphoma NOS
C83 Diffuse non-Hodgkin lymphoma
Includes: morphology codes M9593, M9595, M967-M968 with behaviour code /3
C83.1 Small cleaved cell (diffuse)
C83.2 Mixed small and large cell (diffuse)
Reticulum cell sarcoma
C83.6 Undifferentiated (diffuse)
C83.8 Other types of diffuse non-Hodgkin lymphoma
C83.9 Diffuse non-Hodgkin lymphoma, unspecified
C84 Peripheral and cutaneous T-cell lymphomas
Includes: morphology code M970 with behaviour code /3
C84.3 Lymphoepithelioid lymphoma
Lennert lymphoma
C84.4 Peripheral T-cell lymphoma
C84.5 Other and unspecified T-cell lymphomas
Note: If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
C85 Other and unspecified types of non-Hodgkin lymphoma
Includes: morphology codes M9590-M9592, M9594, M971 with behaviour code /3
C85.1 B-cell lymphoma, unspecified
Note: If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
C85.7 Other specified types of non-Hodgkin lymphoma
Malignant:
• reticuloendotheliosis
• reticulosis
Microglioma
C85.9 Non-Hodgkin lymphoma, unspecified type
Lymphoma NOS
Malignant lymphoma NOS
Non-Hodgkin lymphoma NOS
C88 Malignant immunoproliferative diseases
Includes: morphology code M976 with behaviour code /3
C88.0 Waldenstrom macroglobulinaemia
C88.1 Alpha heavy chain disease
C88.2 Gamma heavy chain disease
Franklin disease
C88.3 Immunoproliferative small intestinal disease
Mediterranean disease
C88.7 Other malignant immunoproliferative diseases
C88.9 Malignant immunoproliferative disease, unspecified
Immunoproliferative disease NOS
C90 Multiple myeloma and malignant plasma cell neoplasms
Includes: morphology codes M973, M9830 with behaviour code /3
Kahler disease
Myelomatosis
Excludes: solitary myeloma (C90.2)
C90.2 Plasmacytoma, extramedullary
Malignant plasma cell tumour NOS
Plasmacytoma NOS
Solitary myeloma
Includes: morphology codes M982, M9940-M9941 with behaviour code /3
C91.0 Acute lymphoblastic leukaemia
Excludes: acute exacerbation of chronic lymphocytic leukaemia (C91.1)
C91.1 Chronic lymphocytic leukaemia
C91.2 Subacute lymphocytic leukaemia
C91.3 Prolymphocytic leukaemia
Leukaemic reticuloendotheliosis
C91.7 Other lymphoid leukaemia
C91.9 Lymphoid leukaemia, unspecified
Includes: leukaemia:
• granulocytic
• myelogenous
morphology codes M986-M988, M9930 with behaviour code /3
Excludes: acute exacerbation of chronic myeloid leukaemia (C92.1)
C92.1 Chronic myeloid leukaemia
C92.2 Subacute myeloid leukaemia
Chloroma
Granulocytic sarcoma
C92.4 Acute promyelocytic leukaemia
C92.5 Acute myelomonocytic leukaemia
C92.9 Myeloid leukaemia, unspecified
Includes: monocytoid leukaemia
morphology code M989 with behaviour code /3
C93.0 Acute monocytic leukaemia
Excludes: acute exacerbation of chronic monocytic leukaemia (C93.1)
C93.1 Chronic monocytic leukaemia
C93.2 Subacute monocytic leukaemia
C93.7 Other monocytic leukaemia
C93.9 Monocytic leukaemia, unspecified
C94 Other leukaemias of specified cell type
Includes: morphology codes M984, M9850, M9900, M9910, M9931-M9932 with behaviour code /3
Excludes: leukaemic reticuloendotheliosis (C91.4)
plasma cell leukaemia (C90.1)
C94.0 Acute erythraemia and erythroleukaemia
Acute erythraemic myelosis
Di Guglielmo disease
Heilmeyer-Schoner disease
C94.2 Acute megakaryoblastic leukaemia
Leukaemia:
• megakaryoblastic (acute)
• megakaryocytic (acute)
C94.7 Other specified leukaemias
Lymphosarcoma cell leukaemia
C95 Leukaemia of unspecified cell type
Includes: morphology code M980 with behaviour code /3
C95.0 Acute leukaemia of unspecified cell type
Blast cell leukaemia
Stem cell leukaemia
Excludes: acute exacerbation of unspecified chronic leukaemia (C95.1)
C95.1 Chronic leukaemia of unspecified cell type
C95.2 Subacute leukaemia of unspecified cell type
C95.7 Other leukaemia of unspecified cell type
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
Includes: morphology codes M972, M974 with behaviour code /3
Nonlipid:
• reticuloendotheliosis
• reticulosis
Histiocytic medullary reticulosis
C96.2 Malignant mast cell tumour
Malignant:
• mastocytoma
• mastocytosis
Mast cell sarcoma
Excludes: mast cell leukaemia (C94.3)
mastocytosis (cutaneous) (Q82.2)
C96.3 True histiocytic lymphoma
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
Malignant neoplasms of independent (primary) multiple sites (C97)
C97 Malignant neoplasms of independent (primary) multiple sites
Note: For use of this category, reference should be made to the mortality coding rules and guidelines in Part 2a Instruction Manual (NCHS).
In situ neoplasms (D00-D09)
Note: Many in situ neoplasms are regarded as being located within a continuum of morphological change between dysplasia and invasive cancer. For example, for cervical intraepithelial neoplasia (CIN) three grades are recognized, the third of which (CIN III) includes both severe dysplasia and carcinoma in situ. This system of grading has been extended to other organs, such as vulva and vagina. Descriptions of grade III intraepithelial neoplasia, with or without mention of severe dysplasia, are assigned to this section; grades I and II are classified as dysplasia of the organ system involved and should be coded to the relevant body system chapter.
Includes: Bowen disease
erythroplasia
morphology codes with behaviour code /2
Queyrat erythroplasia
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
Excludes: melanoma in situ (D03-)
D00.0 Lip, oral cavity and pharynx
Aryepiglottic fold:
• NOS
• hypopharyngeal aspect
• marginal zone
Vermilion border of lip
Excludes: aryepiglottic fold, laryngeal aspect (D02.0)
epiglottis:
• NOS (D02.0)
• suprahyoid portion (D02.0)
D01 Carcinoma in situ of other and unspecified digestive organs
Excludes: melanoma in situ (D03-)
Excludes: rectosigmoid junction (D01.1)
Excludes: anal:
D01.4 Other and unspecified parts of intestine
Excludes: ampulla of Vater (D01.5)
D01.5 Liver, gallbladder and bile ducts
Ampulla of Vater
D01.7 Other specified digestive organs
Pancreas
D01.9 Digestive organ, unspecified
D02 Carcinoma in situ of middle ear and respiratory system
Excludes: melanoma in situ (D03-)
Aryepiglottic fold, laryngeal aspect
Epiglottis (suprahyoid portion)
Excludes: aryepiglottic fold:
• NOS (D00.0)
• hypopharyngeal aspect (D00.0)
• marginal zone (D00.0)
D02.3 Other parts of respiratory system
Accessory sinuses
Middle ear
Nasal cavities
Excludes: ear (external)(skin) (D03.2, D04.2)
nose:
• NOS (D09.7)
D02.4 Respiratory system, unspecified
Includes: morphology codes M872-M879 with behaviour code /2
D03.1 Melanoma in situ of eyelid, including canthus
D03.2 Melanoma in situ of ear and external auricular canal
D03.3 Melanoma in situ of other and unspecified parts of face
D03.4 Melanoma in situ of scalp and neck
D03.5 Melanoma in situ of trunk
Anal:
• margin
• skin
Breast (skin)(soft tissue)
Perianal skin
D03.6 Melanoma in situ of upper limb, including shoulder
D03.7 Melanoma in situ of lower limb, including hip
D03.8 Melanoma in situ of other sites
D03.9 Melanoma in situ, unspecified
Excludes: erythroplasia of Queyrat (penis) NOS (D07.4)
melanoma in situ (D03-)
Excludes: vermilion border of lip (D00.0)
D04.1 Skin of eyelid, including canthus
D04.2 Skin of ear and external auricular canal
D04.3 Skin of other and unspecified parts of face
Anal:
• margin
• skin
Perianal skin
Skin of breast
Excludes: anus NOS (D01.3)
skin of genital organs (D07-)
D04.6 Skin of upper limb, including shoulder
D04.7 Skin of lower limb, including hip
D05 Carcinoma in situ of breast
Excludes: carcinoma in situ of skin of breast (D04.5)
melanoma in situ of breast (skin) (D03.5)
D05.0 Lobular carcinoma in situ
D05.1 Intraductal carcinoma in situ
D05.7 Other carcinoma in situ of breast
D05.9 Carcinoma in situ of breast, unspecified
D06 Carcinoma in situ of cervix uteri
Includes: cervical intraepithelial neoplasia [CIN], grade III, with or without mention of severe dysplasia
Excludes: melanoma in situ of cervix (D03.5)
severe dysplasia of cervix NOS (N87.2)
D07 Carcinoma in situ of other and unspecified genital organs
Excludes: melanoma in situ (D03.5)
Vulvar intraepithelial neoplasia [VIN], grade III, with or without mention of severe dysplasia
Excludes: severe dysplasia of vulva NOS (N90.2)
Vaginal intraepithelial neoplasia [VAIN], grade III, with or without mention of severe dysplasia
Excludes: severe dysplasia of vagina NOS (N89.2)
D07.3 Other and unspecified female genital organs
Erythroplasia of Queyrat NOS
Excludes: low grade dysplasia of prostate (N42.3)
D07.6 Other and unspecified male genital organs
D09 Carcinoma in situ of other and unspecified sites
Excludes: melanoma in situ (D03-)
D09.1 Other and unspecified urinary organs
Excludes: skin of eyelid (D04.1)
D09.3 Thyroid and other endocrine glands
Excludes: endocrine pancreas (D01.7)
ovary (D07.3)
testis (D07.6)
D09.7 Carcinoma in situ of other specified sites
D09.9 Carcinoma in situ, unspecified
Benign neoplasms (D10-D36)
Includes: morphology codes with behaviour code /0
D10 Benign neoplasm of mouth and pharynx
Lip (frenulum) (inner aspect) (mucosa) (vermilion border)
Excludes: skin of lip (D22.0, D23.0)
Lingual tonsil
D10.3 Other and unspecified parts of mouth
Minor salivary gland NOS
Excludes: benign odontogenic neoplasms (D16.4-D16.5)
mucosa of lip (D10.0)
nasopharyngeal surface of soft palate (D10.6)
Tonsil (faucial) (palatine)
Excludes: lingual tonsil (D10.1)
pharyngeal tonsil (D10.6)
tonsillar:
• fossa (D10.5)
• pillars (D10.5)
D10.5 Other parts of oropharynx
Epiglottis, anterior aspect
Tonsillar:
• fossa
• pillars
Vallecula
Excludes: epiglottis:
• NOS (D14.1)
• suprahyoid portion (D14.1)
Pharyngeal tonsil
Posterior margin of septum and choanae
D11 Benign neoplasm of major salivary glands
Excludes: benign neoplasms of specified minor salivary glands which are classified according to their anatomical location
benign neoplasms of minor salivary glands NOS (D10.3)
D11.7 Other major salivary glands
Gland:
• sublingual
• submandibular
D11.9 Major salivary gland, unspecified
D12 Benign neoplasm of colon, rectum, anus and anal canal
Ileocaecal valve
Hepatic flexure
Splenic flexure
Adenomatosis of colon
Large intestine NOS
Polyposis (hereditary) of colon
Excludes: anal:
D13 Benign neoplasm of other and ill-defined parts of digestive system
D13.3 Other and unspecified parts of small intestine
Intrahepatic bile ducts
Excludes: endocrine pancreas (D13.7)
Islet cell tumour
Islets of Langerhans
D13.9 Ill-defined sites within the digestive system
Digestive system NOS
Intestine NOS
Spleen
D14 Benign neoplasm of middle ear and respiratory system
D14.0 Middle ear, nasal cavity and accessory sinuses
Cartilage of nose
Excludes: auricular canal (external) (D22.2, D23.2)
bone of:
• ear (D16.4)
• nose (D16.4)
cartilage of ear (D21.0)
ear (external)(skin) (D22.2, D23.2)
nose:
• NOS (D36.7)
olfactory bulb (D33.3)
polyp (of):
• accessory sinus (J33.8)
• ear (middle) (H74.4)
• nasal (cavity) (J33-)
posterior margin of septum and choanae (D10.6)
Epiglottis (suprahyoid portion)
Excludes: epiglottis, anterior aspect (D10.5)
polyp of vocal cord and larynx (J38.1)
D14.4 Respiratory system, unspecified
D15 Benign neoplasm of other and unspecified intrathoracic organs
Excludes: mesothelial tissue (D19-)
Excludes: great vessels (D21.3)
D15.7 Other specified intrathoracic organs
D15.9 Intrathoracic organ, unspecified
D16 Benign neoplasm of bone and articular cartilage
Excludes: connective tissue of:
• ear (D21.0)
• eyelid (D21.0)
• larynx (D14.1)
• nose (D14.0)
synovia (D21-)
D16.0 Scapula and long bones of upper limb
D16.1 Short bones of upper limb
D16.2 Long bones of lower limb
D16.3 Short bones of lower limb
Maxilla (superior)
Orbital bone
Excludes: lower jaw bone (D16.5)
Excludes: sacrum and coccyx (D16.8)
D16.7 Ribs, sternum and clavicle
D16.8 Pelvic bones, sacrum and coccyx
D16.9 Bone and articular cartilage, unspecified
D17 Benign lipomatous neoplasm
Includes: morphology codes M885-M888 with behaviour code /0
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
D17.4 Benign lipomatous neoplasm of intrathoracic organs
D17.5 Benign lipomatous neoplasm of intra-abdominal organs
Excludes: peritoneum and retroperitoneum (D17.7)
D17.6 Benign lipomatous neoplasm of spermatic cord
D17.7 Benign lipomatous neoplasm of other sites
Peritoneum
Retroperitoneum
D17.9 Benign lipomatous neoplasm, unspecified
Lipoma NOS
D18 Haemangioma and lymphangioma, any site
Includes: morphology codes M912-M917 with behaviour code /0
Excludes: blue or pigmented naevus (D22-)
Angioma NOS
D19 Benign neoplasm of mesothelial tissue
Includes: morphology code M905 with behaviour code /0
D19.0 Mesothelial tissue of pleura
D19.1 Mesothelial tissue of peritoneum
D19.7 Mesothelial tissue of other sites
D19.9 Mesothelial tissue, unspecified
Benign mesothelioma NOS
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum
Excludes: benign lipomatous neoplasm of peritoneum and retroperitoneum (D17.7)
mesothelial tissue (D19-)
D21 Other benign neoplasms of connective and other soft tissue
Includes: blood vessel
bursa
cartilage
fascia
fat
ligament, except uterine
lymphatic channel
muscle
synovia
tendon (sheath)
Excludes: cartilage:
• articular (D16-)
• larynx (D14.1)
• nose (D14.0)
connective tissue of breast (D24)
haemangioma (D18.0)
lipomatous neoplasm (D17-)
lymphangioma (D18.1)
peripheral nerves and autonomic nervous system (D36.1)
peritoneum (D20.1)
retroperitoneum (D20.0)
uterine:
• leiomyoma (D25-)
• ligament, any (D28.2)
vascular tissue (D18-)
D21.0 Connective and other soft tissue of head, face and neck
Connective tissue of:
• ear
• eyelid
Excludes: connective tissue of orbit (D31.6)
D21.1 Connective and other soft tissue of upper limb, including shoulder
D21.2 Connective and other soft tissue of lower limb, including hip
D21.3 Connective and other soft tissue of thorax
Axilla
Diaphragm
Great vessels
Excludes: heart (D15.1)
mediastinum (D15.2)
thymus (D15.0)
D21.4 Connective and other soft tissue of abdomen
D21.5 Connective and other soft tissue of pelvis
Excludes: uterine:
• leiomyoma (D25-)
• ligament, any (D28.2)
D21.6 Connective and other soft tissue of trunk, unspecified
Back NOS
D21.9 Connective and other soft tissue, unspecified
Includes: morphology codes M872-M879 with behaviour code /0
naevus:
• NOS
• blue
• hairy
• pigmented
D22.0 Melanocytic naevi of lip
D22.1 Melanocytic naevi of eyelid, including canthus
D22.2 Melanocytic naevi of ear and external auricular canal
D22.3 Melanocytic naevi of other and unspecified parts of face
D22.4 Melanocytic naevi of scalp and neck
D22.5 Melanocytic naevi of trunk
Anal:
• margin
• skin
Perianal skin
Skin of breast
D22.6 Melanocytic naevi of upper limb, including shoulder
D22.7 Melanocytic naevi of lower limb, including hip
D22.9 Melanocytic naevi, unspecified
D23 Other benign neoplasms of skin
Includes: benign neoplasm of:
• hair follicles
• sebaceous glands
• sweat glands
Excludes: benign lipomatous neoplasms (D17.0-D17.3)
melanocytic naevi (D22-)
Excludes: vermilion border of lip (D10.0)
D23.1 Skin of eyelid, including canthus
D23.2 Skin of ear and external auricular canal
D23.3 Skin of other and unspecified parts of face
Anal:
• margin
• skin
Perianal skin
Skin of breast
Excludes: anus NOS (D12.9)
skin of genital organs (D28-D29)
D23.6 Skin of upper limb, including shoulder
D23.7 Skin of lower limb, including hip
Breast:
• connective tissue
• soft parts
Excludes: benign mammary dysplasia (N60-)
Includes: benign neoplasms of uterus with morphology code M889 and behaviour code /0
fibromyoma of uterus
D25.0 Submucous leiomyoma of uterus
D25.1 Intramural leiomyoma of uterus
D25.2 Subserosal leiomyoma of uterus
D25.9 Leiomyoma of uterus, unspecified
D26 Other benign neoplasms of uterus
D28 Benign neoplasm of other and unspecified female genital organs
Includes: adenomatous polyp
skin of female genital organs
D28.2 Uterine tubes and ligaments
Fallopian tube
Uterine ligament (broad)(round)
D28.7 Other specified female genital organs
D28.9 Female genital organ, unspecified
D29 Benign neoplasm of male genital organs
Includes: skin of male genital organs
Excludes: hyperplasia of prostate (adenomatous) (N40)
prostatic:
• enlargement (N40)
• hypertrophy (N40)
Skin of scrotum
D29.7 Other male genital organs
Seminal vesicle
Spermatic cord
Tunica vaginalis
D29.9 Male genital organ, unspecified
D30 Benign neoplasm of urinary organs
Excludes: renal:
• calyces (D30.1)
• pelvis (D30.1)
Excludes: ureteric orifice of bladder (D30.3)
Orifice of bladder:
• urethral
• ureteric
Excludes: urethral orifice of bladder (D30.3)
Paraurethral glands
D30.9 Urinary organ, unspecified
Urinary system NOS
D31 Benign neoplasm of eye and adnexa
Excludes: connective tissue of eyelid (D21.0)
optic nerve (D33.3)
Lacrimal sac
Nasolacrimal duct
Connective tissue of orbit
Extraocular muscle
Peripheral nerves of orbit
Retrobulbar tissue
Retro-ocular tissue
Excludes: orbital bone (D16.4)
Eyeball
D32 Benign neoplasm of meninges
Meningioma NOS
D33 Benign neoplasm of brain and other parts of central nervous system
Excludes: angioma (D18.0)
meninges (D32-)
peripheral nerves and autonomic nervous system (D36.1)
retro-ocular tissue (D31.6)
Cerebral ventricle
Cerebrum
Frontal
Occipital
Parietal lobe
Temporal
Excludes: fourth ventricle (D33.1)
Brain stem
Cerebellum
Fourth ventricle
Olfactory bulb
D33.7 Other specified parts of central nervous system
D33.9 Central nervous system, unspecified
Nervous system (central) NOS
D34 Benign neoplasm of thyroid gland
D35 Benign neoplasm of other and unspecified endocrine glands
Excludes: endocrine pancreas (D13.7)
ovary (D27)
testis (D29.2)
thymus (D15.0)
D35.6 Aortic body and other paraganglia
D35.7 Other specified endocrine glands
D35.8 Pluriglandular involvement
D35.9 Endocrine gland, unspecified
D36 Benign neoplasm of other and unspecified sites
D36.1 Peripheral nerves and autonomic nervous system
Excludes: peripheral nerves of orbit (D31.6)
Nose NOS
D36.9 Benign neoplasm of unspecified site
Neoplasms of uncertain or unknown behaviour (D37-D48)
Note: Categories D37-D48 classify by site neoplasms of uncertain or unknown behaviour, i.e., there is doubt whether the neoplasm is malignant or benign. Such neoplasms are assigned behaviour code /1 in the classification of the morphology of neoplasms.
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
D37.0 Lip, oral cavity and pharynx
Aryepiglottic fold:
• NOS
• hypopharyngeal aspect
• marginal zone
Major and minor salivary glands
Vermilion border of lip
Excludes: aryepiglottic fold, laryngeal aspect (D38.0)
epiglottis:
• NOS (D38.0)
• suprahyoid portion (D38.0)
skin of lip (D48.5)
Rectosigmoid junction
D37.6 Liver, gallbladder and bile ducts
Ampulla of Vater
Anal:
• canal
• sphincter
Anus NOS
Intestine NOS
Oesophagus
Pancreas
Excludes: anal:
• margin (D48.5)
• skin (D48.5)
perianal skin (D48.5)
D37.9 Digestive organ, unspecified
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
Excludes: heart (D48.7)
Aryepiglottic fold, laryngeal aspect
Epiglottis (suprahyoid portion)
Excludes: aryepiglottic fold:
• NOS (D37.0)
• hypopharyngeal aspect (D37.0)
• marginal zone (D37.0)
D38.1 Trachea, bronchus and lung
D38.5 Other respiratory organs
Accessory sinuses
Cartilage of nose
Middle ear
Nasal cavities
Excludes: ear (external)(skin) (D48.5)
nose:
• NOS (D48.7)
• skin (D48.5)
D38.6 Respiratory organ, unspecified
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
Chorioadenoma destruens
Hydatidiform mole:
• invasive
• malignant
Excludes: hydatidiform mole NOS (O01.9)
D39.7 Other female genital organs
Skin of female genital organs
D39.9 Female genital organ, unspecified
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
D40.7 Other male genital organs
Skin of male genital organs
D40.9 Male genital organ, unspecified
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
Excludes: renal pelvis (D41.1)
D41.9 Urinary organ, unspecified
D42 Neoplasm of uncertain or unknown behaviour of meninges
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
Excludes: peripheral nerves and autonomic nervous system (D48.2)
Cerebral ventricle
Cerebrum
Frontal
Occipital
Parietal lobe
Temporal
Excludes: fourth ventricle (D43.1)
Brain stem
Cerebellum
Fourth ventricle
D43.7 Other parts of central nervous system
D43.9 Central nervous system, unspecified
Nervous system (central) NOS
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
Excludes: endocrine pancreas (D37.7)
ovary (D39.1)
testis (D40.1)
thymus (D38.4)
D44.7 Aortic body and other paraganglia
D44.8 Pluriglandular involvement
Multiple endocrine adenomatosis
D44.9 Endocrine gland, unspecified
Morphology code M9950 with behaviour code /1
Includes: morphology code M998 with behaviour code /1
D46.0 Refractory anaemia without sideroblasts, so stated
D46.1 Refractory anaemia with sideroblasts
D46.2 Refractory anaemia with excess of blasts
D46.3 Refractory anaemia with excess of blasts with transformation
D46.4 Refractory anaemia, unspecified
D46.7 Other myelodysplastic syndromes
D46.9 Myelodysplastic syndrome, unspecified
Myelodysplasia NOS
Preleukaemia (syndrome) NOS
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
Includes: morphology codes M974, M976, M996-M997 with behaviour code /1
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
Mast cell tumour NOS
Mastocytoma NOS
Excludes: mastocytosis (cutaneous) (Q82.2)
D47.1 Chronic myeloproliferative disease
Myelofibrosis (with myeloid metaplasia)
Myeloproliferative disease, unspecified
Myelosclerosis (megakaryocytic) with myeloid metaplasia
D47.2 Monoclonal gammopathy (of undetermined significance (MGUS))
D47.3 Essential (haemorrhagic) thrombocythaemia
Idiopathic haemorrhagic thrombocythaemia
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid,
haematopoietic and related tissue
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
Lymphoproliferative disease NOS
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
Excludes: neurofibromatosis (nonmalignant) (Q85.0)
D48.0 Bone and articular cartilage
Excludes: cartilage of:
• ear (D48.1)
• larynx (D38.0)
• nose (D38.5)
connective tissue of eyelid (D48.1)
synovia (D48.1)
D48.1 Connective and other soft tissue
Connective tissue of:
• ear
• eyelid
Excludes: cartilage (of):
• articular (D48.0)
• larynx (D38.0)
• nose (D38.5)
connective tissue of breast (D48.6)
D48.2 Peripheral nerves and autonomic nervous system
Excludes: peripheral nerves of orbit (D48.7)
Anal:
• margin
• skin
Perianal skin
Skin of breast
Excludes: anus NOS (D37.7)
skin of genital organs (D39.7, [ii]D40.7)
vermilion border of lip (D37.0)
Connective tissue of breast
Cystosarcoma phyllodes
Excludes: skin of breast (D48.5)
Eye
Heart
Peripheral nerves of orbit
Excludes: connective tissue (D48.1)
skin of eyelid (D48.5)
D48.9 Neoplasm of uncertain or unknown behaviour, unspecified
"Growth" NOS
Neoplasm NOS
New growth NOS
Tumour NOS
CHAPTER III - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Excludes: autoimmune disease (systemic) NOS (M35.9)
certain conditions originating in the perinatal period (P00-P96)
complications of pregnancy, childbirth and the puerperium (O00-O99)
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
endocrine, nutritional and metabolic diseases (E00-E90)
human immunodeficiency virus [HIV] disease (B20-B24)
injury, poisoning and certain other consequences of external causes (S00-T98)
neoplasms (C00-D48)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
This chapter contains the following blocks:
D50-D53 Nutritional anaemias
D55-D59 Haemolytic anaemias
D60-D64 Aplastic and other anaemias
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
D70-D77 Other diseases of blood and blood-forming organs
D80-D89 Certain disorders involving the immune mechanism
Asterisk categories for this chapter are provided as follows:
D63* Anaemia in chronic diseases classified elsewhere
D77* Other disorders of blood and blood-forming organs in diseases classified elsewhere
Nutritional anaemias (D50-D53)
Includes: anaemia:
• asiderotic
• hypochromic
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)
Posthaemorrhagic anaemia (chronic)
Excludes: acute posthaemorrhagic anaemia (D62)
congenital anaemia from fetal blood loss (P61.3)
Kelly-Paterson syndrome
Plummer-Vinson syndrome
D50.8 Other iron deficiency anaemias
D50.9 Iron deficiency anaemia, unspecified
Excludes: vitamin B12 deficiency (E53.8)
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
Anaemia:
• Addison
• Biermer
• pernicious (congenital)
Congenital intrinsic factor deficiency
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
Imerslund(-Grasbeck) syndrome
Megaloblastic hereditary anaemia
D51.2 Transcobalamin II deficiency
D51.3 Other dietary vitamin B12 deficiency anaemia
Vegan anaemia
D51.8 Other vitamin B12 deficiency anaemias
D51.9 Vitamin B12 deficiency anaemia, unspecified
D52.0 Dietary folate deficiency anaemia
Nutritional megaloblastic anaemia
D52.1 Drug-induced folate deficiency anaemia
Use additional external cause code (Chapter XX), if desired, to identify drug.
D52.8 Other folate deficiency anaemias
D52.9 Folate deficiency anaemia, unspecified
Folic acid deficiency anaemia NOS
D53 Other nutritional anaemias
Includes: megaloblastic anaemia unresponsive to vitamin B12 or folate therapy
D53.0 Protein deficiency anaemia
Amino-acid deficiency anaemia
Orotaciduric anaemia
Excludes: Lesch-Nyhan syndrome (E79.1)
D53.1 Other megaloblastic anaemias, not elsewhere classified
Megaloblastic anaemia NOS
Excludes: Di Guglielmo disease (C94.0)
Excludes: scurvy (E54)
D53.8 Other specified nutritional anaemias
Anaemia associated with deficiency of:
• copper
• molybdenum
• zinc
Excludes: nutritional deficiencies without mention of anaemia, such as:
• copper deficiency (E61.0)
• molybdenum deficiency (E61.5)
• zinc deficiency (E60)
D53.9 Nutritional anaemia, unspecified
Simple chronic anaemia
Excludes: anaemia NOS (D64.9)
Haemolytic anaemias (D55-D59)
D55 Anaemia due to enzyme disorders
Excludes: drug-induced enzyme deficiency anaemia (D59.2)
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
Favism
G6PD deficiency anaemia
D55.1 Anaemia due to other disorders of glutathione metabolism
Anaemia (due to):
• enzyme deficiencies, except G6PD, related to the hexose monophosphate [HMP] shunt pathway
• haemolytic nonspherocytic (hereditary), type I
D55.2 Anaemia due to disorders of glycolytic enzymes
Anaemia:
• haemolytic nonspherocytic (hereditary), type II
• hexokinase deficiency
• pyruvate kinase [PK] deficiency
• triose-phosphate isomerase deficiency
D55.3 Anaemia due to disorders of nucleotide metabolism
D55.8 Other anaemias due to enzyme disorders
D55.9 Anaemia due to enzyme disorder, unspecified
Excludes: hydrops fetalis due to haemolytic disease (P56-)
Cooley anaemia
Severe beta thalassaemia
Thalassaemia:
• intermedia
• major
D56.4 Hereditary persistence of fetal haemoglobin [HPFH]
D56.9 Thalassaemia, unspecified
Mediterranean anaemia (with other haemoglobinopathy)
Thalassaemia (minor)(mixed)(with other haemoglobinopathy)
Excludes: other haemoglobinopathies (D58-)
D57.0 Sickle-cell anaemia with crisis
Hb-SS disease with crisis
D57.1 Sickle-cell anaemia without crisis
Sickle-cell:
• anaemia
• disease NOS
• disorder
D57.2 Double heterozygous sickling disorders
Disease:
• Hb-SC
• Hb-SD
• Hb-SE
• sickle-cell thalassaemia
Hb-S trait
Heterozygous haemoglobin S [HbAS]
D57.8 Other sickle-cell disorders
D58 Other hereditary haemolytic anaemias
D58.0 Hereditary spherocytosis
Acholuric (familial) jaundice
Congenital (spherocytic) haemolytic icterus
Minkowski-Chauffard syndrome
D58.1 Hereditary elliptocytosis
Elliptocytosis (congenital)
Ovalocytosis (congenital)(hereditary)
D58.2 Other haemoglobinopathies
Abnormal haemoglobin NOS
Congenital Heinz body anaemia
Disease:
• Hb-C
• Hb-D
• Hb-E
Haemoglobinopathy NOS
Unstable haemoglobin haemolytic disease
Excludes: familial polycythaemia (D75.0)
Hb-M disease (D74.0)
hereditary persistence of fetal haemoglobin [HPFH] (D56.4)
high-altitude polycythaemia (D75.1)
methaemoglobinaemia (D74-)
D58.8 Other specified hereditary haemolytic anaemias
Stomatocytosis
D58.9 Hereditary haemolytic anaemia, unspecified
D59 Acquired haemolytic anaemia
D59.0 Drug-induced autoimmune haemolytic anaemia
Use additional external cause code (Chapter XX), if desired, to identify drug.
D59.1 Other autoimmune haemolytic anaemias
Autoimmune haemolytic disease (cold type)(warm type)
Chronic cold haemagglutinin disease
Cold agglutinin:
• disease
• haemoglobinuria
Haemolytic anaemia:
• cold type (secondary)(symptomatic)
• warm type (secondary)(symptomatic)
Excludes: Evans syndrome (D69.3)
haemolytic disease of fetus and newborn (P55-)
paroxysmal cold haemoglobinuria (D59.6)
D59.2 Drug-induced nonautoimmune haemolytic anaemia
Drug-induced enzyme deficiency anaemia
Use additional external cause code (Chapter XX), if desired, to identify drug.
D59.3 Haemolytic-uraemic syndrome
D59.4 Other nonautoimmune haemolytic anaemias
Haemolytic anaemia:
• mechanical
• microangiopathic
• toxic
Use additional external cause code (Chapter XX), if desired, to identify cause.
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
Excludes: haemoglobinuria NOS (R82.3)
D59.6 Haemoglobinuria due to haemolysis from other external causes
Haemoglobinuria:
• from exertion
• march
• paroxysmal cold
Use additional external cause code (Chapter XX), if desired, to identify cause.
Excludes: haemoglobinuria NOS (R82.3)
D59.8 Other acquired haemolytic anaemias
D59.9 Acquired haemolytic anaemia, unspecified
Idiopathic haemolytic anaemia, chronic
Aplastic and other anaemias (D60-D64)
D60 Acquired pure red cell aplasia [erythroblastopenia]
Includes: red cell aplasia (acquired)(adult)(with thymoma)
D60.0 Chronic acquired pure red cell aplasia
D60.1 Transient acquired pure red cell aplasia
D60.8 Other acquired pure red cell aplasias
D60.9 Acquired pure red cell aplasia, unspecified
Excludes: agranulocytosis (D70)
D61.0 Constitutional aplastic anaemia
Aplasia, (pure) red cell (of):
• congenital
• infants
• primary
Blackfan-Diamond syndrome
Familial hypoplastic anaemia
Fanconi anaemia
Pancytopenia with malformations
D61.1 Drug-induced aplastic anaemia
Use additional external cause code (Chapter XX), if desired, to identify drug.
D61.2 Aplastic anaemia due to other external agents
Use additional external cause code (Chapter XX), if desired, to identify cause.
D61.3 Idiopathic aplastic anaemia
D61.8 Other specified aplastic anaemias
D61.9 Aplastic anaemia, unspecified
Hypoplastic anaemia NOS
Medullary hypoplasia
Panmyelophthisis
D62 Acute posthaemorrhagic anaemia
Excludes: congenital anaemia from fetal blood loss (P61.3)
D63 Anaemia in chronic diseases classified elsewhere
D63.0* Anaemia in neoplastic disease (C00-D48†)
D63.8* Anaemia in other chronic diseases classified elsewhere
Anaemia in chronic kidney disease > stage 3 (N18.3-N18.5†)
Excludes: refractory anaemia:
• NOS (D46.4)
• with excess of blasts (D46.2)
• with transformation (D46.3)
• with sideroblasts (D46.1)
• without sideroblasts (D46.0)
D64.0 Hereditary sideroblastic anaemia
Sex-linked hypochromic sideroblastic anaemia
D64.1 Secondary sideroblastic anaemia due to disease
Use additional code, if desired, to identify disease.
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
Use additional external cause code (Chapter XX), if desired, to identify cause.
D64.3 Other sideroblastic anaemias
Sideroblastic anaemia:
• NOS
• pyridoxine-responsive NEC
D64.4 Congenital dyserythropoietic anaemia
Dyshaematopoietic anaemia (congenital)
Excludes: Blackfan-Diamond syndrome (D61.0)
Di Guglielmo disease (C94.0)
D64.8 Other specified anaemias
Infantile pseudoleukaemia
Leukoerythroblastic anaemia
Coagulation defects, purpura and other haemorrhagic conditions (D65-D69)
D65 Disseminated intravascular coagulation [defibrination syndrome]
Afibrinogenaemia, acquired
Consumption coagulopathy
Diffuse or disseminated intravascular coagulation [DIC]
Fibrinolytic haemorrhage, acquired
Purpura:
• fibrinolytic
• fulminans
Excludes: that (complicating):
• abortion or ectopic or molar pregnancy (O00-O07, O08.1)
• in newborn (P60)
• pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
D66 Hereditary factor VIII deficiency
Deficiency factor VIII (with functional defect)
Haemophilia:
• NOS
• A
• classical
Excludes: factor VIII deficiency with vascular defect (D68.0)
D67 Hereditary factor IX deficiency
Christmas disease
Deficiency:
• factor IX (with functional defect)
• plasma thromboplastin component [PTC]
Haemophilia B
Excludes: those complicating:
• abortion or ectopic or molar pregnancy (O00-O07, O08.1)
• pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
Angiohaemophilia
Factor VIII deficiency with vascular defect
Vascular haemophilia
Excludes: capillary fragility (hereditary) (D69.8)
factor VIII deficiency:
• NOS (D66)
• with functional defect (D66)
D68.1 Hereditary factor XI deficiency
Haemophilia C
Plasma thromoplastin antecedent [PTA] deficiency
D68.2 Hereditary deficiency of other clotting factors
Congenital afibrinogenaemia
Deficiency:
• AC globulin
• proaccelerin
Deficiency of factor:
• I [fibrinogen]
• II [prothrombin]
• V [labile]
• VII [stable]
• X [Stuart-Prower]
• XII [Hageman]
• XIII [fibrin-stabilizing]
Dysfibrinogenaemia (congenital)
Hypoproconvertinaemia
Owren disease
D68.3 Haemorrhagic disorder due to circulating anticoagulants
Haemorrhage during long term use of anticoagulants
Hyperheparinaemia
Increase in:
• antithrombin
• anti-VIIIa
• anti-IXa
• anti-Xa
• anti-XIa
Use additional external cause code (Chapter XX), if desired, to identify any administered anticoagulant.
Excludes: long term use of anticoagulants without haemorrhage ([i]Z92.1)
D68.4 Acquired coagulation factor deficiency
Deficiency of coagulation factor due to:
• liver disease
• vitamin K deficiency
Excludes: vitamin K deficiency of newborn (P53)
Activated protein C resistance [factor V Leiden mutation]
Deficiency:
• antithrombin
• protein C
• protein S
Prothrombin gene mutation
Anticardiolipin syndrome
Antiphospholipid syndrome
Presence of the lupus anticoagulant
Excludes: disseminated intravascular coagulation (D65)
hyperhomocysteinemia (E72.1)
D68.8 Other specified coagulation defects
D68.9 Coagulation defect, unspecified
D69 Purpura and other haemorrhagic conditions
Excludes: benign hypergammaglobulinaemic purpura (D89.0)
cryoglobulinaemic purpura (D89.1)
essential (haemorrhagic) thrombocythaemia (D47.3)
purpura fulminans (D65)
thrombotic thrombocytopenic purpura (M31.1)
Purpura:
• anaphylactoid
• Henoch(-Schonlein)
• nonthrombocytopenic:
• haemorrhagic
• idiopathic
• vascular
Vasculitis, allergic
D69.1 Qualitative platelet defects
Bernard-Soulier [giant platelet] syndrome
Glanzmann disease
Grey platelet syndrome
Thromboasthenia (haemorrhagic)(hereditary)
Thrombocytopathy
Excludes: von Willebrand disease (D68.0)
D69.2 Other nonthrombocytopenic purpura
Purpura:
• NOS
• senile
• simplex
D69.3 Idiopathic thrombocytopenic purpura
Evans syndrome
D69.4 Other primary thrombocytopenia
Excludes: thrombocytopenia with absent radius (Q87.2)
transient neonatal thrombocytopenia (P61.0)
Wiskott-Aldrich syndrome (D82.0)
D69.5 Secondary thrombocytopenia
Use additional external cause code (Chapter XX), if desired, to identify cause.
D69.6 Thrombocytopenia, unspecified
D69.8 Other specified haemorrhagic conditions
Capillary fragility (hereditary)
Vascular pseudohaemophilia
D69.9 Haemorrhagic condition, unspecified
Other diseases of blood and blood-forming organs (D70-D77)
Agranulocytic angina
Infantile genetic agranulocytosis
Kostmann disease
Neutropenia:
• NOS
• congenital
• cyclic
• drug-induced
• periodic
• splenic (primary)
• toxic
Neutropenic splenomegaly
Werner-Schultz disease
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
Excludes: transient neonatal neutropenia (P61.5)
D71 Functional disorders of polymorphonuclear neutrophils
Cell membrane receptor complex [CR3] defect
Chronic (childhood) granulomatous disease
Congenital dysphagocytosis
Progressive septic granulomatosis
D72 Other disorders of white blood cells
Excludes: abnormal white blood cells (count)(R72)
basophilia (D75.8)
immunity disorders (D80-D89)
neutropenia (D70)
preleukaemia (syndrome) (D46.9)
D72.0 Genetic anomalies of leukocytes
Anomaly (granulation)(granulocyte) or syndrome:
• Alder
• May-Hegglin
• Pelger-Huet
Hereditary:
• leukocytic:
• hypersegmentation
• hyposegmentation
• leukomelanopathy
Excludes: Chediak(-Steinbrinck)-Higashi syndrome (E70.3)
Eosinophilia:
• allergic
• hereditary
D72.8 Other specified disorders of white blood cells
Leukaemoid reaction:
• lymphocytic
• monocytic
• myelocytic
Leukocytosis
Lymphocytosis (symptomatic)
Lymphopenia
Monocytosis (symptomatic)
Plasmacytosis
D72.9 Disorder of white blood cells, unspecified
Asplenia, postsurgical
Atrophy of spleen
Excludes: asplenia (congenital) (Q89.0)
Excludes: splenomegaly:
• NOS (R16.1)
• congenital (Q89.0)
D73.2 Chronic congestive splenomegaly
Splenic rupture, nontraumatic
Torsion of spleen
Excludes: traumatic rupture of spleen (S36.0)
D73.8 Other diseases of spleen
Fibrosis of spleen NOS
Perisplenitis
Splenitis NOS
D73.9 Disease of spleen, unspecified
D74.0 Congenital methaemoglobinaemia
Congenital NADH-methaemoglobin reductase deficiency
Haemoglobin-M [Hb-M] disease
Methaemoglobinaemia, hereditary
D74.8 Other methaemoglobinaemias
Acquired methaemoglobinaemia (with sulfhaemoglobinaemia)
Toxic methaemoglobinaemia
Use additional external cause code (Chapter XX), if desired, to identify cause.
D74.9 Methaemoglobinaemia, unspecified
D75 Other diseases of blood and blood-forming organs
Excludes: enlarged lymph nodes (R59-)
hypergammaglobulinaemia NOS (D89.2)
lymphadenitis:
• NOS (I88.9)
• acute (L04-)
• chronic (I88.1)
• mesenteric (acute)(chronic) (I88.0)
Polycythaemia:
• benign
• familial
Excludes: hereditary ovalocytosis (D58.1)
Erythrocytosis NOS
Polycythaemia:
• acquired
• due to:
• erythropoietin
• fall in plasma volume
• high altitude
• stress
• emotional
• hypoxaemic
• nephrogenous
• relative
Excludes: polycythaemia:
• neonatorum (P61.1)
• vera (D45)
D75.2 Essential thrombocytosis
Excludes: essential (haemorrhagic) thrombocythaemia (D47.3)
D75.8 Other specified diseases of blood and blood-forming organs
Basophilia
D75.9 Disease of blood and blood-forming organs, unspecified
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
Excludes: Letterer-Siwe disease (C96.0)
malignant histiocytosis (C96.1)
reticuloendotheliosis or reticulosis:
• histiocytic medullary (C96.1)
• leukaemic (C91.4)
• lipomelanotic (I89.8)
• malignant (C85.7)
• nonlipid (C96.0)
D76.0 Langerhans cell histiocytosis, not elsewhere classified
Eosinophilic granuloma
Hand-Schuller-Christian disease
Histiocytosis X (chronic)
D76.1 Haemophagocytic lymphohistiocytosis
Familial haemophagocytic reticulosis
Histiocytoses of mononuclear phagocytes other than Langerhans cells NOS
D76.2 Haemophagocytic syndrome, infection-associated
Use additional code, if desired, to identify infectious agent or disease.
D76.3 Other histiocytosis syndromes
Reticulohistiocytoma (giant-cell)
Sinus histiocytosis with massive lymphadenopathy
Xanthogranuloma
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
Fibrosis of spleen in schistosomiasis [bilharziasis] (B65†)
Certain disorders involving the immune mechanism (D80-D89)
Includes: defects in the complement system
immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
sarcoidosis
Excludes: autoimmune disease (systemic) NOS (M35.9)
functional disorders of polymorphonuclear neutrophils (D71)
human immunodeficiency virus [HIV] disease (B20-B24)
human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium (O98.7)
D80 Immunodeficiency with predominantly antibody defects
D80.0 Hereditary hypogammaglobulinaemia
Autosomal recessive agammaglobulinaemia (Swiss type)
X-linked agammaglobulinaemia [Bruton] (with growth hormone deficiency)
D80.1 Nonfamilial hypogammaglobulinaemia
Agammaglobulinaemia with immunoglobulin-bearing B-lymphocytes
Common variable agammaglobulinaemia [CVAgamma]
Hypogammaglobulinaemia NOS
D80.2 Selective deficiency of immunoglobulin A [IgA]
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
D80.4 Selective deficiency of immunoglobulin M [IgM]
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
D80.7 Transient hypogammaglobulinaemia of infancy
D80.8 Other immunodeficiencies with predominantly antibody defects
Kappa light chain deficiency
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
D81 Combined immunodeficiencies
Excludes: autosomal recessive agammaglobulinaemia (Swiss type) (D80.0)
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
D81.3 Adenosine deaminase [ADA] deficiency
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
D81.6 Major histocompatibility complex class I deficiency
Bare lymphocyte syndrome
D81.7 Major histocompatibility complex class II deficiency
D81.8 Other combined immunodeficiencies
Biotin-dependent carboxylase deficiency
D81.9 Combined immunodeficiency, unspecified
Severe combined immunodeficiency disorder [SCID] NOS
D82 Immunodeficiency associated with other major defects
Excludes: ataxia telangiectasia [Louis-Bar] (G11.3)
D82.0 Wiskott-Aldrich syndrome
Immunodeficiency with thrombocytopenia and eczema
Pharyngeal pouch syndrome
Thymic:
• alymphoplasia
• aplasia or hypoplasia with immunodeficiency
D82.2 Immunodeficiency with short-limbed stature
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
X-linked lymphoproliferative disease
D82.4 Hyperimmunoglobulin E [IgE] syndrome
D82.8 Immunodeficiency associated with other specified major defects
D82.9 Immunodeficiency associated with major defect, unspecified
D83 Common variable immunodeficiency
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
D83.8 Other common variable immunodeficiencies
D83.9 Common variable immunodeficiency, unspecified
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
D84.1 Defects in the complement system
C1 esterase inhibitor [C1-INH] deficiency
D84.8 Other specified immunodeficiencies
D84.9 Immunodeficiency, unspecified
D86.1 Sarcoidosis of lymph nodes
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.8 Sarcoidosis of other and combined sites
Iridocyclitis in sarcoidosis† (H22.1*)
Multiple cranial nerve palsies in sarcoidosis† (G53.2*)
Sarcoid:
• arthropathy† (M14.8*)
• myocarditis† (I41.8*)
• myositis† (M63.3*)
Uveoparotid fever [Heerfordt]
D86.9 Sarcoidosis, unspecified
D89 Other disorders involving the immune mechanism, not elsewhere classified
Excludes: hyperglobulinaemia NOS (R77.1)
monoclonal gammopathy (D47.2)
transplant failure and rejection (T86-)
D89.0 Polyclonal hypergammaglobulinaemia
Benign hypergammaglobulinaemic purpura
Polyclonal gammopathy NOS
Cryoglobulinaemia:
• essential
• idiopathic
• mixed
• primary
• secondary
Cryoglobulinaemic:
• purpura
• vasculitis
D89.2 Hypergammaglobulinaemia, unspecified
D89.3 Immune reconstitution syndrome
Immune reconstitution inflammatory syndrome [IRIS]
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
D89.9 Disorder involving the immune mechanism, unspecified
Immune disease NOS
CHAPTER IV - Endocrine, nutritional and metabolic diseases (E00-E90)
Note: All neoplasms, whether functionally active or not, are classified in Chapter II. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34-) may be used, if desired, as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes: complications of pregnancy, childbirth and the puerperium (O00-O99)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
transitory endocrine and metabolic disorders specific to fetus and newborn (P70-P74)
This chapter contains the following blocks:
E00-E07 Disorders of thyroid gland
E10-E14 Diabetes mellitus
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
E20-E35 Disorders of other endocrine glands
E40-E46 Malnutrition
E50-E64 Other nutritional deficiencies
E65-E68 Obesity and other hyperalimentation
E70-E90 Metabolic disorders
Asterisk categories for this chapter are provided as follows:
E35* Disorders of endocrine glands in diseases classified elsewhere
E90* Nutritional and metabolic disorders in diseases classified elsewhere
Disorders of thyroid gland (E00-E07)
E00 Congenital iodine-deficiency syndrome
Includes: endemic conditions associated with environmental iodine deficiency either directly or as a consequence of maternal iodine deficiency. Some of the conditions have no current hypothyroidism but are the consequence of inadequate thyroid hormone secretion in the developing fetus. Environmental goitrogens may be associated.
Use additional code (F70-F79), if desired, to identify associated mental retardation.
Excludes: subclinical iodine-deficiency hypothyroidism (E02)
E00.0 Congenital iodine-deficiency syndrome, neurological type
Endemic cretinism, neurological type
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
Endemic cretinism:
• hypothyroid
• myxoedematous type
E00.2 Congenital iodine-deficiency syndrome, mixed type
Endemic cretinism, mixed type
E00.9 Congenital iodine-deficiency syndrome, unspecified
Congenital iodine-deficiency hypothyroidism NOS
Endemic cretinism NOS
E01 Iodine-deficiency-related thyroid disorders and allied conditions
Excludes: congenital iodine-deficiency syndrome (E00-)
subclinical iodine-deficiency hypothyroidism (E02)
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
Iodine-deficiency-related nodular goitre
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
Endemic goitre NOS
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
Acquired iodine-deficiency hypothyroidism NOS
E02 Subclinical iodine-deficiency hypothyroidism
Excludes: iodine-deficiency-related hypothyroidism (E00-E02)
postprocedural hypothyroidism (E89.0)
E03.0 Congenital hypothyroidism with diffuse goitre
Goitre (nontoxic) congenital:
• NOS
• parenchymatous
Excludes: transitory congenital goitre with normal function (P72.0)
E03.1 Congenital hypothyroidism without goitre
Aplasia of thyroid (with myxoedema)
Congenital:
• atrophy of thyroid
• hypothyroidism NOS
E03.2 Hypothyroidism due to medicaments and other exogenous substances
Use additional external cause code (Chapter XX), if desired, to identify cause.
E03.3 Postinfectious hypothyroidism
E03.4 Atrophy of thyroid (acquired)
Excludes: congenital atrophy of thyroid (E03.1)
E03.8 Other specified hypothyroidism
E03.9 Hypothyroidism, unspecified
Myxoedema NOS
E03.90 Advanced hypothyroidism
Grave hypothyroidism
Severe hypothyroidism
Excludes: congenital goitre:
• NOS
• diffuse (E03.0)
• parenchymatous
• iodine-deficiency-related goitre (E00-E02)
Goitre, nontoxic:
• diffuse (colloid)
• simple
E04.1 Nontoxic single thyroid nodule
Colloid nodule (cystic)(thyroid)
Nontoxic uninodular goitre
Thyroid (cystic) nodule NOS
E04.2 Nontoxic multinodular goitre
Cystic goitre NOS
Multinodular (cystic) goitre NOS
E04.8 Other specified nontoxic goitre
E04.9 Nontoxic goitre, unspecified
Goitre NOS
Nodular goitre (nontoxic) NOS
E05 Thyrotoxicosis [hyperthyroidism]
Excludes: chronic thyroiditis with transient thyrotoxicosis (E06.2)
neonatal thyrotoxicosis (P72.1)
E05.0 Thyrotoxicosis with diffuse goitre
Exophthalmic or toxic goitre NOS
Graves disease
Toxic diffuse goitre
E05.1 Thyrotoxicosis with toxic single thyroid nodule
Thyrotoxicosis with toxic uninodular goitre
E05.2 Thyrotoxicosis with toxic multinodular goitre
Toxic nodular goitre NOS
E05.3 Thyrotoxicosis from ectopic thyroid tissue
Overproduction of thyroid-stimulating hormone
Use additional external cause code (Chapter XX), if desired, to identify cause.
E05.9 Thyrotoxicosis, unspecified
Hyperthyroidism NOS
Thyrotoxic heart disease† (I43.8*)
Excludes: postpartum thyroiditis (O90.5)
Abscess of thyroid
Thyroiditis:
• pyogenic
• suppurative
Use additional code (B95-B97), if desired, to identify infectious agent.
Thyroiditis:
• de Quervain
• giant-cell
• granulomatous
• nonsuppurative
Excludes: autoimmune thyroiditis (E06.3)
E06.2 Chronic thyroiditis with transient thyrotoxicosis
Excludes: autoimmune thyroiditis (E06.3)
Hashimoto thyroiditis
Hashitoxicosis (transient)
Lymphadenoid goitre
Lymphocytic thyroiditis
Struma lymphomatosa
E06.4 Drug-induced thyroiditis
Use additional external cause code (Chapter XX), if desired, to identify drug.
E06.5 Other chronic thyroiditis
Thyroiditis:
• chronic:
• NOS
• fibrous
• ligneous
• Riedel
E06.9 Thyroiditis, unspecified
E07 Other disorders of thyroid
E07.0 Hypersecretion of calcitonin
C-cell hyperplasia of thyroid
Hypersecretion of thyrocalcitonin
Familial dyshormogenetic goitre
Pendred syndrome
Excludes: transitory congenital goitre with normal function (P72.0)
E07.8 Other specified disorders of thyroid
Abnormality of thyroid-binding globulin
Haemorrhage
Infarction of thyroid
Sick-euthyroid syndrome
E07.9 Disorder of thyroid, unspecified
Diabetes mellitus (E10-E14)
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
The following fourth-character subdivisions are for use with categories E10-E14:
.0 With coma
Diabetic:
• coma with or without ketoacidosis
• hyperosmolar coma
• hypoglycaemic coma
Hyperglycaemic coma NOS
.1 With ketoacidosis
Diabetic:
• acididosis
• ketoacidoss without mention of coma
.2† With renal complications
Diabetic nephropathy (N08.3*)
Intracapillary glomerulonephrosis (N08.3*)
Kimmelstiel-Wilson syndrome (N08.3*)
.3† With ophthalmic complications
Diabetic:
• cataract (H28.0*)
• retinopathy (H36.0*)
.4† With neurological complications
Diabetic:
• amyotrophy (G73.0*)
• autonomic neuropathy (G99.0*)
• mononeuropathy (G59.0*)
• polyneuropathy (G63.2*)
• autonomic (G99.0*)
.5 With peripheral circulatory complications
Diabetic:
• gangrene
• peripheral angiopathy† (I79.2*)
• ulcer
.6 With other specified complications
Diabetic arthropathy† (M14.2*)
• neuropathic† (M14.6*)
.7 With multiple complications
.8 With unspecified complications
.9 Without complications
[See before E10 for subdivisions]
Includes: diabetes (mellitus):
• brittle
• juvenile-onset
• ketosis-prone
Excludes: diabetes mellitus (in):
• malnutrition-related (E12-)
• neonatal (P70.2)
• pregnancy, childbirth and the puerperium (O24-)
glycosuria:
• NOS (R81)
• renal (E74.8)
impaired glucose tolerance (R73.0)
postsurgical hypoinsulinaemia (E89.1)
[See before E10 for subdivisions]
Includes: diabetes (mellitus)(nonobese)(obese):
• adult-onset
• maturity-onset
• nonketotic
• stable
Excludes: diabetes mellitus (in):
• malnutrition-related (E12-)
• neonatal (P70.2)
• pregnancy, childbirth and the puerperium (O24-)
glycosuria:
• NOS (R81)
• renal (E74.8)
impaired glucose tolerance (R73.0)
postsurgical hypoinsulinaemia (E89.1)
E12 Malnutrition-related diabetes mellitus
[See before E10 for subdivisions]
Includes: malnutrition-related diabetes mellitus:
• type 1
• type 2
Excludes: diabetes mellitus in pregnancy, childbirth and the puerperium (O24-)
glycosuria:
• NOS (R81)
• renal (E74.8)
impaired glucose tolerance (R73.0)
neonatal diabetes mellitus (P70.2)
postsurgical hypoinsulinaemia (E89.1)
E13 Other specified diabetes mellitus
[See before E10 for subdivisions]
Excludes: diabetes mellitus (in):
• malnutrition-related (E12-)
• neonatal (P70.2)
• pregnancy, childbirth and the puerperium (O24-)
• type 1 (E10-)
• type 2 (E11-)
glycosuria:
• NOS (R81)
• renal (E74.8)
impaired glucose tolerance (R73.0)
postsurgical hypoinsulinaemia (E89.1)
E14 Unspecified diabetes mellitus
[See before E10 for subdivisions]
Includes: diabetes NOS
Excludes: diabetes mellitus (in):
• malnutrition-related (E12-)
• neonatal (P70.2)
• pregnancy, childbirth and the puerperium (O24-)
• type 1 (E10-)
• type 2 (E11-)
glycosuria:
• NOS (R81)
• renal (E74.8)
impaired glucose tolerance (R73.0)
postsurgical hypoinsulinaemia (E89.1)
Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)
E15 Nondiabetic hypoglycaemic coma
Drug-induced insulin coma in nondiabetic
Hyperinsulinism with hypoglycaemic coma
Hypoglycaemic coma NOS
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
E16 Other disorders of pancreatic internal secretion
E16.0 Drug-induced hypoglycaemia without coma
Use additional external cause code (Chapter XX), if desired, to identify drug.
Functional nonhyperinsulinaemic hypoglycaemia
Hyperinsulinism:
• NOS
• functional
Hyperplasia of pancreatic islet beta cells NOS
Posthypoglycaemic coma encephalopathy
E16.2 Hypoglycaemia, unspecified
E16.3 Increased secretion of glucagon
Hyperplasia of pancreatic endocrine cells with glucagon excess
E16.4 Abnormal secretion of gastrin
Hypergastrinaemia
Zollinger-Ellison syndrome
E16.8 Other specified disorders of pancreatic internal secretion
Increased secretion from endocrine pancreas of:
• growth hormone-releasing hormone
• pancreatic polypeptide
• somatostatin
• vasoactive-intestinal polypeptide
E16.9 Disorder of pancreatic internal secretion, unspecified
Islet-cell hyperplasia NOS
Pancreatic endocrine cell hyperplasia NOS
Disorders of other endocrine glands (E20-E35)
Excludes: galactorrhoea (N64.3)
gynaecomastia (N62)
Excludes: Di George syndrome (D82.1)
postprocedural hypoparathyroidism (E89.2)
tetany NOS (R29.0 )
transitory neonatal hypoparathyroidism (P71.4)
E20.0 Idiopathic hypoparathyroidism
E20.1 Pseudohypoparathyroidism
E20.8 Other hypoparathyroidism
E20.9 Hypoparathyroidism, unspecified
Parathyroid tetany
E21 Hyperparathyroidism and other disorders of parathyroid gland
Excludes: osteomalacia:
• adult (M83-)
• infantile and juvenile (E55.0)
E21.0 Primary hyperparathyroidism
Hyperplasia of parathyroid
Osteitis fibrosa cystica generalisata [von Recklinghausen disease of bone]
E21.1 Secondary hyperparathyroidism, not elsewhere classified
Excludes: secondary hyperparathyroidism of renal origin (N25.8)
E21.2 Other hyperparathyroidism
Tertiary hyperparathyroidism
Excludes: familial hypocalciuric hypercalcaemia (E83.5)
E21.3 Hyperparathyroidism, unspecified
E21.4 Other specified disorders of parathyroid gland
E21.5 Disorder of parathyroid gland, unspecified
E22 Hyperfunction of pituitary gland
Excludes: Cushing syndrome (E24-)
Nelson syndrome (E24.1)
overproduction of:
• ACTH not associated with Cushing disease (E27.0)
• pituitary ACTH (E24.0)
• thyroid-stimulating hormone (E05.8)
E22.0 Acromegaly and pituitary gigantism
Arthropathy associated with acromegaly† (M14.5*)
Overproduction of growth hormone
Excludes: constitutional:
• gigantism (E34.4)
• tall stature (E34.4)
increased secretion from endocrine pancreas of growth hormone-releasing hormone (E16.8)
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
E22.8 Other hyperfunction of pituitary gland
Central precocious puberty
E22.9 Hyperfunction of pituitary gland, unspecified
E23 Hypofunction and other disorders of pituitary gland
Includes: the listed conditions whether the disorder is in the pituitary or the hypothalamus
Excludes: postprocedural hypopituitarism (E89.3)
Fertile eunuch syndrome
Hypogonadotropic hypogonadism
Idiopathic growth hormone deficiency
Isolated deficiency of:
• gonadotropin
• growth hormone
• pituitary hormone
Kallmann syndrome
Lorain-Levi short stature
Necrosis of pituitary gland (postpartum)
Panhypopituitarism
Pituitary:
• cachexia
• insufficiency NOS
• short stature
Sheehan syndrome
Simmonds disease
E23.1 Drug-induced hypopituitarism
Use additional external cause code (Chapter XX), if desired, to identify drug.
Excludes: nephrogenic diabetes insipidus (N25.1)
E23.3 Hypothalamic dysfunction, not elsewhere classified
Excludes: Prader-Willi syndrome (Q87.1)
Russell-Silver syndrome (Q87.1)
E23.6 Other disorders of pituitary gland
Abscess of pituitary
Adiposogenital dystrophy
E23.7 Disorder of pituitary gland, unspecified
E24.0 Pituitary-dependent Cushing disease
Overproduction of pituitary ACTH
Pituitary-dependent hyperadrenocorticism
E24.2 Drug-induced Cushing syndrome
Use additional external cause code (Chapter XX), if desired, to identify drug.
E24.4 Alcohol-induced pseudo-Cushing syndrome
E24.9 Cushing syndrome, unspecified
Includes: adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
female:
• adrenal pseudohermaphroditism
• heterosexual precocious pseudopuberty
male:
• isosexual precocious pseudopuberty
• macrogenitosomia praecox
• sexual precocity with adrenal hyperplasia
virilization (female)
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
Congenital adrenal hyperplasia
21-Hydroxylase deficiency
Salt-losing congenital adrenal hyperplasia
E25.8 Other adrenogenital disorders
Idiopathic adrenogenital disorder
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
E25.9 Adrenogenital disorder, unspecified
Adrenogenital syndrome NOS
E26.0 Primary hyperaldosteronism
Conn syndrome
Primary aldosteronism due to adrenal hyperplasia (bilateral)
E26.1 Secondary hyperaldosteronism
E26.8 Other hyperaldosteronism
Bartter syndrome
E26.9 Hyperaldosteronism, unspecified
E27 Other disorders of adrenal gland
E27.0 Other adrenocortical overactivity
Overproduction of ACTH, not associated with Cushing disease
Premature adrenarche
Excludes: Cushing syndrome (E24-)
E27.1 Primary adrenocortical insufficiency
Addison disease
Autoimmune adrenalitis
Excludes: amyloidosis (E85-)
tuberculous Addison disease (A18.7)
Waterhouse-Friderichsen syndrome (A39.1)
Adrenal crisis
Adrenocortical crisis
E27.3 Drug-induced adrenocortical insufficiency
Use additional external cause code (Chapter XX), if desired, to identify drug.
E27.4 Other and unspecified adrenocortical insufficiency
Adrenal:
• haemorrhage
• infarction
Adrenocortical insufficiency NOS
Hypoaldosteronism
Excludes: adrenoleukodystrophy [Addison-Schilder] (E71.3)
Waterhouse-Friderichsen syndrome (A39.1)
E27.5 Adrenomedullary hyperfunction
Adrenomedullary hyperplasia
Catecholamine hypersecretion
E27.8 Other specified disorders of adrenal gland
Abnormality of cortisol-binding globulin
E27.9 Disorder of adrenal gland, unspecified
Excludes: isolated gonadotropin deficiency (E23.0)
postprocedural ovarian failure (E89.4)
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
Hypersecretion of ovarian androgens
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
E28.2 Polycystic ovarian syndrome
Sclerocystic ovary syndrome
Stein-Leventhal syndrome
Decreased estrogen
Premature menopause NOS
Resistant ovary syndrome
Excludes: menopausal and female climacteric states (N95.1)
pure gonadal dysgenesis (Q99.1)
Turner syndrome (Q96-)
E28.8 Other ovarian dysfunction
Ovarian hyperfunction NOS
E28.9 Ovarian dysfunction, unspecified
Excludes: androgen resistance syndrome (E34.5)
azoospermia or oligospermia NOS (N46)
isolated gonadotropin deficiency (E23.0)
Klinefelter syndrome (Q98.0-Q98.2, Q98.4)
postprocedural testicular hypofunction (E89.5)
testicular feminization (syndrome) (E34.5)
E29.0 Testicular hyperfunction
Hypersecretion of testicular hormones
Defective biosynthesis of testicular androgen NOS
5-α-Reductase deficiency (with male pseudohermaphroditism)
Testicular hypogonadism NOS
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
E29.8 Other testicular dysfunction
E29.9 Testicular dysfunction, unspecified
E30 Disorders of puberty, not elsewhere classified
Constitutional delay of puberty
Delayed sexual development
Precocious menstruation
Excludes: Albright(-McCune)(-Sternberg) syndrome (Q78.1)
central precocious puberty (E22.8)
congenital adrenal hyperplasia (E25.0)
female heterosexual precocious pseudopuberty (E25-)
male isosexual precocious pseudopuberty (E25-)
E30.8 Other disorders of puberty
Premature thelarche
E30.9 Disorder of puberty, unspecified
Excludes: ataxia telangiectasia [Louis-Bar] (G11.3)
dystrophia myotonica [Steinert] (G71.1)
pseudohypoparathyroidism (E20.1)
E31.0 Autoimmune polyglandular failure
Schmidt syndrome
E31.1 Polyglandular hyperfunction
Excludes: multiple endocrine adenomatosis (D44.8)
E31.8 Other polyglandular dysfunction
E31.9 Polyglandular dysfunction, unspecified
Excludes: aplasia or hypoplasia with immunodeficiency (D82.1)
myasthenia gravis (G70.0)
E32.0 Persistent hyperplasia of thymus
Hypertrophy of thymus
E32.8 Other diseases of thymus
E32.9 Disease of thymus, unspecified
Excludes: pseudohypoparathyroidism (E20.1)
Note: May be used as an additional code, if desired, to identify functional activity associated with a carcinoid tumour.
E34.1 Other hypersecretion of intestinal hormones
E34.2 Ectopic hormone secretion, not elsewhere classified
E34.3 Short stature, not elsewhere classified
Short stature:
• NOS
• constitutional
• Laron-type
• psychosocial
Excludes: progeria (E34.8)
Russell-Silver syndrome (Q87.1)
short-limbed stature with immunodeficiency (D82.2)
short stature:
• achondroplastic (Q77.4)
• hypochondroplastic (Q77.4)
• in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
• nutritional (E45)
• pituitary (E23.0)
• renal (N25.0)
E34.4 Constitutional tall stature
Constitutional gigantism
E34.5 Androgen resistance syndrome
Male pseudohermaphroditism with androgen resistance
Peripheral hormonal receptor disorder
Reifenstein syndrome
Testicular feminization (syndrome)
E34.8 Other specified endocrine disorders
Pineal gland dysfunction
Progeria
E34.9 Endocrine disorder, unspecified
Disturbance:
• endocrine NOS
• hormone NOS
E35 Disorders of endocrine glands in diseases classified elsewhere
E35.0* Disorders of thyroid gland in diseases classified elsewhere
Tuberculosis of thyroid gland (A18.8†)
E35.1* Disorders of adrenal glands in diseases classified elsewhere
Tuberculous Addison disease (A18.7†)
Waterhouse-Friderichsen syndrome (meningococcal) (A39.1†)
E35.8* Disorders of other endocrine glands in diseases classified elsewhere
Malnutrition (E40-E46)
Note: The degree of malnutrition is usually measured in terms of weight, expressed in standard deviations from the mean of the relevant reference population. When one or more previous measurements are available, lack of weight gain in children, or evidence of weight loss in children or adults, is usually indicative of malnutrition. When only one measurement is available, the diagnosis is based on probabilities and is not definitive without other clinical or laboratory tests. In the exceptional circumstances that no measurement of weight is available, reliance should be placed on clinical evidence.
If an observed weight is below the mean value of the reference population, there is a high probability of severe malnutrition if there is an observed value situated 3 or more standard deviations below the mean value of the reference population; a high probability of moderate malnutrition for an observed value located between 2 and less than 3 standard deviations below this mean; and a high probability of mild malnutrition for an observed value located between 1 and less than 2 standard deviations below this mean.
Excludes: intestinal malabsorption (K90-)
nutritional anaemias (D50-D53)
sequelae of protein-energy malnutrition (E64.0)
slim disease (B22.2)
starvation (T73.0)
Severe malnutrition with nutritional oedema with dyspigmentation of skin and hair.
Excludes: marasmic kwashiorkor (E42)
Severe malnutrition with marasmus
Excludes: marasmic kwashiorkor (E42)
Severe protein-energy malnutrition [as in E43]:
• intermediate form
• with signs of both kwashiorkor and marasmus
E43 Unspecified severe protein-energy malnutrition
Severe loss of weight [wasting] in children or adults, or lack of weight gain in children leading to an observed weight that is at least 3 standard deviations below the mean value for the reference population (or a similar loss expressed through other statistical approaches). When only one measurement is available, there is a high probability of severe wasting when the observed weight is 3 or more standard deviations below the mean of the reference population.
Starvation oedema
E44 Protein-energy malnutrition of moderate and mild degree
E44.0 Moderate protein-energy malnutrition
Weight loss in children or adults, or lack of weight gain in children leading to an observed weight that is 2 or more but less than 3 standard deviations below the mean value for the reference population (or a similar loss expressed through other statistical approaches). When only one measurement is available, there is a high probability of moderate protein-energy malnutrition when the observed weight is 2 or more but less than 3 standard deviations below the mean of the reference population.
E44.1 Mild protein-energy malnutrition
Weight loss in children or adults, or lack of weight gain in children leading to an observed weight that is 1 or more but less than 2 standard deviations below the mean value for the reference population (or a similar loss expressed through other statistical approaches). When only one measurement is available, there is a high probability of mild protein-energy malnutrition when the observed weight is 1 or more but less than 2 standard deviations below the mean of the reference population.
E45 Retarded development following protein-energy malnutrition
Nutritional:
• short stature
• stunting
Physical retardation due to malnutrition
E46 Unspecified protein-energy malnutrition
Malnutrition NOS
Protein-energy imbalance NOS
Other nutritional deficiencies (E50-E64)
Excludes: nutritional anaemias (D50-D53)
Excludes: sequelae of vitamin A deficiency (E64.1)
E50.0 Vitamin A deficiency with conjunctival xerosis
E50.1 Vitamin A deficiency with Bitot spot and conjunctival xerosis
Bitot spot in the young child
E50.2 Vitamin A deficiency with corneal xerosis
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
E50.4 Vitamin A deficiency with keratomalacia
E50.5 Vitamin A deficiency with night blindness
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
E50.7 Other ocular manifestations of vitamin A deficiency
Xerophthalmia NOS
E50.8 Other manifestations of vitamin A deficiency
Follicular keratosis Follicular keratosis
Xeroderma Xeroderma
E50.9 Vitamin A deficiency, unspecified
Hypovitaminosis A NOS
Excludes: sequelae of thiamine deficiency (E64.8)
Beriberi:
• dry
• wet† (I98.8*)
E51.8 Other manifestations of thiamine deficiency
E51.9 Thiamine deficiency, unspecified
E52 Niacin deficiency [pellagra]
Deficiency:
• niacin(-tryptophan)